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CHAPTER 1 
General introduction 
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During the past half century, a combination of public health measures, vaccination 
programmes and antimicrobial drugs has brought about an impressive decline in the 
incidence of traditional infectious diseases in the western world. Despite this development, 
doctors are still confronted with severe infections in a growing number of patients. Many 
of these infections are acquired in the hospital and many are indirectly the result of medical 
treatment. The development and widespread use of broadspectrum antimicrobial drugs 
has caused the emergence of multiply resistant strains of bacteria that are more difficult 
to fight. Moreover, many patients' host defenses are compromised by old age, immunosup-
presive therapy, cancer, or cancer chemotherapy. Advances in surgical techniques, such 
as insertion of prosthetic devices and organ transplantation have created new problems 
of infection. Confronted with increased morbidity and mortality from severe nosocomial 
infections, especially in intensive care units, and the relative failure of traditional measures 
such as antimicrobial drugs to control these infections, researchers have in recent years 
focussed on amelioration of host defense as a means to improve outcome of infections. 
HOST DEFENSE 
Once infecting microorganisms are acquired, the outcome is determined by the interplay 
between microbial virulence factors and the defense mechanism of the host. The host's 
immune response involves recognition of the offending pathogen and mounting a reaction 
against it to eliminate it. Broadly speaking, the immune response falls into two categories: 
innate (or non-specific) immune responses, and specific immune responses. The important 
difference between the two is that a specific immune response is highly specific for a 
particular pathogen and improves with each succesive encounter with the same pathogen, 
while the innate response does not alter on repeated exposure to a given infectious agent. 
Immune responses are mediated primarily by leucocytes, of which phagocytic cells and 
lymphocytes are most important in host defense. Phagocytic cells, such as monocytes, 
macrophages, and granulocytes bind to microorganisms, internalize them and kill them. 
Since their non-specific recognition systems allow them to bind to a variety of microbial 
products, they are mediating innate immune responses. Lymphocytes are central to all 
specific immune responses, since they specifically recognize individual pathogens, whether 
they are inside host cells or outside in the tissue fluids or blood. Lymphocytes fall into two 
categories: Τ lymphocytes (or Τ cells) and В lymphocytes (or В cells). В cells combat 
extracellular pathogens and their products by releasing specific antibodies that allow the 
pathogen to be ingested and destroyed by phagocytes, while Τ cells have a wider range of 
activities, including control of В cell development and antibody production, interaction 
with phagocytes to help them destroy pathogens, and recognition and destruction of virus-
infected cells and foreign cells. 
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CYTOKINES 
Most immune responses to infectious organisms are made up of a combination of innate 
and specific components, and in practice there is considerable interaction between the 
lymphocytes and phagocytes. This interaction calls for a well-developed intercellular 
communication network. In the course of the immune response a variety of soluble factors 
called cytokines are produced by lymphocytes and phagocytes, and the interplay between 
these signaling molecules and the leucocytes is often referred to as the "cytokine network". 
Upon stimulation with live microorganism or bacterial products such as endotoxin, 
mononuclear phagocytes produce potent pro-inflammatory cytokines such as interleukin-1 
(IL-1) and tumor necrosis factor (TNF). The physiologic role of these cytokines is discussed 
in Chapter 2. Pro-inflammatory cytokines that are produced by the host in response to 
invading bacteria and their products induce a cascade of events that may be beneficial to 
the host. However, in severe infections unchecked release of pro-inflammatory cytokines 
results in organ dysfunction and finally multiple organ failure and death. 
ANTI-CYTOKINE STRATEGIES 
The latter observations have led researchers to explore the possible benefits of anti-endotoxin 
and anti-cytokine strategies in sepsis. This approach was facilitated by the development 
of specific anti-cytokine antibodies and even more by the discovery of endogenously 
produced inhibitors of the pro-inflammatory cytokines: interleukin-1 receptor antagonist 
(IL-lra) and soluble TNF receptors (sTNFR's). IL-lra and sTNFR's appear in the circulation 
early in the course of an inflammatory response, and exogenous administration of these 
molecules could specifically inhibit the actions of IL-1 and TNF. However, despite promising 
results in animal studies, the effect of anti-endotoxin or anti-cytokine strategies has been 
disappointing in clinical studies in septic patients. 
Another approach to improve non-specific host defense is prophylactic treatment to 
prevent overproduction of pro-inflammatory cytokines in patient groups at risk of 
developing sepsis. Theoretically, one wants to prevent an overshoot in cytokine production 
without interfering with a physiological immune response. The demonstration by Endres 
et al. that a fish-oil supplemented diet could inhibit ex vivo production of IL-1 and TNF 
by human mononuclear cells made this latter approach feasible [1]. This hallmark study 
was the immediate inspiration of the studies that are presented in this thesis. Our general 
question was whether dietary or pharmacological interventions can modulate the host's 
cytokine production and what consequences this modification has for the defense against 
invading pathogens. 
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OUTLINE OF THE STUDIES 
In Chapter 2, an overview of studies regarding the effects of dietary n-3 fatty acids on 
inflammation and cytokine production is given, because in 5 of the 7 intervention studies 
in this thesis dietary fish-oil supplementation is used as a means to modulate cytokine 
production. 
As a follow-up of the study of Endres et al, we investigated the long-term effects of dietary 
fish-oil supplementation on the circulating concentrations and the ex-vivo production of 
pro and anti-inflammatory cytokines in human volunteers, asking the question whether 
the uncontrolled results of Endres et al. were reproducible in a placebo-controlled long-term 
study (Chapter 3). 
Based on the impressive inhibition of cytokine production by peripheral blood 
mononuclear cells of humans following dietary fish-oil supplementation, we hypothesized 
that fish-oil supplementation would influence outcome in experimental gram-negative 
infection in mice. Because the deleterious role of the pro-inflammatory cytokines was well 
established in the experimental model of cerebral malaria in mice, the effects of fish-oil 
supplementation were investigated here as well. In addition, the effect offish-oil supplemen-
tation on cytokine production capacity was investigated in mice. These studies are presented 
in Chapter 4. 
Cutaneous leis/imama-infection in mice is another experimental model in which both 
pro- and anti-inflammatory cytokines have a crucial role. Leishmania spp infect mammalian 
macrophages, and the outcome of an infection depends on whether macrophages become 
activated to destroy the intracellular parasite. In our earlier work in mice, we observed that 
fish-oil supplementation facilitated the activation of macrophages, as reflected by their 
increased cytokine production capacity after ex vivo endotoxin stimulation. We therefore 
questioned whether dietary fish-oil supplementation could facilitate the activation of 
macrophages that become infected with Leishmania and thus ameliorate the outcome of 
this infection (Chapter 5). 
Previous work had demonstrated that pretreatment with cytokines effectively reduced 
the development of liver schizonts of the rodent malaria parasite Plasmodium bergheï in 
rats. The question whether dietary fish-oil supplementation would affect cytokine 
production and liver schizont development in rats was investigated in Chapter 6. 
In the course of our experiments in mice, we noticed a substantial increase in spleen 
size in the fish-oil fed animals. In Chapter 7 we tried to answer the question how the increase 
in spleen size was produced. 
Vitamin A supplementation has been reported to improve host defense. Since vitamin 
Aupregulates the production of IL-1 and facilitates the release of TNF in human monocytes, 
we asked the question whether vitamin A deficiency would impair host defense against 
experimental gram-negative infection and whether it would interfere with the production 
of pro-inflammatory cytokines (Chapter 8). 
Many studies have reported on the effects of anti-cytokine antibodies and anti-
inflammatory cytokines in endotoxic shock in experimental animals. Based on these studies, 
GENERAL INTRODUCTION 13 
clinical studies with antibodies against endotoxin or TNF, or with IL-1 receptor antagonist 
have been done in septic patients. Most of these studies yielded disappointing results. We 
questioned whether pharmacological inhibition of TNF production is effective in 
experimental infections with live microorganisms in mice, and how these effects relate to 
endotoxic shock. In the same models, cytokine production was studied {Chapter 9). 
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ABSTRACT 
The production of pro-inflammatory cytokines, such as interleukin-1 and tumor necrosis factor, 
is pivotal in the response to infection. However, overproduction of these cytokines might be 
detrimental. It has been suggested that (n-3) fatty acids suppress inflammation and ameliorate the 
course of infection by decreasing the production of pro-inflammatory cytokines. We here, review 
these effects. Use of (n-3) fatty acids induced moderate clinical improvements in rheumatoid arthritis, 
psoriasis and colitis, but not in systemic lupus erythematosus. Data on critically ill burn or post-
operative cancer patients are still inconclusive. The (n-3) fatty acids markedly inhibited sterile 
inflammation in animal studies and improved survival in some experimental infections. T-cell 
responses decreased in healthy volunteers, but remained unchanged or increased in certain patient 
groups. The production of pro-inflammatory cytokines decreased in most human studies. The (n-3) 
fatty acids increased cytokine production capacity in mice. Differences in cytokine producing cell 
types studied may account for these paradoxical responses in humans and in mice. Although the 
increased cytokine production in mice is partly mediated by effects on prostaglandins, mechanisms 
of action in other species remain to be elucidated. The (n-3) fatty acids may be of moderate benefit 
in some chronic inflammatory diseases. Their therapeutic value and possible hazards in critically 
ill patients remain to be established. 
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The (n-3) polyunsaturated fatty acids have been been investigated for use in the treatment 
of inflammatory diseases such as rheumatoid arthritis, psoriasis and ulcerative colitis. 
Presently, enteral tube feeding preparations containing relatively large amounts of (n-3) 
fatty acids are advanced for use in critically ill patients because of the presumed anti-
inflammatory effects of these fatty acids [1-4]. Although the anti-inflammatory effects of 
(n-3) fatty acids have originally been attributed to changes in the production of prostaglan-
dins and leukotrienes [5-7], recent studies have emphasized reduced production of cytokines 
as a possible mechanism [8,9]. Here, we review studies in humans and in animals on the 
effects of (n-3) fatty acids on inflammation, resistance to infection, and cytokine production. 
CYTOKINES AND INFLAMMATION 
Cytokines are small proteins that are produced by a variety of cell types. They act on nearly 
every tissue and organ system. The cytokines interleukin-la (IL-la)1, interleukin-lß (IL-lß), 
tumor necrosis factor α (TNF) and interleukin-6 (IL-6) are often designated pro­
inflammatory cytokines. They are mainly produced by the mononuclear phagocytic cells, 
including both circulating monocytes and tissue macrophages. These cytokines mediate 
the response of the host to inflammatory stimuli. They induce fever, activation of В and 
Τ lymphocytes and endothelial cells, synthesis of acute phase proteins by the liver, and many 
other effects that are all part of the acute phase response (Table 1) [10]. The term "acute 
phase response" refers to a set of local and systemic neurologic, endocrine, and metabolic 
changes through which the organism reacts to various stimuli, including infections, forms 
of sterile inflammation such as auto-immune disease, bleeding, injury (e.g. burn trauma 
and major surgery), or heavy exercise. The early events in the acute phase response are local 
and serve to check bleeding, to demarcate damaged tissues, and to recruit cells for the 
subsequent reparative phase, which requires a systemic response. This second, systemic 
phase involves fever, anorexia, leukocytosis, and metabolic changes that include an increased 
flow of amino acids from muscle to liver and a rearrangement of the pattern of protein 
synthesis in the liver: albumin production decreases and acute phase proteins such as 
fibrinogen, C-reactive protein, and serum amyloid A are synthesized. Their appearance 
in the plasma contributes to a well-known phenomenon in inflammation: the elevated 
erythrocyte sedimentation rate. 
Most of these changes are mediated by IL-1, TNF and IL-6. They can trigger cells to 
secrete other inflammatory mediators, including other cytokines such as the T-lymphocyte 
products interferon gamma and interleukin-2 (IL-2), and lipid mediators such as 
prostaglandins, leukotrienes and platelet activating factor. Elevated plasma concentrations 
of IL-6, TNF or IL-1 have been observed in patients with infections, endotoxemia, trauma, 
1. Abbreviations used: ELISA, enzyme linked immunosorbent assay; IL-1, interleukin-1; IL-2, interleukin-2; 
IL-6, interleukin-6; LTB,, leukotriene B4; PGE¡, prostaglandin E,; RIA, radio immuno assay; TNF, tumor 
necrosis factor; 
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Table 1. Biobgical effects of the pro-inflammatory cytokines interkukm-1 (IL-l), tumor necrosL· 
factor (TNF) and interleuktn-6 (IL-6)' 
Biological effect 
Induction of fever in experimental animals and in man 
Production of acute phase proteins by the liver 
Activation of T-lymphocytes 
Activation of B-lymphocytcs 
Activation of hematopoiesis 
Gene expression of cyclooxygenase and phosphohpase A22 
Activation of endothelial cells 
Activation of synovial cells (e g collagenase production) 
Osteoclast activation (bone resorption) 
Induction of hypotension 
Induction of II -1, TNF, IL-6, and IL 8 
1 - indicates that the effect is absent, H indicates a moderate effect, ++ indicates a strong effect 
2 The induction of these enzymes is pivotal in the formation of the so called lipid mediators prostaglandins, leukotnenes 
and platelet activating factor 
or bums, but also in acute bouts of auto-immune disease such as rheumatoid arthritis or 
systemic lupus erythematosus, and in patients undergoing organ transplant rejection [11]. 
Increased IL-1 production by peripheral blood mononuclear cells and by colonic mono-
nuclear cells has been reported in patients with active inflammatory bowel disease [12,13]. 
Although production of pro-inflammatory cytokines is believed to benefit the host defense 
system, high concentrations of circulating pro-inflammatory cytokines have been shown 
to correlate with poor outcome in severe disease states such as meningococcal septic shock 
[14,15], other forms of septic shock [16,17], and cerebral malaria [18]. Elevated concentra-
tions of circulating or in vitro stimulated TNF and IL-l were also reported in AIDS patients 
by several groups [19-22], although not by others [23,24]. Anti-cytokine strategies such 
as treatment with antibodies against TNF and treatment with the interleukin-1 receptor 
antagonist were shown to reduce the severity of inflammation and to protect against 
mortality in animal models of septic shock, cerebral malaria and colitis [18,25-28]. From 
these observations, the concept of "lethal cytokinemia" has emerged, which implies that 
exaggerated cytokine production may be harmful or even lethal [29]. It is also felt that the 
chronically elevated concentrations of cytokines in rheumatoid arthritis contribute to the 
perpetuating inflammation and are harmful to the patient [30,31 ]. These observations have 
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caused researchers to investigate the possible benefits of reducing cytokine production 
capacity through dietary intervention; of such interventions, the use of very long chain 
essential fatty acids of the (n-3) family has received considerable attention. 
(N-3) FATTY ACIDS AND INFLAMMATION IN HUMANS 
Table 2 summarizes studies on the effects of dietary (n-3) fatty acids in inflammatory disease 
states in humans. Several investigators have developed tube feeding formulas with, among 
other modifications, (n-3) fatty acids as the major lipid source. These modified formulas 
have been investigated in burn patients [4] and in patients operated on for upper 
gastointestinal malignancies [3]. Both studies claimed reduction in infectious complications 
and in the length of hospital stay. However, both studies were not double blind, and disease 
severity or age were not evenly distributed between the study groups. In two recent, better 
controlled studies, intensive care patients receiving a modified formula high in (n-3) fatty 
acids experienced fewer infectious complications, less multiple organ failure, and a shorter 
hospital stay [32,33]. 
In placebo-controlled studies, patients with rheumatoid arthritis experienced small 
improvements of symptoms after ingestion of a fish oil concentrate for periods ranging 
from 8 to 24 weeks. However, hard endpoints such as erythrocyte sedimentation rate, 
concentration of circulating acute phase proteins, and rheumatoid factor titer were not 
influenced by dietary fish-oil supplementation. Similarly, minimal to moderate clinical 
improvements were reported in patients with psoriasis, bronchial asthma and ulcerative 
colitis after dietary supplementation with fish oil. 
Even less convincing are the results on fish oil feeding in patients with systemic lupus 
erythematosus (SLE) [52]. In one double-blind, crossover study using olive oil as the control, 
patients with moderately active systemic lupus erythematosus showed significant clinical 
and serological benefits after 3 mo on fish oil, but after 6 mo there was no difference between 
the treatment groups [ 54 ]. Dietary fish-oil supplementation had no effect on renal outcome 
in patients with systemic-lupus-erythmatosus-associated nephritis [53]. 
Taken together, these studies suggest some attenuation of inflammation and thus of the 
acute phase response by (n-3) fatty acids in humans. However, the rise in concentration 
of circulating acute phase proteins induced by heavy exercise was increased in healthy 
volunteers after 3 wk of dietary supplementation with (n-3) fatty acids [57], suggesting 
increased rather than decreased formation of pro-inflammatory mediators after fish oil. 
Thus, (n-3) fatty acids appear to have some beneficial effects in rheumatoid arthritis, 
psoriasis and ulcerative colitis, but only after prolonged ingestion, and laboratory indices 
of inflammation were not affected. The effects in bronchial asthma and SLE were minimal 
to absent. Data on short-term treatment with (n-3) fatty acids in burn patients and in 
postoperative cancer patients are still inconclusive, although the results of 
two recent studies in intensive care unit patients are promising. 
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(N-3) FATTY ACIDS AND INFLAMMATION IN ANIMALS 
Studies on the effects of dietary (n-3) fatty acids in experimental inflammations in animals 
are summarized in Table 3. Several studies have shown favorable effects of dietary fish-oil 
supplementation in mouse models of systemic lupus erythematosus (SLE). These genetically 
susceptible mice spontaneously develop an SLE-like syndrome including glomerulonephritis, 
and the animals die before reaching 1 year of age. Administration offish oil convincingly 
retarded both the development of glomerulonephritis and premature death [58,59]. In a 
model of autoimmune arthritis in mice, dietary fish-oil supplementation reduced the severity 
of joint inflammation [60]. However, in similarly afflicted rats this effect was absent [61]. 
In mice immunized with collagen, plasma concentrations of amyloid Ρ component, an acute 
phase protein, were significantly reduced following a fish-oil diet [62]. Inflammatory 
responses have been implicated in the etiology of noninsulin-dependent diabetes mellitus. 
In ВНЕ rats, an animal model of noninsulin-dependent diabetes mellitus, longevity was 
shortened after a life-long fish oil diet [63]. However, the development of glucose intolerance 
and lipemia was delayed in these animals. Rats with immune complex-induced enteropathy 
developed significantly fewer severe inflammatory lesions after a fish oil diet than after a 
beef tallow diet [64]. Thus, most animal studies demonstrated a modulating effect of (n-3) 
fatty acids on inflammation. 
Exogenous administration of IL-1 or TNF to experimental animals induces an acute phase 
response, including anorexia and fever [73-75]. Apart from interference with cytokine 
production, dietary fish oil supplementation has been associated with attenuation of some 
of the responses to exogenously administered cytokines. In guinea pigs, the febrile response 
to an injection of recombinant murine IL-1 was attenuated after 6 wk of a fish-oil enriched 
diet compared with control diet [69]. In rats, feeding fish oil for 6 wk attenuated the 
catabolic response to a combined infusion of IL-1 and TNF, as reflected by reduced whole-
body leucine oxidation and increased net hepatic protein anabolism [71]. Similarly, the 
anorexia induced by IL-1 administration was markedly decreased in rats fed fish oil for 
6 wk [72], and thermogenic and pyrogenic responses to IL-1 were inhibited in rats after 
4 to 9 wk of (n-3) fatty acid supplementation [70]. These fish oil effects may be mediated 
by a reduced formation of prostaglandins, since both IL-1 induced fever and anorexia are 
attenuated by treatment with cyclooxygenase inhibitors [72,76] 
Thus, in several animal models of auto-immune disease and in experimentally induced 
acute phase response, severity of inflammation appears to be favorably influenced by fish 
oils. In these animal studies, the effects of (n-3) fatty acids appear much stronger than in 
the clinical studies mentioned above. This difference could relate to the fact that most of 
these studies involve feeding experimental diets to the animals before the appearance of 
any disease symptoms, while studies in humans have exclusively examined the activity of 
(n-3) fatty acids against a background of an existing clinical disease. Moreover, the relative 
amount of (n-3) fatty acids ingested in the animal studies is substantially higher than in 
the human studies. 
CHAPTER 2 
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(N-3) FATTY ACIDS AND IMMUNE RESPONSE 
Does such a suppression of sterile inflammation coincide with a general downregulation 
of the immune response, thereby decreasing host resistance to infection? This question has 
been addressed in various ways. In several studies, human peripheral blood mononuclear 
cells from healthy volunteers were cultured in vitro. In these studies, Τ cell proliferation 
was inhibited by the additon of (n-3) fatty acids to the culture medium [77,78]. In vivo 
studies on peripheral blood mononuclear cells after dietary supplementation with (n-3) 
fatty acids are summarized in Table 4. Most studies in healthy volunteers show a decreased 
proliferative response of Τ lymphocytes to specific stimulants such as phytohemagglutinin 
or concanavalin A. The production capacity of Τ cell-derived cytokines and the T4/T8 ratio 
were found to be unchanged or depressed. On the other hand, studies in certain patient 
groups such as asthma patients and intensive care unit patients found a positive effect of 
dietary (n-3) fatty acids on Τ cell responses. One recent study even reported increased 
production of interferon-gamma following consumption of (n-3) fatty acids [79]. At present 
it is unclear why Τ cell responses to dietary (n-3) fatty acids differ between healthy subjects 
and certain patient groups. Depressed T-cell responses at baseline may play a role here. 
Well-controlled studies comparing different patient groups with healthy volunteers at 
baseline and after consumption of dietary (n-3) fatty acids are certainly needed to clarify 
this issue. 
Because decreased Τ cell functions may affect resistance to cancer, the possible impact 
of dietary (n-3) fatty acids on carcinogenesis has been of concern. Epidemiological studies 
show that total fat intake is related to breast and colon cancer mortality [80,81]. Animal 
studies suggest that (n-6) fatty acids may have a tumor promoting effect and that (n-3) 
fatty acids may exert an inhibitory effect on chemically-induced mammary and colon 
tumorigenesis [82]. In a recent human study, low tissue levels of alpha-linolenic acid (18:3, 
n-3) were found to be associated with early metastasis in breast cancer, suggesting a 
protective effect of (n-3) fatty acids [83]. At present it is not clear whether the effects of 
dietary (n-3) fatty acids on carcinogenesis are related to their influence on T-cell function. 
The incidence of certain infectious diseases such as tuberculosis and diarrheal diseases 
has reportedly been increased in Eskimo populations. Since many socioeconomic and genetic 
factors contribute to the incidence of infectious diseases, it is difficult to establish the 
contribution of dietary (n-3) fatty acids to this phenomenon [84]. 
In animal studies, the effects of dietary (n-3) fatty acids on infections have been 
investigated with live pathogenic microorganisms or bacterial endotoxins, since gram-
negative bacteria such as Escherichia colt and meningococci are pathogenic largely because 
of the endotoxins that they release. In controlled studies, guinea pigs were protected against 
metabolic acidosis and death from endotoxin administration when they had been fed a 
fish oil supplemented diet for 6 wk [85,86], and the physiological response to endotoxin 
infusion was favorably influenced when guinea pigs had been on total parenteral nutrition 
containing (n-3) fatty acids for only 3.5 d prior to administration of endotoxin [93] (Table 
5). Two studies reported a negative effect of (n-3) fatty acids on outcome of experimental 
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infection with live microorganisms. Chang et al. observed a decreased survival rate offish-oil 
fed Swiss mice infected perorally with Salmonella typhimurium [94], and D'Ambola et al. 
reported diminished lung clearance of inspired Staphylococcus aureus in neonatal rabbits 
supplemented with high dose fish oil or safflower oil [95]. However, most studies indicate 
that the anti-inflammatory effect of dietary fish oil supplementation in animals in general 
does not lead to an increased susceptibility to infection, and in several models of infection, 
outcome was even improved (Table 5). This suggests that in certain cases (n-3) fatty acids 
wiH prevent the excessive production of cytokines that, if unchecked, leads to death in septic 
animals. 
(N-3) FATTY ACIDS AND CYTOKINE PRODUCTION 
Methodological problems 
Cytokine assays and their validity. Cytokines can exert their effects at extremely low 
concentrations (ng/L), and under normal physiological conditions (e.g., in the absence of 
disease or trauma) circulating cytokines are often below the detection limits for most assay 
systems. Therefore, in many clinical studies with healthy human subjects cytokine-producing 
cells are isolated, cultured, and then stimulated in vitro in order to obtain detectable cytokine 
concentrations. Such studies tell us more about the cytokine production capacity of a given 
cell-type in vitro than about changes in actual cytokine production occurring in vivo. 
In most human studies, peripheral blood mononuclear cells are isolated using a density 
gradient. Subsequently, these cells are cultured for a short period (e.g. overnight) and 
stimulated to produce cytokines. In many animal studies, resident macrophages are isolated 
from the peritoneal cavity or from organs such as the liver (Kupffer cells). Although culture 
principles for human and animal cells are basically the same, it cannot be excluded that 
the differences in origin of these cells have some bearing on their cytokine production 
capacity in vitro. 
Cytokines can be quantitated by bioassay or by immunochemical methods. In bioassays, 
cell lines are used that are dependent on specific cytokines for growth. Such bioassays can 
detect cytokines at low concentrations, but their specificity is poor. More recently, the 
availability of specific monoclonal and polyclonal antibodies against various cytokines has 
enabled the development of immunological detection methods such as enzyme linked 
immunosorbent assay (ELISA) and radiolabelled immunoassay (RIA). 
In body fluids, cytokines may be bound to specific proteins such as soluble receptors 
for TNF, or to non-specific ligands such as cc2 macroglobulin and uromodulin. Such 
molecules may interfere with both bioassays and immunoassays. Receptor blocking 
molecules such as the naturally occurring protein designated IL-1 receptor antagonist 
interfere with bioassays only [ 10]. On the other hand, with ELISA and RIA one might be 
measuring biologically non-active proteins. In general, the reproducibility and validity of 
immunoassays are superior to those of bioassays. 
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Design of dietary trials. Several human studies evaluating the influence of (n-3) fatty acids 
on cytokine production have compared baseline values with post-treatment values, without 
a concurrent control group. The contribution of aspecific fluctuations in cytokine 
production such as reduced stress through adaptation to the study protocol cannot be 
appreciated in such a before-and-after design. It also cannot be deduced from such studies 
whether the observed effects are specific for the type of polyunsaturated fatty acids employed. 
On the other hand, in placebo-controlled studies the type and amount of placebo fatty 
acids may be problematic. In human studies, the dietary fat supplementation constitutes 
only a small percentage of the total energy intake, but in animal studies the fat supplement 
may account for 30% of total energy intake. When control groups receive such an amount 
of corn oil or safflower oil, both very rich in (n-6) fatty acids, this may well influence the 
production of prostaglandins and leukotrienes and thus may have some bearing on the 
resultant cytokine production measured in these studies [5]. Ideally, in both human and 
animal supplementation studies, control groups should receive an isoenergetic quantity 
of fatty acids without disturbing the ratio of (n-3) to (n-6) fatty acids that was present in 
their diets before the start of the study. 
The effects of (n-3) fatty acids on cytokine production in humans 
Table 6 presents an overview of human studies concerning the effects of (n-3) fatty acids 
on cytokine production. In several studies peripheral blood mononuclear cells were isolated 
and profound decreases in ex vivo production of IL-1, TNF and IL-6 were noted [9,89]. 
Unfortunately, these studies did not employ a placebo group taking an isoenergetic amount 
of a fatty acid supplement low in polyunsaturated fatty acids and a (n-6) to (n-3) ratio 
similar to that in the subjects' normal diet. Meydani et al. reported on cytokine production 
capacity in 22 subjects before and after 24 weeks on a low-fat diet [90]. The diets were either 
low or high in (n-3) fatty acids, which were provided as natural food components. Ex vivo 
production of IL-Iß, TNF and IL-6 by isolated peripheral blood mononuclear cells fell 
significantly in the high (n-3) fatty acids group. In contrast, IL-Iß and TNF production 
increased in the low (n-3) fatty acids group. The two groups were not studied simulta-
neously, as the authors state, to avoid seasonal differences. Molvig et al. studied ex vivo 
cytokine production after low-dose and high-dose dietary fish oil supplementations in 
healthy young men and in subjects with diabetes [102]. Control subjects took an isoenergetic 
amount of a triglyceride blend. After 7 wk of oil supplementation, concentrations of secreted 
IL-lß, and of secreted and cell-associated TNF were not different between groups. Only 
cell-associated IL-lß was decreased in the fish oil group. This finding is surprising, because 
it is IL-la that remains cell-associated while IL-lß is mainly released into the culture 
medium [103]. In contrast with the findings of Endres et al. [9], no differences in ex vivo 
cytokine production were noted between the groups 10 wk after cessation of the diet. Even 
though the authors had an appropriate control group, the conclusions from this study 
should be viewed with caution. This is because the authors do not present the values from 
the start of the study. Such a design (i.e., repeated measures) would have greatly strengthened 
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Table 6. Effects of (n-3) fatty acids on cytokine production in humans 
Reference Subjects Number (n-3) FA Duration Control Source of Cytokine Effect of (n-3) FA 
dose of diet group cytokines assay (Maximum 
(g/d)' change in %) 
[9] 
[89] 
[90] 
[40] 
[102] 
[87] 
[41] 
Healthy men 13 
Healthy older 
and younger 
women 
Healthy men 
and women 
over age 40 
Rheumatoid 
arthritis 
patients 
Healthy men, 
diabetics 
Healthy men 
Rheumatoid 
arthritis 
patients 
12 
22 
49 
33 
6 
32 
[104] Healthy men 29 
[105] Older healthy 12 
subjects 
46 6wk Normal PBMC3 
diet 
2 4 1,2 and None PBMC 
3mo 
123 24 wk Low-fat, PBMC 
0 27 g/d 
(n-3) FAS 
3 3/6 7 24 wk Olive oil PBMC 
15/3 0 7wk Tnglycen PBMC' 
de blend 
3 0 6wk Olive oil PBMC 
36 
1 15-156 
30 
12 wk 
6-8 wk 
4 mo 
Mixture 
of fatty 
aads 
Normal 
diet 
Iso-
energetic 
neutral 
fat 
Plasma 
Whole 
blood 
culture 
PBMC 
RIA 
RIA 
RIA 
Bioassay7 
ELISA 
EIA 
RIA 
Bioassay 
RIA 
IL-Iß 1 (-61%)3 
IL-Ia 1 (-39%) 
TNF 1 (-40%) 
IL-lßl (-90%)' 
TNF 1 (-70%) 
IL-6 1 (-60%) 
IL-lß 1 (-40%)6 
TNF 1 (-35%) 
IL-6 1 (-34%) 
IL-1 J in treated 
(-54 7%) and m 
controls (-38 5%) 
IL-lß and TNF 
secretion not 
different between 
groups' 
IL-2 1 
IL-lß I ' 
TNFtt = 
IL-1 I " 
IL-6 1 
TNF = 
IL-lß = 
1 Abbreviation used ELISA, enzyme linked immunosorbent assay; FA, fatty acids, IL-1, interleukin-1,1L-2, interleukin-2, IL-6, 
interleukin-6, PBMC, peripheral blood mononuclear cells, RIA, radiolabelled immunoassay, TNF, tumor necrosis factor 
2 Peripheral blood mononuclear cells were isolated after 6 wk of supplementation and again at 10 and 20 wk after cessation of the diet 
Cytokine production by the cultured cells was stimulated with endotoxin, phytohemaggkramn or heat-killed Staphylococcus epidermide 
Cytokines were determined by specific radioimmunoassays of the supematants after lysis of the cells, and thus consisted of both secreted 
and cell-associated fractions 
3 Changes in cytokine production capacity were maximal at 10 weeks after cessation of the supplementation 
4 The reductions were more pronounced in older women than in younger women The authors did not report on cytokine production 
after cessation of the dietary intervention 
5 The (n 3) FA in the control group were plant-denved 
6 Ina non-concurrent control group on a low-fat/low (n-3) fatty aads diet, IL-lß increased with 62% and TNF increased with 47% 
7 20 patients received low-dose and 17 patients received high-dose fish oil concentrate per day, and control patients received olive oil 
Peripheral blood mononuclear cells were cultured for 24 h with or without endotoxin It should be noted that the bioassay employed 
in this study does not discriminate between IL-1 and IL-6 Phytohcmagglutmin-stnmulated interleukin-2 production also tended to 
decrease over time in both age groups during fish-oil supplementation, but this reduction did not reach statistical significance 
8 Peripheral blood mononuclear cells were isolated at baseline, after 7 wk of oil supplementation, and again 10 wk after cessation of 
the diet The cells were cultured for 20 h with and without endotoxin, and secreted and cell-associated cytokines were determined 
separately From this paper the percentage of change from baseline cannot be deduced Only cell-associated IL- Iß was decreased in 
the (n-3) fatty acids group 
9 Initial plasma IL-lß concentrations were not elevated, soil IL-lß was reduced after fish-oil supplementation 
10 Local and systemic inflammatory responses to typhoid vacane injection were attenuated in the subjects taking fish oil supplement 
11 From this paper the percentual change from baseline cannot be deduced 
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this study, because it can help control for inherent intrasubject variation. In other words, 
it is the changes in cytokine production that (n-3) fatty acids cause that is really most 
important and not the absolute amount of cytokine made by each subject. In a study in 
rheumatoid arthritis patients, IL-1 fell over time in all groups, including the control group 
taking olive oil [40]. Cooper et al. studied young volunteers before and after dietary 
supplementation with fish oil during 6 to 8 wk [ 104]. A concurrent control group did not 
alter their usual diets. Using a somewhat different method of cytokine measurement (whole 
blood culture), they found that ex-vivo production of IL-1 and IL-6 was suppressed after 
fish oil supplementation. However, production of TNF was not significantly altered. 
Interestingly, these investigators found an attenuation of the inflammatory response to 
an intramuscular injection of typhoid vaccine in the fish oil group. Recently, Cannon et 
al. found no differences in ex-vivo stimulated IL-Iß production in older subjects after 4 
mo of dietary fish oil supplementation compared with controls taking a placebo of neutral 
fat composition [105]. Again, in this study no conclusions can be drawn about changes in 
cytokine concentrations induced by fish oil, and possible effects may be masked by 
intersubject variations. Espersen et al. reported a reduction in plasma IL-Iß concentrations 
after fish oil supplementation in rheumatoid arthritis patients that did not occur in the 
concurrent control group [41]. 
In the Endres/Meydani studies, peripheral blood mononuclear cells were cultured in 
the presence of autologous serum or plasma [9,89], while in Molvig's and Cannon's studies, 
pooled normal human serum was used [102,106]. Theoretically, the fatty acids present in 
the autologous serum could have influenced the in vitro cytokine production. However, 
preincubation of human peripheral blood mononuclear cells with eicosapentanoic acid 
resulted only in a marginal suppression of IL-Iß synthesis, while TNF synthesis was not 
affected at all [107]. 
Whether (n-3) fatty acids reduce inflammation in certain human disease states through 
inhibition of cytokine production remains speculative, but most studies, controlled or not, 
report a decrease in one or more pro-inflammatory cytokines after dietary (n-3) fatty acids. 
(N-3) fatty acids and cytokine production in animals 
Animal studies concerning the production of cytokines after dietary (n-3) polyunsaturated 
fatty acid supplementation are summarized in Table 7. 
Rats. Billiar et al. reported decreased bioactivity of IL-1 and TNF produced in vitro by liver 
macrophages of rats after 6 wk of dietary supplementation with fish oil [8]. Control animals 
were fed an equal amount of corn oil. However, animals receiving safflower oil, rich in n-6 
polyunsaturated fatty acids, showed a decrease in IL-1 and TNF production similar to that 
in animals fed fish oil. This latter finding is difficult to interpret, since in both corn oil and 
safflower oil the predominant fatty acid is linoleic acid. Grimm et al. also found decreased 
production of IL-6 and TNF in peripheral blood mononuclear cells of rats fed (n-3) fatty 
acids for four days [108]. 
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In contrast to these findings, Turek et al. reported increased TNF production capacity 
of resident peritoneal macrophages in rats fed linseed oil for 30 d [109]. Linseed oil is rich 
in a-linolenic acid, an (n-3) fatty acid and precursor of eicosapentanoic acid (EPA). Control 
animals received corn oil. Interestingly, when the peritoneal cells were elicited by the in 
vivo administration of complete Freund's adjuvant, the differences in TNF production in 
the two dietary groups were no longer apparent. 
Mice. There seems to be a contrast between the effects of (n-3) fatty acids on cytokine 
production in mice and in the other species studied. Watanabe et al. studied the effects of 
feeding a-linolenic acid on TNF production by murine peritoneal macrophages [110]. 
Control animals received safflower oil, rich in linoleic acid and low in (n-3) fatty acids. Diets 
were given for 4 to 5 wk. Endotoxin-stimulated TNF production by peritoneal macrophages 
was significantly higher in the a-linolenic acid group than in the control group. The authors 
also reported a considerably higher serum TNF activity in the a-linolenic acid group after 
in-vivo injection of endotoxin. 
Lokesh et al. studied the synthesis of IL-1 and TNF by mouse peritoneal macrophages 
after 4 wk of dietary supplementation with fish oil, corn oil or olive oil [111]. An IL-1 
bioassay was performed on the supematants of cultured peritoneal macrophages stimulated 
with endotoxin after lysis of the cells, and thus probably reflected mainly IL-la. The TNF 
bioactivity was measured in the supematants of these macrophages. Both IL-1 and TNF 
were markedly increased in the mice fed fish oil compared with control animals. Similarly, 
Hardardottir and Kinsella found enhanced in-vitro stimulated TNF production by resident 
peritoneal macrophages in mice that had been on an (n-3) fatty acid supplemented diet 
for 5 wk [ 117]. Enlarging on these observations, the same group studied the kinetics of TNF 
release by in-vitro stimulated murine resident peritoneal macrophages after 4 wk of fish 
oil or control diet [113]. Although total TNF production was again increased, the kinetics 
of maximum TNF production appeared not to be affected by the diets. These findings were 
basically confirmed by Somers and Erickson [115]. 
Our group has studied ex vivo production of IL-1 and TNF by peritoneal cells from mice 
fed fish oil, corn oil or palm oil for 6 wk [98]. IL-la, IL-lß and TNF were measured by 
specific immunoassays. IL-la and TNF production by peritoneal cells were significantly 
higher in the fish-oil fed animals than in controls. Ertel et al. found increased IL-lß release 
by peritoneal macrophages of mice following experimental hemorrhagic shock [114]. 
Thus, the effects of dietary (n-3) fatty acids on cytokine production in mice are opposite 
to those in humans: in mice, several controlled studies have independently shown increased 
cytokine production after (n-3) fatty acid supplementation, whereas in humans decreased 
cytokine production was found. As can be seen in tables 6 and 7, human studies have 
exclusively used peripheral blood cells while most animal studies (rats and mice) used 
isolated tissue macrophages. Thus, as pointed out before, differences in origin of the cell 
types used to study cytokine production may account for the paradoxical responses to (n-3) 
fatty acids in humans and animals. This hypothesis is supported by the only animal study 
using peripheral blood mononuclear cells, which found decreased IL-6 and TNF production 
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[ 108]. To clarify this issue, studies are needed to evaluate the influence of dietary (n-3) fatty 
acids on cytokine production in isolated peripheral blood mononuclear cells and tissue 
macrophages simultaneously. 
As in the human studies, there is no evidence that the alleviation of inflammation by 
(n-3) fatty acids in animal studies is mediated by alterations in cytokine production. Studies 
employing (n-3) fatty acids simultaneously with control measures such as agonists or 
antagonists of cytokines have not been performed. 
POSSIBLE MECHANISMS OF THE MODULATION OF CYTOKINE PRODUCTION BY 
DIETARY (N-3) FATTY ACID INTAKE 
At present, the mechanisms by which dietary (n-3) fatty acids modulate cytokine production 
have not been elucidated. Until recently, the alleviation of inflammation after the ingestion 
of (n-3) fatty acids has mainly been attributed to a reduced production by leukocytes of 
the eicosanoids prostaglandin Έ^ (PGE2) and leukotriene B^LTB^. Inflammatory agonists 
stimulate eicosanoid synthesis by enhancing the release of arachidonic acid from the 
intracellular phospholipid pool through activation of phospholipases. Subsequently, the 
free arachidonic acid is metabolized into prostaglandins and leukotrienes by the enzymes 
cydooxygenase and lipoxygenase, respectively. Eicosapentanoic acid (EPA), one of the (n-3) 
polyunsaturated fatty acids found in high concentrations in fish oil, is rapidly incorporated 
into cell membrane phospholipids where it replaces arachidonic acid as a substrate and 
is converted into the biologically less active prostaglandin E3 (PGE,) and leukotriene B, 
(LTB5) [6]. Moreover, (n-3) fatty acids have been shown to be poorly metabolized by 
cydooxygenase, thereby reducing the total production of eicosanoids [6]. 
Prostaglandins. Changes in the production of the eicosanoids PGE2 and LTB4 have been 
postulated as mechanisms of altered cytokine production after dietary fatty acid supplemen­
tation. In vitro addition of PGE2 to human peripheral blood mononuclear cells inhibits 
TNF production, probably by increasing intracellular cyclic AMP [ 118,119]. Initially, the 
in vitro production of IL-1 has also been reported to be under inhibitory control of PGE2, 
but since the availability of specific IL-1 assays it has become clear that in vitro IL-1 secretion 
is not inhibited by PGF^ [118,120]. In vivo inhibition of PGE2 production by administration 
of a cydooxygenase inhibitor has been reported to increase circulating concentrations of 
IL-6 and TNF during acute endotoxinemia in humans [121]. Since PGE2 concentrations 
are decreased following an (n-3) fatty acid-rich diet, it is unlikely that prostaglandins play 
an important role in the decreased TNF production observed in humans and in some other 
species. In mice, however, decreased PGE2 production could account for the observed 
increases in TNF after (n-3) fatty acids. Two groups reported that the increase in TNF 
production by peritoneal macrophages from mice fed fish oil or control diets could be 
substantially reduced by treating these cells with PGF^ [ 112,122 ]. However, TNF production 
capacity was still elevated in the mice fed (n-3) fatty acids compared with controls. 
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Hardardottir and Kinsella also showed that after abolition of PGEj production in all dietary 
groups by indomethacin, peritoneal macrophages of fish-oil fed mice still produced 
significantly more TNF [112]. This indicates that in mice, reduced PGE2 production is not 
the only mechanism responsible for the increased TNF production. 
Leukotrienes. As suggested by Endres et al. [9], a fish-oil induced decrease in the synthesis 
of lipoxygenation products of arachidonic acid may account for inhibition of cytokine 
production. However, studies on the effect of leukotrienes on IL-1 production have shown 
divergent results. Leukotriene B4 was reported to enhance lipopolysaccharide-induced IL-1 
production by human monocytes in vitro [123], but specific leukotriene inhibitors failed 
to reduce IL-1 production by human and mouse mononuclear cells at concentrations that 
completely inhibited leukotriene synthesis [ 124,125 ]. In mice, treatment with lipoxygenase 
inhibitors suppressed the circulating TNF concentrations after endotoxin injection as well 
as the ex-vivo TNF production by peritoneal macrophages [126]. Endres et al. suggested 
that the profound decrease in IL-1 and TNF production at 10 wk after cessation of the fish 
oil diet might have been due to reduced production of LTB4 [9]. However, others reported 
complete restoration of LTB4 formation by neutrophils and peripheral blood mononuclear 
cells within 8 wk after cessation of a similar diet [127]. These data suggest that reduced 
synthesis of leukotrienes is unlikely to cause the reduced cytokine production after (n-3) 
fatty acid administration. 
Dual inhibihon. Studies with agents that inhibit both the lipoxygenase- and cydooxygenase-
mediated metabolism of arachidonic acid are of interest, because dietary (n-3) fatty acid 
supplementation results in a similar reduction of both prostaglandins and leukotrienes. 
One of these agents, tebufelone, enhanced IL-1 and TNF synthesis by human peripheral 
blood mononuclear cells at concentrations which suppressed leukotriene formation [128]. 
Another dual cydooxygenase/lipoxygenase inhibitor, SK&F 86002, protected mice from 
endotoxin-induced mortality and reduced circulating TNF concentrations [ 129]. Differences 
in species studied may account for these divergent findings. However, because dual 
cydooxygenase/lipoxygenase inhibitors seem to increase cytokine production in human 
cells and decrease cytokine production in mice, these observations are opposite to the 
observed decrease in cytokine production in humans and the increased cytokine production 
in mice induced by (n-3) fatty acids. Thus, these observation again argue against reduced 
eicosanoid synthesis as an explanation for these effects. 
Vitamin E and cytokine production. Fish-oil concentrates used in clinical and experimental 
studies are enriched in vitamin E in order to prevent lipid peroxidation. The effects of dietary 
fish-oil supplementation on cytokine production could thus theoretically be due to the 
vitamin E rather than to the n-3 fatty acids. 
Meydani et al. studied this issue in a group of elderly human volunteers who consumed 
800 IU of all-rac-or-tocopheryl acetate daily for 30 days. Endotoxin-stimulated IL-1 
bioactivity was not affected by this vitamin E supplementation [130]. Cannon et al. studied 
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male volunteers who supplemented their diets with 800 IU of aR-rac-a-tocopherol daily 
for 48 d [106]. After a session of heavy exercise, IL-lß production capacity rose in subjects 
on placebo, but not in vitamin Ε-supplemented subjects. TNF production capacity was 
not affected by vitamin E; IL-6 production capacity was, however, significantly reduced 
in the vitamin E group. These studies show that vitamin E supplementation in itself may 
exert some influence on cytokine production. However, the amount of vitamin E employed 
in these studies is much higher than that ingested in the fish-oil studies (800 IU versus 
approximately 20 IU per day). Therefore it remains questionable whether vitamin E may 
account for the changes observed after dietary fish-oil supplementation. 
Modulation of signal transduction. Some studies have addressed the question whether (n-3) 
fatty acids alter intracellular signal transduction pathways involved in the synthesis of 
cytokines. In mice, 10 d of dietary supplementation with (n-3) fatty acids significantly 
increased the diacylglycerol concentration in concanavalin Α-stimulated splenocytes [131]. 
The (n-3) fatty acids seemed to modulate the activities of protein kinase С and cAMP-
dependent protein kinases in a lymphoma cell line [132]. It is thus conceivable that (n-3) 
fatty acids induce changes in the concentrations or activities of intracellular factors involved 
in cytokine production. Clearly, these data need to be confirmed and related to changes 
in cytokine production. 
CONCLUSIONS 
Anti-inflammatory effects of dietary fish-oil supplementation have been observed in clinical 
studies of rheumatoid arthritis, psoriasis, and ulcerative colitis. The effects of (n-3) fatty 
acids seem to be stronger in animal models of chronic inflammation than in the clinical 
studies. This may relate to the early institution of supplementation and the very high intake 
of (n-3) fatty acids in the animal studies. In humans, the anti-inflammatory potential of 
fish oil appears to be limited. Studies in critically ui burn or postoperative cancer patients 
yielded inconclusive results, but two recent studies in intensive care unit patients are 
promising. It is unclear whether the anti-inflammatory effects offish oil in humans are 
mediated through a reduction in cytokine production or through other mechanisms such 
as reduced production of lipid mediators; studies in humans have reported impressive 
reductions in cytokine production capacity, although not all studies were properly 
controlled. The data from studies in mice show the opposite: increased IL-1 and TNF 
production capacity after (n-3) fatty acids supplementation. Differences in origin of 
cytokine-producing cells may account for this paradoxical response to (n-3) fatty acids in 
humans and mice. 
Interference with the negative feed-back of prostaglandins on TNF production partly 
accounts for the increased TNF production after (n-3) fatty acids supplementation in mice. 
The mechanism of action of (n-3) fatty acids on IL-1 production in mice and on cytokine 
production in other species remains to be elucidated. 
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The issue whether dietary (n-3) fatty acids decrease host resistance to infections is still 
unresolved. Τ cell responses increased in certain patient groups after (n-3) fatty acids 
consumption but decreased in healthy subjects. Baseline Τ cell activation may play a role 
here. Some animal studies suggest a beneficial effect of (n-3) fatty acids on outcome of 
infections, while others report an adverse or no effect. Thus, at present there is no firm 
scientific evidence that enteral feedings enriched in (n-3) fatty acids are of benefit in the 
treatment of critically Ш patients. Future research in this field may be directed in several 
ways. First, studies are needed to relate the contributions of the various lipid mediators 
and the intracellular signal transduction systems to the observed effects of (n-3) fatty acids 
on inflammation and on cytokine production. Second, different cytokine-producing cell 
types should be studied simultaneously in one species to unravel the paradoxical responses 
to dietary (n-3) fatty acids in humans and in mice. Third, in view of the preliminary studies 
already performed and given the increasing number of immunocompromised patients in 
our hospitals and intensive care units, well-designed studies are needed to assess the potential 
benefit of dietary (n-3) fatty acids in this group of patients. 
ACKNOWLEDGEMENTS 
We thank Stefan Endres for valuable suggestions. 
REFERENCES 
1. Cerra FB, Lehmann S, Konstantinides Ν, et al. Improvement in immune function in ICU patients by 
enteral nutrition supplemented with arginine, RNA, and menhaden oil is independent of nitrogen balance. 
Nutrition 1991; 7: 193-199. 
2. Cerra FB, Holman RT, Bankey PE, Mazuski JE, LiCari JJ. Omega 3 polyunsaturated fatty acids as 
modulators of cellular function in the critically ill. Pharmacotherapy 1991; 11: 71-76. 
3. Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and 
omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 
1992;112:56-67. 
4. Gottschlich MM, Jenkins M, Warden GD, et al. Differential effects of three enteral dietary regimens on 
selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr 1990; 14: 225-236. 
5. Kinsella JE, Lokesh B, Broughton S, Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: 
potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 1990; 
6: 24-44. 
6. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and 
docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil 
function. N Engl J Med 1985; 312: 1217-1224. 
7. Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher Η. Triene prostaglandins: prostacyclin and 
thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sei U S A 1979; 76:944-948. 
36 CHAPTER 2 
8. Billiar TR, Bankey PE, Svingen BA, et al. Fatty acid intake and Kupffer cell function: fish oil alters 
eicosanoid and monokine production to endotoxin stimulation. Surgery 1988; 104: 343-349. 
9. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated 
fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J 
Med 1989; 320: 265-271. 
10. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652. 
11. Dinarello CA. Role of Interleukin-1 and Tumor Necrosis Factor in Systemic Responses to Infection and 
Inflammation. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical 
Correlates. 2nd edition. New York: Raven Press.Ltd., 1992: 211-231. 
12. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated 
from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989; 30: 835-838. 
13. Mazlam MZ, Hodgson HJ. Peripheral blood monocyte cytokine production and acute phase response 
in inflammatory bowel disease. Gut 1992; 33: 773-778. 
14. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome 
in patients with meningococcal disease. Lancet 1987; 1: 355-357. 
15. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum 
from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and 
fatal outcome. J Exp Med 1989; 169: 333-338. 
16. Cannon JG, Tompkins RG, Gelfand JA, et al. Circulating interleukin-1 and tumor necrosis factor in septic 
shock and experimental endotoxin fever. J Infect Dis 1990; 161: 79-84. 
17. Calandra Τ, Baumgartner JD, Grau GE, et al. Prognostic values of tumor necrosis factor/cachectin, 
interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. 
Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990; 161: 982-987. 
18. Grau GE, Piguet PF, Vassalli Ρ, Lambert PH. Tumor-necrosis factor and other cytokines in cerebral malaria: 
experimental and clinical data. Immunol Rev 1989; 112: 49-70. 
19. Berman MA, Sandborg CI, Calabia BS, Andrews BS, Friou G J. Interleukin 1 inhibitor masks high 
interleukin 1 production in acquired immunodeficiency syndrome (AIDS). Clin Immunol Immunopathol 
1987;42:133-140. 
20. Lahdevirta J, Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor 
in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 289-291. 
21. Lepe-Zuniga JL, Mansell PW, Hersh EM. Idiopathic production of interleukin-1 in acquired immune 
deficiency syndrome. J Clin Microbiol 1987; 25: 1695-1700. 
22. Wright SC, Jewett A, Mitsuyasu R, Bonavida B. Spontaneous cytotoxicity and tumor necrosis factor 
production by peripheral blood monocytes from AIDS patients. J Immunol 1988; 141: 99-104. 
23. Molina JM, Scadden DT, Bym R, Dinarello CA, Groopman JE. Production of tumor necrosis factor alpha 
and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J Clin Invest 
1989; 84: 733-737. 
24. Molina JM, Schindler R, Feniani R, et al. Production of cytokines by peripheral blood 
monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1 ). J Infect Dis 1990; 
161:888-893. 
25. Cominelli F, Nast CC, Clark BD, et al. Interleukin 1 (IL-1 ) gene expression, synthesis, and effect of specific 
IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990; 86: 972-980. 
N-3 FATTY ACIDS AND INFLAMMATION 37 
26. Curfs JHAJ, Vogels МТБ, Eling WMC, van der Meer JWM. IL-1 receptor antagonist prevents cerebral 
malaria in Plasmodium berghei-infected mice. In: Ghezzi P, Mantovani A, eds. Pathophysiology and 
pharmacology of cytokines. Augusta, Georgia: Biomedical Press, 1992: 105-111. 
27. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces 
mortality from endotoxin shock. Nature 1990; 348: 550-552. 
28. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock 
during lethal bacteremia. Nature 1987; 330: 662-664. 
29. van der Meer JWM. Options for the treatment of serious infections with interleukin-1. Biotherapy 1989; 
1:313-317. 
30. Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di-Giovine FS, Duff GW. Correlation of plasma 
interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988; 2: 706-709. 
31. Firestein GS, Zvaifler NJ. Rheumatoid Arthritis. A Disease of Disordered Immunity. In: Gallin JI, Goldstein 
IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. 2nd edition. New York: 
Raven Press Ltd., 1992: 959-975. 
32. Moore FA, Moore ЕЕ, Kudsk KA, et al. Clinical benefits of an immune-enhancing diet for early postinjury 
enteral feeding. J Trauma 1994; 37: 607-615. 
33. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented 
with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, 
randomized, clinical trial. Crit Care Med 1995; 23: 436-449. 
34. Kremer JM, Michalek A, Lininger L. Effects of manipulation of dietary fatty acids on clinical manifestations 
of rheumatoid arthritis. Lancet 1985; 1: 184-187. 
35. Kremer JM, Jubiz W, Michalek A, et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis. 
A double-blinded, controlled, crossover study. Ann Intern Med 1987; 106:497-503. 
36. Sperling RI, Weinblatt M, Robin JL, et al. Effects of dietary supplementation with marine fish oil on leukocyte 
lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 1987; 30:988-997. 
37. Belch JJ, Ansell D, Madhok R, O'Dowd A, Sturrock RD. Effects of altering dietary essential fatty acids 
on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double 
blind placebo controlled study. Ann Rheum Dis 1988; 47: 96-104. 
38. Cleland LG, French JK, Betts WH, Murphy GA, Elliott MJ. Clinical and biochemical effects of dietary 
fish oil supplements in rheumatoid arthritis. J Rheumatol 1988; 15:1471-1475. 
39. van der Tempel H, Tulleken JE, Limburg PC, Muskiet FA, van Rijswijk ΜΗ. Effects of fish oil 
supplementation in rheumatoid arthritis. Ann Rheum Dis 1990; 49: 76-80. 
40. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with 
rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990; 33: 810-820. 
41. Espersen GT, Grunnet N, Lervang HH, et al. Decreased interleukin-1 beta levels in plasma from rheumatoid 
arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol 
1992; 11: 393-395. 
42. Ziboh VA, Cohen KA, Ellis CN, et al. Effects of dietary supplementation of fish oil on neutrophil and 
epidermal fatty acids. Modulation of clinical course of psoriatic subjects. Arch Dermatol 1986; 122: 
1277-1282. 
43. Maurice PD, Allen BR, Barkley AS, Cockbill SR, Stammers J, Bather PC. The effects of dietary 
supplementation with fish oil in patients with psoriasis. Br J Dermatol 1987; 117: 599-606. 
38 CHAPTER 2 
44. Bittiner SB, Tucker WF, Cartwiight I, Bleehen SS. A double-blind, randomised, placebo-controlled trial 
offish oil in psoriasis. Lancet 1988; 1: 378-380. 
45. Bjomeboe A, Klemeyer Smith A, Bjomeboe GA, Thune PO, Drevon CA. Effect of dietary supplementation 
with n-3 fatty acids on clinical manifestations of psoriasis. Br J Dermatol 1988; 118: 77-83. 
46. Lassus A, Dahlgren AL, Halpem MJ, Santalahti J, Happonen HP. Effects of dietary supplementation with 
polyunsaturated ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic arthritis. J Int Med 
Res 1990; 18: 68-73. 
47. McCall ТВ, O'Leary D, Bloomfield J, O'Morain CA. Therapeutic potential offish oil in the treatment 
of ulcerative colitis. Aliment Pharmacol Ther 1989; 3: 415-424. 
48. Salomon P, Kombluth AA, Janowitz HD. Treatment of ulcerative colitis with fish oil n—3-omega-fatty 
acid: an open trial. J Clin Gastroenterol 1990; 12: 157-161. 
49. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser Τ, Loeschke К. Supplementation with n-3 fatty 
acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo-controlled, double-blind 
cross-over trial. J Intern Med Suppl 1989; 225: 225-232. 
50. Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern 
Med 1992; 116: 609-614. 
51. Asian A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, 
placebo-controlled, crossover study. Am J Gastroenterol 1992; 87: 432-437. 
52. Moore GF, Yarboro C, Sebring NG. Eicosapentanoic acid (EPA) in the treatment of systemic lupus 
erythematosus (SLE). Arthritis Rheum 1987; 30: S33. 
53. Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ, Falardeau P. Omega-3 fatty acid dietary supplementa­
tion in systemic lupus erythematosus. Kidney Int 1989; 36: 653-660. 
54. Westberg G, Tarkowski A. Effect of MaxEPA in patients with SLE. A double-blind, crossover study. Scand 
J Rheumatol 1990; 19: 137-143. 
55. Arm JP, Horton CE, Mencia-Huerta JM, et al. Effect of dietary supplementation with fish oil lipids on 
mild asthma. Thorax 1988; 43: 84-92. 
56. Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH. The effects of dietary supplementation with 
fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989; 
139: 1395-1400. 
57. Ernst E, Saradeth T, Achhammer G. n-3 fatty acids and acute-phase proteins. Eur J Clin Invest 1991; 21: 
77-82. 
58. Kelley VE, Ferretti A, Izui S, Strom ТВ. A fish oil diet rich in eicosapentaenoic acid reduces cydooxygenase 
metabolites, and suppresses lupus in MRL-lpr mice. J Immunol 1985; 134: 1914-1919. 
59. Prickett JD, Robinson DR, Steinberg AD. Dietary enrichment with the polyunsaturated fatty acid 
eicosapentaenoic prevents proteinuria and prolongs survival in NZB χ NZW Fl mice. J Clin Invest 1981; 
68: 556-559. 
60. Leslie CA, Gonnerman WA, Ullman MD, Hayes КС, Franzblau С, Cathcart ES. Dietary fish oil modulates 
macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med 1985; 162: 1336-1349. 
61. Prickett JD, Trentham DE, Robinson DR. Dietary fish oil augments the induction of arthritis in rats 
immunized with type II collagen. J Immunol 1984; 132: 725. 
62. Cathcart ES, Mortensen RF, Leslie CA, Conte JM, Gonnerman WA. A fish oil diet inhibits amyloid Ρ 
component (AP) acute phase responses in arthritis susceptible mice. J Immunol 1987; 139: 89-91. 
N-3 FATTY ACIDS AND INFLAMMATION 39 
63. Berdanier CD, Johnson B, Hartle DK, Crowell W. Life span is shortened in BHE/cdb rats fed a diet 
containing 9% menhaden oil and 1% corn oil. J Nutr 1992; 122: 1309-1317. 
64. Bloch KJ, Ho B, Xu LL, Bloch M, Robinson DR. Effect offish-fat or beef-fat supplemented diet on immune 
complex-induced enteropathy in the rat. Prostaglandins 1989; 38: 385-396. 
65. Prickett JD, Robinson DR, Steinberg AD. Effects of dietary enrichment with eicosapentaenoic acid upon 
autoimmune nephritis in female NZB χ NZW/F1 mice. Arthritis Rheum 1983; 26:133-139. 
66. Robinson DR, Prickett JD, Makoul GT, Steinberg AD, Colvin RB. Dietary fish oil reduces progression 
of established renal disease in (NZB χ NZWJF1 mice and delays renal disease in BXSB and MRL/1 strains. 
Arthritis Rheum 1986; 29: 539-546. 
67. Guamer F, Vilaseca J, Malagelada JR. Dietary manipulation in experimental inflammatory bowel disease. 
Agents Actions 1992; Spec. No:: C10-C14. 
68. Empey LR, Jewell LD, Garg ML, Thomson AB, Clandinin MT, Fedorak RN. Fish oil-enriched diet is 
mucosal protective against acetic acid-induced colitis in rats. Can J Physiol Pharmacol 1991; 69:480-487. 
69. Pomposelli JJ, Mascioli EA, Bistrian BR, Lopes SM, Blackburn GL. Attenuation of the febrile response 
in guinea pigs by fish oil enriched diets. JPEN J Parenter Enteral Nutr 1989; 13: 136-140. 
70. Cooper AL, Rothwell NJ. Inhibition of the thermogenic and pyrogenic responses to interleukin-1 beta 
in the rat by dietary N-3 fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 
615-626. 
71. Hirschberg Y, Pomposelli JJ, Blackburn GL, Istfan NW, Babayan V, Bistrian BR. The effects of chronic fish 
oil feeding in rats on protein catabolism induced by recombinant mediators. Metabolism 1990; 39:397-402. 
72. Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA. Interleukin-1-induced anorexia in the 
rat. Influence of prostaglandins. J Clin Invest 1989; 84: 228-235. 
73. McCarthy DO, Kluger MJ, Vander AJ. Suppression of food intake during infections: Is interleukin-1 
involved? Am J Clin Nutr 1985; 42:1179-1182. 
74. Moldawer LL, Anderson C, Gelin J, Lundhold KG. Regulation of food intake and hepatic protein synthesis 
by recombinant-derived cytokines. Am J Physiol 1988; 254: G450-G456. 
75. Tracey KJ, Wei H, Manogue KB, Kuo G, Lowry SF, Cerami A. Weight loss, cachexia and inflammation 
in rats treated with recombinant cachectin. J Exp Med 1988; 167: 1211-1227. 
76. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state 
in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 
1988;81:1162-1172. 
77. Calder PC, Sherrington EJ, Askanazi J, Newsholme EA. Inhibition of lymphocyte proliferation in vitro 
by two lipid emulsions with different fatty acid compositions. Clin Nutr 1994; 13: 69-74. 
78. Soyland E, Nenseter MS, Braathen L, Drevon CA. Very long chain n-3 and n-6 polyunsaturated fatty 
acids inhibit proliferation of human T-lymphocytes in vitro. Eur J Clin Invest 1993; 23: 112-121. 
79. Kernen M, Senkal M, Homann H-Η, et al. Early postoperative enteral nutrition with arginine-omega-3 
fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: An immunologic 
evaluation of Impact. Crit Care Med 1995; 23: 652-659. 
80. Kromhout D. The importance of N-6 and N-3 fatty acids in carcinogenesis. Med Oncol Tumor 
Pharmacother 1990; 7: 173-176. 
81. Wynder EL, Rose DP, Cohen LA. Diet and breast cancer in causation and therapy. Cancer 1986; 58: 
1804-1813. 
40 CHAPTER 2 
82 Carrol] KK, Braden LM Dietary fat and mammary carcinogenesis Nutr Cancer 1984, 6 254-259 
83 Bougnoux P, Koscielny S, Chafes V, Descamps P, Couet C, Calais G alpha-Linolenic acid content of 
adipose breast tissue a host determinant of the risk of early metastasis in breast cancer Br J Cancer 1994, 
70 330-334 
84 Grzybowski S, Dorken E Tuberculosis in Inuit Ecol Dis 1983, 2 145-148 
85 Mascioli EA, Iwasa Y, Trimbo S, Leader L, Bistnan BR, Blackburn GL Endotoxin challenge after menhaden 
oil diet effects on survival of guinea pigs Am I Clm Nutr 1989, 49 277-282 
86 Teo TC, Selleck KM, Wan JM, et al Long-term feeding with structured lipid composed of medium-chain 
and N-3 fatty acids ameliorates endotoxic shock in guinea pigs Metabolism 1991, 40 1152-1159 
87 Virella G, Fourspnng K, Hyman B, et al Immunosuppressive effects of fish oil in normal human 
volunteers correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes Clin 
Immunol Immunopathol 1991, 61 161 176 
88 Kelley DS, Branch LB, Love JE, Taylor PC, Rivera YM, Iacono JM Dietary alpha-hnolenic acid and 
immunocompetence in humans Am J Clin Nutr 1991, 53 40-46 
89 Meydani SN, bndres S, Woods MM, et al Oral (n-3) fatty acid supplementation suppresses cytokine 
production and lymphocyte proliferation comparison between young and older women J Nutr 1991, 
121 547-555 
90 Meydani SN, Lichtenstein AH, Cornwall S, et al Immunologic effects of National Cholesterol Education 
Panel step-2 diets with and without fish-derived n-3 fatty acid enrichment J Clin Invest 1993,92 105-113 
91 Payan DG, Wong MY, Chernov-Rogan T, et al Alterations in human leukocyte function induced by 
ingestion of eicosapentaenoic acid J Clin Immunol 1986,6 402-410 
92 Soyland E, Lea T, Sandstad B, Drevon A Dietary supplementation with very long-chain η 3 fatty acids 
in man decreases expression of the interleukin 2 receptor (CD25) on mitogen-stimulated lymphocytes 
from patients with inflammatory skin diseases Eur J Clin Invest 1994, 24 236-242 
93 Pomposelh JJ, Mores E, Hirschberg Y, et al Short-term TPN containing n-3 fatty acids ameliorate lactic 
acidosis induced by endotoxin in guinea pigs Am J Clin Nutr 1990, 52 548 552 
94 Chang HR, Dulloo AG, Vladoianu IR, et al Fish oil decreases natural resistance of mice to infection with 
Salmonella typhimunum Metabolism 1992, 41 1-2 
95 D'Ambola JB, Aeberhard ЕЕ, Trang N, Gaffar S, Barrett CT, Sherman MP Effect of dietary (n-3) and 
(n-6) fatty acids on in vivo pulmonary bacterial clearance by neonatal rabbits J Nutr 1991,121 1262-1269 
96 Rubin RH, Wilkinson RA, Xu L, Robinson DR Dietary manne lipid does not alter susceptibility of 
(NZBxNZW)Fl mice to pathogenic microorganisms Prostaglandins 1989, 38 251-262 
97 Clouva-Molyvdas P, Peck MD, Alexander JW Short-term dietary lipid manipulation does not affect 
survival in two models of murine sepsis JPEN J Parenter Enteral Nutr 1992, 16 343-347 
98 Blok WL, Vogels MT, Curfs JH, Eling WM, Buurman WA, van der Meer JWM Dietary fish-od 
supplementation in experimental gram-negative infection and in cerebral malaria in mice J Infect Dis 
1992, 165 898-903 
99 Fernandes G, Tomar V, Venkatraman MN, Venkatraman JT Potential of diet therapy on murine AIDS 
J Nutr 1992,122 716-722 
100 Barton RG, Wells CL, Carlson A, Singh R, Sullivan JJ, Cerra FB Dietary omega-3 fatty acids decrease 
mortality and Kupffer cell prostaglandin E2 production in a rat model of chronic sepsis J Trauma 1991, 
31 768-773 
N-3 FATTY ACIDS AND INFLAMMATION 41 
101. Kumaratilake LM, Robinson BS, Ferrante A, Poulos A. Antimalarial properties of n-3 and n-6 
polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei. 
I Clin Invest 1992; 89: 961-967. 
102. Molvig J, Pociot F, Worsaae II, et al. Dietary supplementation with omega-3-polyunsaturated fatty acids 
decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in 
healthy and insulin-dependent diabetic individuals. Scand J Immunol 1991; 34: 399-410. 
103. Lonnemann G, Endres S, van der Meer JWM, Cannon JG, Koch KM, Dinarello CA. Differences in the 
synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from 
human mononuclear cells.Eur J Immunol 1989; 19: 1531-1536. 
104. Cooper AL, Gibbons L, Horan MA, Little RA, Rothwell NJ. Effect of dietary fish oil supplementation 
on fever and cytokine production in human volunteers. Clin Nutr 1993; 12: 321-328. 
105. Cannon JG, Fiatarone MA, Meydani M, et al. Aging and dietary modulation of elastase and interleukin-1 β 
secretion. Am J Physiol 1995; 268: R208-R213. 
106. Cannon IG, Meydani SN, Fielding RA, et al. Acute phase response in exercise. II. Associations between 
vitamin E, cytokines, and muscle proteolysis. Am J Physiol 1991; 260: R1235-R1240. 
107. Sinha B, Stoll D, Weber PC, Endres S. Polyunsaturated fatty acids modulate synthesis of TNF-a and 
interleukin-Iß by human mnc in vitro [abstract]. Cytokine 1991; 3: 457. 
108. Grimm H, Tibell A, Norrlind B, Blecher C, Wilker S, Schwemmle K. Immunoregulation by parenteral 
lipids: impact of the n-3 to n-6 fatty acid ratio. JPEN J Parenter Enteral Nutr 1994; 18: 417-421. 
109. Turek JJ, Schoenlein IA, Bottoms GD. The effect of dietary n-3 and n-6 fatty acids on tumor necrosis 
factor-alpha production and leucine aminopeptidase levels in rat peritoneal macrophages. Prostaglandins 
Leukot Essent Fatty Acids 1991; 43: 141-149. 
110. Watanabe S, Hayashi H, Onozaki K, Okuyama H. Effect of dietary alpha-linolenate/linoleate balance 
on lipopolysaccharide-induced tumor necrosis factor production in mouse macrophages. Life Sci 1991; 
48:2013-2020. 
111. Lokesh BR, Sayers TJ, Kinsella JE. Interleukin-1 and tumor necrosis factor synthesis by mouse peritoneal 
macrophages is enhanced by dietary n-3 polyunsaturated fatty acids. Immunol Lett 1990; 23: 281-285. 
112. Hardardottir I, Kinsella JE. Tumor necrosis factor production by murine resident peritoneal macrophages 
is enhanced by dietary n-3 polyunsaturated fatty acids. Biochim Biophys Acta 1991; 1095:187-195. 
113. Hardardottir I, Whelan J, Kinsella JE. Kinetics of tumour necrosis factor and prostaglandin production 
by murine resident peritoneal macrophages as affected by dietary n-3 polyunsaturated fatty acids. 
Immunology 1992; 76: 572-577. 
114. Ertel W, Morrison MH, Ayala A, Chaudry IH. Modulation of macrophage membrane phospholipids 
by n-3 polyunsaturated fatty acids increases interleukin-1 release and prevents suppression of cellular 
immunity following hemorrhagic shock. Arch Surg 1993; 128: 15-21. 
115. Somers SD, Erickson KL. Alteration of tumor necrosis factor-α production by macrophages from mice 
fed diets high in eicosapentaenoic and docosahexaenoic fatty acids. Cell Immunol 1994; 153: 287-297. 
116. Morris DD, Henry MM, Moore JN, Fischer JK. Effect of dietary alpha-linolenic acid on endotoxin-induced 
production of tumor necrosis factor by peritoneal macrophages in horses. Am J Vet Res 1991; 52: 528-532. 
117. Hardardottir I, Kinsella JE. Increasing the dietary (n-3) to (n-6) polyunsaturated fatty acid ratio increases 
tumor necrosis factor production by murine resident peritoneal macrophages without an effect on elicited 
peritoneal macrophages. J Nutr 1992; 122: 1942-1951. 
42 CHAPTER 2 
118. Endres S, Fülle HJ, Sinha В, et al. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis 
factor-alpha and interleukin-1 beta by human mononuclear cells. Immunology 1991; 72: 56-60. 
119. Renz H, Gong JH, Schmidt A, Nain M, Gemsa D. Release of tumor necrosis factor-alpha from 
macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and 
cyclic nucleotides. J Immunol 1988; 141: 2388-2393. 
120. Scales WE, Chensue SW, Ottemess I, Kunkel SL. Regulation of monokine gene expression: prostaglandin 
E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated 
bioactivity. J Leukoc Biol 1989; 45: 416-421. 
121. Spinas GA, Bloesch D, Keller U, Zimmerli W, Cammisuli S. Pretreatment with Ibuprofen augments 
circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia. J Infect 
Dis 1991; 163: 89-95. 
122. Hubbard NE, Somers SD, Erickson KL. Eicosapentaenoic and docosahexaenoic acids alter murine 
macrophage TNFct activity [abstract]. Cytokine 1991; 3: 462. 
123. Rola-Pleszczynski M, Lemaire I. Leukotrienes augment interleukin 1 production by human monocytes. 
J Immunol 1985; 135: 3958-3961. 
124. Hoffman T, Lee YL, Lizzio EF, et al. Absence of modulation of monokine production via endogenous 
cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[ l-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropy-
lindol-2-yI]-2,2-dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive 
interleukin-1 beta, or TNF-alpha production by human monocytes in vitro. Clin Immunol Immunopathol 
1991; 58: 399-408. 
125. Parkar BA, McCormick ME, Foster SJ. Leukotrienes do not regulate interleukin 1 production by activated 
macrophages. Biochem Biophys Res Commun 1990; 169: 422-429. 
126. Schade UF, Emst M, Reinke M, Wolter DT. Lipoxygenase inhibitors suppress formation of tumor necrosis 
factor in vitro and in vivo. Biochem Biophys Res Commun 1989; 159: 748-754. 
127. Tulleken JE, Limburg PC, van Rijswijk ΜΗ. Omega-3 polyunsaturated fatty acids, interleukin-1 and tumor 
necrosis factor [letter]. N Engl J Med 1989; 320: 55-56. 
128. Sirko SP, Schindler R, Doyle MJ, Weisman SM, Dinarello CA. Transcription, translation and secretion 
of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase 
inhibitor. Eur J Immunol 1991; 21: 243-250. 
129. Badger AM, Olivera D, Talmadge JE, Hanna N. Protective effect of SK8cF 86002, a novel dual inhibitor 
of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor 
as a possible mechanism of action. Circ Shock 1989; 27: 51-61. 
130. Meydani SN, Meydani M, Barklund PM, et al. Effect of vitamin E supplementation on immune 
responsiveness of the aged. Ann Ν Y Acad Sci 1989; 570: 283-290. 
131. Fowler KH, McMurray DN, Fan YY, Aukema HM, Chapkin RS. Purified dietary n-3 polyunsaturated 
fatty acids alter diacylglycerol mass and molecular species composition in concanavalin A-stimulated 
murine splenocytes. Biochim Biophys Acta 1993; 1210: 89-96. 
132. Speizer LA, Watson MJ, Brunton LL. Differential effects of omega-3 fish oils on protein kinase activities 
in vitro. Am J Physiol 1991; 261: E109-E114. 
CHAPTER 3 
Pro and anti-inflammatory cytokines in healthy 
volunteers fed various doses offish oil for one year 
Willem L. Blok (1), Jean-Paul Deslypere (2), Pierre N. M. Demacker 
(1), Johanna van der Ven-Jongekrijg (1), Magda P. С Hectors (1), 
Jos W.M. van der Meer (1), and Martijn B. Katan (1, 3) 
Department of General Internal Medicine (1), University Hospital Nijmegen, P.O. Box 
9101, 6500 HB Nijmegen, The Netherlands, Department of Endocrinology (2), University 
Hospital Ghent, Belgium, and Department of Human Nutrition (3), Agricultural 
University, Wageningen, The Netherlands 
Submitted 
44 CHAPTER 3 
ABSTRACT 
Dietary supplementation with n-3 fatty acids from fish oil alleviates inflammation in various chronic 
inflammatory disease states. Reductions in the production of pro-inflammatory cytokines interleukin-
1 (IL-1), tumour necrosis factor (TNF), and interleukin-6 (IL-6) have been seen in humans after 
short-term n-3 fatty acids supplementation. We investigated long-term effects of dietary n-3 fatty 
acids on circulating cytokine concentrations and on ex-vivo stimulated whole-blood production 
of IL-1, TNF and interleukin-1 receptor antagonist (IL-IRa), the naturally occuring antagonist of 
IL-1. 58 monks with a mean age of 56 year were randomised into four groups that supplemented 
their diets with 0, 3,6, or 9 g offish oil, providing 0,1.06, 2.13, or 3.19 g of n-3 fatty acids per day. 
Subjects received equal amounts of saturated fatty acids, vitamin E, and cholesterol. Compliance 
was excellent and erythrocyte fatty acid profiles closely reflected the amounts of n-3 fatty acids inge-
sted. In the group receiving 9 g offish oil per day, no influence of n-3 FA on circulating cytokine 
concentrations was observed relative to placebo. Endotoxin-stimulated whole-blood cytokine 
production was measured at 26 and 52 weeks after the start, and at 4,8, and 26 weeks after cessation 
of supplementation. In all groups, the production of IL-lß and IL-IRa was higher during supplemen-
tation than afterwards. However, no differences in cytokine production were noted between the 
placebo group and the various treatment groups at any point in time. Our results suggest that the 
long-term effects of dietary fish-oil supplementation on cytokine production in humans differ from 
short-term effects. 
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INTRODUCTION 
N-3 (omega-3) polyunsaturated fatty acids have been been investigated for use in the 
treatment of various inflammatory diseases [1]. In patients with rheumatoid arthritis, 
ulcerative colitis and psoriasis an alleviation of clinical symptoms has been noted after 
ingestion of n-3 fatty acids in the form of a fish-oil concentrate [1-5]. N-3 fatty acids have 
also been advanced for use in patients with bum trauma and in postoperative cancer patients 
[6-9]. The anti-inflammatory effects of n-3 fatty acids have originally been attributed to 
changes in the production of prostaglandins and leukotrienes [10-12]. More recently, 
however, reduced production of the pro-inflammatory cytokines interleukin-1 (IL-1) and 
tumour necrosis factor alpha (TNFa) has been emphasized as a possible mechanism [13]. 
IL-1, interleukin-6 (IL-6), and TNFa are small proteins that are produced by cells of 
mononuclear phagocytic origin, including circulating monocytes and tissue macrophages. 
These cytokines mediate the response of the host to various inflammatory stimuli. They 
induce fever, activation of В and Τ lymphocytes and endothelial cells, synthesis of acute 
phase proteins by the liver, and many other effects that are all part of the acute phase res­
ponse [14]. 
In four studies in healthy volunteers, significant reductions in IL-1 and TNFa production 
capacity of isolated peripheral blood mononuclear cells were observed after six weeks to 
three months of dietary fish-oil supplementation [13,15-17]. However, two controlled study 
did not find differences in cytokine production capacity after 7 weeks and 4 months of 
dietary fish-oil supplementation [18,19]. Here we report on circulating IL-lß, IL-6, and 
TNFa, and on whole-blood ex-vivo production of IL-lß and TNFa in a one-year placebo-
controlled trial with graded doses of dietary fish-oil supplementation. Also, circulating 
concentrations and cellular production capacity of the anti-inflammatory cytokine IL-1 
receptor antagonist (IL-IRa), the naturally occuring antagonist of IL-1, was determined 
since increased IL- IRa production may theoretically also account for the anti-inflammatory 
effects of n-3 fatty acids [14]. 
SUBJECTS AND METHODS 
Subjects. Fifty-eight monks from one Trappist and three Benedictine monasteries in the 
Netherlands participated in the study. They were all in good health and without known 
underlying disease such as diabetes, cancer, or coronary heart disease. The ages of the sub-
jects ranged between 21 and 87 years with a mean ± SD of 56.2 ± 16.5 years. Body mass 
indexes were below 30 kg/m2; systolic and diastolic blood pressures were below 160 mmHg 
and 95 mmHg, respectively, concentrations of serum total cholesterol were below 7.0 mmol/1 
and triglycerides below 3.0 mmol/1. 
Ten monks were Trappists and thus vegetarians. During the study period, the subjects 
did not take medications influencing lipid metabolism or non-steroidal anti-inflammatory 
drugs. The study was approved by the Ethical Committee of the Department of Human 
Nutrition, and all subjects gave informed consent. 
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Experimental design. The study consisted of a two-week baseline period, followed by a one-
year treatment and a six-month follow-up period. Within each monastery, the subjects 
were randomly and blindly divided into four groups, which received zero (n=14), three 
(n=15), six (n=15), or nine (n=14) fish-oil capsules per day. In each dosage group the total 
number of capsules was made up to nine by adding nine, six, three or zero placebo capsules, 
respectively. Periodically, every subject received three bottles with dark-coloured capsules. 
Depending on the dosage group, none, one, two, or all three of the bottles contained fish-oil 
capsules while the remaining bottles contained placebo capsules. At each meal one capsule 
was taken from every botde. At regular intervals compliance was established by counting 
the remaining capsules. 
A clinical examination including weight, height, waist-hip and thigh circumferences, 
and blood pressure was done 8 times during the trial: on days -14,0 (start of the supplemen-
tation), 56,182, 363 (end of the supplementation), 396,424, and 536. At these times blood 
was also drawn. The conditions used for whole-blood ex-vivo production of IL-lß, TNFa, 
and IL-IRa turned out to have been inappropriate until 26 weeks after the start of the dietary 
supplementation. Therefore, these data are available only at 26 and 52 weeks of supple-
mentation and at 4, 8 and 26 weeks after cessation of the supplementation. In weeks 26 
and 52 the subjects recorded their habitual food consumption by writing down what they 
had eaten during three days. These data were completed by a trained dietician who 
interviewed the subjects, weighed portion sizes and checked recipes. 
All subjects received a diary to record use of medicine, illness, alcohol intake, inadvertent 
omission of capsule intake, and other relevant facts. 
Oil supplements. Eicosapentanoic (EPA)-rich fish-oil capsules were a kind gift of Labaz 
(Brussels, Belgium). The placebo capsules contained olive oil (Puget, Marseille, France) 
and palm oil (Loders- Kroklaan, Wormerveer, The Netherlands). Cholesterol (Merck, 
Darmstadt, FRG) and vitamin E (Organon, Oss, The Netherlands) were added. The placebo 
capsules were also manufactured by Labaz. Fatty acids composition and cholesterol content 
of the capsules were determined in our laboratory using capillary gas-liquid chromatography. 
Vitamin E content was measured by Dr. J. Schrijver (СГ О-TNO, Zeist, The Netherlands) 
using an HPLC method. The composition of the fish-oil and placebo capsules is shown 
in Table 1. EPA accounted for 72% of all n-3 FA in the fish oil. The fish-oil and the placebo 
capsules contained equal amounts of saturated fatty acids, vitamin E, and cholesterol. There 
was a small difference in the concentration of n-6 fatty acids. The n-3 fatty acids of the fish-
oil capsules were replaced by neutral monounsaturated fatty acids (largely oleic acid) plus 
some linoleic acid in the placebo capsules. Both capsules contained 1 g of fat, thus every 
subject had 9 g of extra fat per day. The daily intake of eicosapentanoic acid (EPA, С 20:5 
n-3), docosahexanoic acid (DHA, С 22:6 n-3), and С 22:5 n-3 in the various treatment 
groups is shown in Table 2. 
Measurement of fatty adds. After an overnight fast, venous blood was drawn into a 10 ml 
vacutainer tube with EDTA as anticoagulant. The tubes were centrifuged on the spot at 
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Table 1. Mean fatty acid composition, mean cholesterol and mean vitamin E content offish-oil 
and placebo capsules 
Fish-oil capsule Placebo capsule 
Saturated fatty acids (% mass of methylesters) 24 24 
Mono-unsaturated fatty acids (% mass of mcthylestcrs) 26 65 
N-3 fatty acids (% mass of methylesters) 37 0.6 
N-6 fatty acids (% mass of methylesters) 5 10 
Cholesterol (mg/100 g) 115 119 
VitaminE(IU/100g) 63 63 
low speed at 4°C to separate red blood ceUs. The cells were washed twice with ice cold saline, 
transferred into stoppered plastic tubes (Greiner, Nuttingen, FRG), and hemolysed by 
freezing at -80° С for at least 2 h. The hemolysates were stored at -20° С for a maximum 
of 7 days. Fatty acids of the hemolysates were measured by capillary gas chromatography. 
Cytokine measurements. Venous blood was drawn into three 4-mL evacuated gamma-steri­
lized blood collection tubes (Becton Dickinson, Vacutainer Systems, Rutherford, NJ, USA) 
containing 48 μι EDTA. The tubes were filled with blood by vacuo aspiration. 250 ul 
aprotinin with an activity of 10.000 kallikrein inactivating units per mL (Trasylol, Bayer, 
Leverkusen, Germany) was added per tube. One tube was centrifuged immediately and 
the resultant plasma was drawn off, stored in dry ice, transported to the laboratory, and 
stored at -80°C until assay of circulating cytokines. One of the remaining two samples was 
stimulated by addition of 50 ul endotoxin (lipopolysaccharide, LPS, E. colt serotype 055:B5, 
Sigma, St. Louis, MI, USA), concentration 800 μg/ml, final concentration 10 μg/ml. The 
control sample did not have endotoxin added. The two samples were inverted gently to 
mix and incubated for 24 h at 25 °C in a circulating water bath. The samples were incubated 
within five minutes after drawing, and incubation at 25° С was secured by keeping the 
samples in a portable stove throughout transportation to the laboratory. Following the 
incubation, samples were centrifuged at 1250 g for 10 min. For removal of platelets, the 
resultant plasma was spun in an Eppendorf centrifuge at 13.000 rpm for 5 min. Platelet-poor 
plasma, containing the secreted products of endotoxin-stimulated blood cells, was drawn 
off and stored at -80 е С until assay of cytokines. 
IL-lß, TNFa and IL-IRa were determined by radioimmunoassay as described [20-22]. 
Detection limit of IL-lß was 50 pg/ml, of TNFa 50 pg/ml, and of IL-IRa 100 pg/ml. 
Circulating concentrations of IL-6 were measured by ELISA [23], with a detection limit 
of 6 pg/ml. To avoid experimental fluctuations one batch of LPS and one batch of blood 
collecting tubes was used throughout the study. All samples of one subject were determined 
in the same series and in each series an equal number of samples of each treatment group 
was analysed to avoid bias due to assay variability. 
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Table 2. Daily n-3 fatty acid (g/day) intake in the various treatment groups 
n-3 fatty acid 
EPA (C 20 5, n-3) 
С 22 5, n-3 
DHA (C 22 6, n-3) 
Total 
Low dose fish-oil 
(3g/d) 
0 81 
0 09 
0 16 
106 
group Medium-dose fish-oil 
group (6 g/d) 
162 
0 18 
0 33 
2 13 
High-dose fish-oil group 
(9 g/d) 
2 43 
0 27 
0 49 
3 19 
EPA=eicosapentanoic acid, DHA=docosahexanoic acid 
Statistical analysis. Cytokine concentrations of the various diet groups were compared by 
multivariate rank test according to Koziol [24,25]. This is a non-parametric test for the 
comparison of growth curves, which accounts for missing data at certain time points. 
RESULTS 
Compliance. The interviews taken by the dieticians and the counting of the capsules revealed 
an excellent adherence to the experimental protocol throughout the 78 weeks that this study 
lasted. The determinations of fatty acid profiles of red blood cells closely reflected the 
amount of n-3 fatty acids ingested by the four experimental groups (Table 3) [26]. 26 weeks 
after cessation of the fat supplementation, the fatty acid profiles of the red blood cells had 
returned to pretreatment values. None of the subjects experienced adverse effects. 
Circulating cytokines. The concentrations of circulating IL-lß, IL-6, TNFa, and IL-IRa were 
determined in the groups receiving 0 and 9 g of fish oil per day only. As expected, these 
concentrations were low. The concentrations of IL-lß, TNFcc, and IL-IRa were well above 
the detection limit of the assay in all subjects, but IL-6 was below detection limit in all 
samples. For the circulating cytokines that could be measured, there was no significant diffe-
rence between the two treatment groups at any point in time, either in absolute concentra-
tions or in changes relative to baseline (figure 1). Basal concentrations of circulating 
cytokines were not different between vegetarians and non-vegetarians (data not shown). 
Ex-vivo production of IL-lß, TNFa, and IL-IRa after whole blood stimulation. In all three 
dose groups as well as in the placebo group, endotoxin-stimulated secretion of IL-lß and 
IL-IRa was significantly higher during oil supplementation than at 8 and 26 weeks after 
cessation of capsule intake (figure 2). A similar trend was observed in the secretion of TNFa, 
although differences over time were not statistically significant. The ex-vivo production 
of IL-lß, TNFa, and IL-IRa was not significantly different between the four diet groups 
at any point in time. The inter-individual variations in cytokine production were large. 
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Figure 1. Circulating concentrations ofIL-lß (top), TNFa (middle) and IL-IRa (bottom) at 
various timepoints before, during, and after dietary supplementation with placebo or 3.19 g 
n-3 fatty acids per day. Results expressed as mean ± SD. 
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Figure 2. Concentrations of IL-Iß (top), TNF a (middle) andlL-IRa (bottom) after stimulation 
of whole blood with lipopolysaccharide (10 μξ/ml) for 24 h. Subjects tookO, 1.06,2.13, or 3.19 
gn-3 fatty acids per day. ForlL-IRa, only thegroups receivingO or 3.19 gper day were analysed 
Results expressed as mean ± SD. 
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Table 3. Concentration of eicosapentaenotc acid (EPA) (C20:5 n-3) m erythrocyte hpids as 
a function of duration and level offish-oil supplementation. Values are represented as grams 
of EPA per 100 grams fatty acids 
Week of experiment * Daily ingestion of fish oil (g) 
0 3 6 9 
0 791021 
0 85 ±0 19 
0 83 ±0 16 
0 86 ± 0 30 
1 12 ± 0 24 
0 83 + 0 28 
0 88 ± 0 28 
0 78 ± 0 19 
0 83 ±0 17 
0 78 ± 0 22 
1 50 ± 0 20 
1 83 ± 0 37 
2 31 ±0 37 
3 06 ± 0 38 
2 82 ± 0 34 
1 89 + 0 27 
1 50 ± 0 24 
0 86 ± 0 20 
0 74 ± 0 18 
2 00 ± 0 25 
2 69 ±0 31 
3 41 ±0 58 
4 87 ± 0 63 
4 31 ±0 92 
2 77 ± 0 58 
2 13 ±0 53 
0 94 ± 0 30 
0 70 ± 0 22 
2 49 ± 0 48 
3 50 ± 0 55 
4 60 ± 0 86 
6 16 ± 1 04 
5 86 ± 1 22 
3 22 ± 1 06 
2 52 ± 0 58 
102 ±0 31 
* Fish oil supplementation from week 0 through week 52 From week 56 on, post supplementation values are represented 
When the values obtained at 78 weeks, i.e. 26 weeks after cessation of the fat supplementa-
tion, are taken as baseline values, percentual changes over time can be evaluated. Again, 
these values were not significantly different between the various experimental groups at 
any point in time (data not shown). 26 weeks after cessation of the dietary supplementation, 
cytokine production capacity was not different between vegetarians and non-vegetarians 
(data not shown). 
DISCUSSION 
The findings in this long-term placebo-controlled study differ from the results of previously 
published studies regarding the effects of dietary fish-oil supplementation on ex-vivo 
cytokine production [13,16,17,27]. In contrast to those studies, we found the ex-vivo 
production of pro-inflammatory cytokines to be greatest during supplementation and to 
be reduced after cessation of capsule intake. However, this trend was observed independent 
of dosage, and was even seen in the placebo-treated controls. 
In two controlled studies, no effect of dietary fish-oil on ex-vivo production of IL-Iß 
or TNFcc was found at 7 weeks and 4 months of supplementation [18,19]. Effects of n-3 
fatty acids that are apparent at 6 weeks, may thus have disappeared at 26 weeks of dietary 
fish-oil supplementation. 
The question remains why the ex-vivo production of IL-lß and IL-IRa was higher during 
the dietary supplementation in both the placebo and the n-3 fatty-acids supplemented 
groups. It is unlikely that the daily ingestion of placebo capsules containing 9 gram of a 
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mixture of olive and palm oil exerts such profound biological effects, since the fatty acid 
composition of cholesterylesters (not shown) and erythrocyte membranes did not change 
during intake of the placebo capsules. The time points studied rule out a seasonal effect 
on cytokine production capacity. 
The changes in fatty acid profiles were similar to those observed in the other studies 
mentioned. Therefore, the dose of n-3 fatty acids ingested cannot account for the lack of 
an effect on cytokine production. 
We have evaluated the cytokine production capacity of whole blood samples, whereas 
others employed in-vitro stimulation of mononuclear cells that were isolated by density 
gradient centrifugation. The relative simplicity of the whole-blood stimulation may render 
this method less prone to experimental biases: manipulation of the cell population studied 
is minimal, stimulation is started immediately upon removal of the cells from the circulation, 
and experimental conditions can easily be kept constant. Moreover, Nerad et al. have shown 
a good correlation between whole blood IL-Iß measurement and the method in which 
mononuclear cells are separated by density gradient centrifugation and stimulated ex vivo 
[22]. Therefore, whole blood stimulation may represent a reflection of cytokine production 
capacity that is at least as relevant as method using cell separation techniques. 
The concentrations of circulating cytokines were, as expected, very low. Higher concen-
trations can be found in severe disease states such as septic shock, burn trauma, and after 
experimental administration of endotoxin [28-31]. In rheumatoid arthritis patients, dietary 
fish-oil supplementation during 12 weeks resulted in decreased circulating concentrations 
of IL-Iß [32]. Our results indicate that dietary fish-oil supplementation does not affect the 
low concentrations of circulating cytokines that are found under physiological, unstimulated 
circumstances. 
In conclusion, in this long-term controlled trial we could not confirm the fish-oil induced 
reduction of ex-vivo stimulated cytokine production that was observed in most short term 
studies until now, but the results corroborate those of the medium term study of Cannon 
et al [19]. Our findings underscore the need for a well-controlled intervention trial 
comparing short-term and long-term effects of dietary fish-oil supplementation. 
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ABSTRACT 
Dietary fish-oil supplementation interferes with eicosanoid production and appears to decrease 
production of interleukin-1 (IL-1) and tumor necrosis factor (TNF). The effect offish oil was 
investigated in an intramuscular Klebsielh pneumoniae-infection in Swiss mice and in cerebral malaria 
induced by Plasmodium bergheï in C57B1/6 mice. After a low inoculum of К pneumoniae, 90% of 
fish oil-fed mice survived; survival in control mice fed equal amounts of corn oil, palm oil or normal 
chow was 30%, 40% and 0% respectively. Cerebral malaria occurred in only 23% of fish oil-fed mice; 
in the controls cerebral malaria developed in 61%, 81% and 78% respectively. Contrary to what 
was expected, lipopolysaccharide-induced ex vivo production of IL-la and TNFa by peritoneal 
cells was significantly enhanced in fish oil-fed mice compared with controls. Indomethacin treatment 
did not alter the outcome in these two infections, thus arguing against reduced prostaglandin 
synthesis as an explanation for the increase in resistance to infection. 
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INTRODUCTION 
In a variety of experimental and clinical situations, dietary fish-oil supplementation has 
been shown to inhibit inflammation. In mice, development of lupus nephritis and induction 
of amyloidosis were significantly inhibited; in guinea pigs, survival after endotoxin 
administration was enhanced [1-3]. Moreover, the febrile response to interleukin-1 (IL-1) 
was attenuated by a fish oil-enriched diet in guinea pigs [4]. In clinical studies, rheumatoid 
arthritis was alleviated and psoriasis improved after 6-8 weeks of treatment with a fish-oil 
concentrate [5,6]. In human volunteers, there was a slightly reduced febrile response to 
endotoxin [7]. The reduced inflammation induced by fish oil has been attributed mainly 
to alterations in eicosanoid metabolism. Eicosapentaenoic acid is regarded as the active 
fatty acid in fish oil because of its structural similarity to arachidonic acid, the usual substrate 
for the enzymes cyclooxygenase and lipoxygenase. After prolonged ingestion of fish oil, 
the production of prostaglandin E2 (PGE2) and leukotriene (LT) B4 is markedly reduced, 
while the biologically less active PGE3 and LTB5 are formed [8,9]. 
More recently, alterations have been described in the production of the pro-inflammatory 
cytokines IL-1 and tumor necrosis factor α (TNF) after a fish oil- supplemented diet. In 
rats, production of these cytokines by Kupffer cells was significantly decreased after 6 weeks 
of a fish oil-enriched diet [ 10]. In humans, 6 weeks of dietary fish-oil supplementation 
resulted in a decreased ex vivo production of IL-la, IL-Iß and TNFa by stimulated 
peripheral blood mononuclear cells, the effect being even more pronounced 10 weeks after 
cessation of the diet [11]. In contrast, IL-1 and TNF synthesis by mouse peritoneal 
macrophages was reported to be enhanced after 16 days of a fish oil-enriched diet when 
compared with controls receiving corn oil [12]. 
In many forms of severe infection, important roles for IL-1 and TNF have been 
postulated. Circulating levels of IL-Iß and TNF were elevated in septic patients and after 
endotoxin infusion in human volunteers [13]. Elevated concentrations of TNF have been 
noted in the serum of malaria patients and in children with Plasmodium fakiparum-malana, 
serum TNF concentrations correlated with disease severity [14]. Antibodies against TNF 
have prevented death in experimental gram-negative infection and in experimental cerebral 
malaria [15,16]. Because of the role of these cytokines in infection and the modulation of 
their production by fish oil, we investigated the effects of a fish oil-enriched diet on resistance 
to infection in two experimental models, lethal gram-negative infection and cerebral malaria 
in mice. 
METHODS 
Gram-negative bacterial infection. Female Swiss mice of ~25 g were obtained from a local 
colony and housed under specific pathogen-free conditions. Klebsiella pneumoniae (ATCC 
43816), a strain that produces a lethal infection in normal mice, was inoculated in the left 
thigh muscle of nonneutropenic mice as described elsewhere [17]. Inocula used ranged 
from 0.5 χ 103 to 0.5 χ IO6 cfu. Survival was scored up to 5 days after infection. 
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Cerebral malana. For the malaria experiments, an inbred susceptible mouse strain has to 
be used. Female C57B1/6J mice -20 g were obtained from a local colony and housed under 
specific pathogen-free conditions. Plasmodium berghe'i К173 was maintained by weekly 
transfer of parasitized erythrocytes from infected to naive mice. Mice were infected with 
1000 parasitized erythrocytes intraperitoneally. In this model, death occurs in the second 
week after infection and is associated with a collapse of thermoregulation [18]. Histologi­
cally, the brains of these animals show loss of endothelial wall integrity, perivascular edema, 
hemorrhages and sequestration of leukocytes in the cerebral vessels [19]. On days 7,9, and 
11 after infection, thin blood films were made from tail blood and stained with May-
Griinwald and Giemsa solutions to score parasitemia. After death, light and electron 
microscopy of brain tissue using routine histological procedures was done to detect cerebral 
hemorrhages. 
Diets. In the first series of experiments, mice were fed standard lab chow (Hope Farms, 
Woerden, Netherlands) with daily supplementation of 0.2 ml of a fish oil-concentrate 
(Mepatrin, gift of Sanofi, Maassluis, Netherlands and Epax, gift of Jahres Fabrikker, 
Sandefjord, Norway, both preparations contained 34% eicosapentanoic acid and docosa-
hexanoic acid), administered by gastric instillation. Control animals received 0.2 ml of palm 
oil (Kriskol, gift of Loders-Croklaan, Wormerveer, Netherlands) or com oil (Mazóla; Knorr, 
CPC, Utrecht, Netherlands) by the same route. Oil supplementation represented about 
10% of total caloric intake. 
In subsequent experiments, the animals were fed a fat-free standard reference diet as 
a dry powder (Hope Farms), supplemented (wt/wt) with 14% fish oil and 1% corn oil (fish-
oil group), 15% com oil (corn-oil group), 15% palm oil (palm oil group) or standard lab 
chow without oil supplementation. In these experiments, oil supplements represented ~28% 
of total caloric intake. Twice a week, the food containing the supplements was freshly 
prepared and stored at 4°C. In the malaria experiments, p-aminobenzoic acid (PABA) was 
added to the drinking water to overcome the PABA-deficiency of the standard reference 
diet, which otherwise would have interfered with parasite proliferation. Diets were started 
6 weeks before infectious challenge and continued thereafter. 
Indomethaan. In separate experiments, the effects of inhibition of prostaglandin production 
were evaluated. In these experiments, mice were fed normal lab chow. In the K. pneumoniae-
infection, indomethacin 1 mg/kg, dispersed in 0.2 ml of carboxy-methyl cellulose 1% 
(CMC), was given by gastric instillation once a day starting 6 h before infection. In the 
malaria experiment, the same dosage of the drug was administrated daily from infection 
until death. Control animals received the same volume of CMC only. 
IL-1 and TNF. After 6 weeks on the diets, subsets of mice were killed and peritoneal cells 
were harvested by rinsing, using cold PBS with 0.38% sodium citrate as described elsewhere 
[20]. Cells were then centrifuged and resuspended in RPMI1640 (Dutch modificatio; Flow 
Laboratories, Irvine, UK), containing 1% pyruvate, 1% glutamate and 1% gentamicin (Essex, 
FISH OIL IN GRAM-NEGATIVE INFECTION AND CELEBRAI, MALARIA 59 
Amstelveen, Netherlands). After counting, concentration was adjusted to 2 χ IO6 cells/ml 
and volumes of 100 ul of cell suspensions were layered onto round-bottom microtiter plates 
(Greiner, Nürtingen, Germany) to which either 100 ul of medium or medium containing 
Escherichia colt (serotype 055:B5)-lipopolysaccharide (LPS, Sigma, St. Louis) at a final 
concentration of 100 ng/ml was added. After 24 h of culture at 37° С in a water-saturated 
atmosphere with 5% C02, the culture supernatants were harvested and frozen at -70°C 
until assay, 200 μΐ of medium was added to the adherent cells and these cells were frozen 
at -70 °C. Three freeze-thaw cycles were done before assay of cell-associated cytokines. 
Mouse IL-la and IL-Iß were determined by specific RI As [21]. Murine recombinant 
IL-la (rIL-la; a gift of P. Lomedico, Hoffmann-Laroche, Nutley, NJ) and murine rIL-lß 
(a gift of A. Shaw, Glaxo, Geneva) were labeled with 125I by a modification of the chloramine-
T method and purified by chromatography over Sephadex G-50. All antibodies were 
prepared at our institute. The assay buffer consisted of 0.01 M sodium phosphate in 0.9% 
saline (pH 7.4) with 0.25% bovine serum albumin (BSA; Sigma) and 0.25% sodium azide. 
Reference standards from 104 to 40 pg/ml were prepared in RPMI1640 by serial two-fold 
dilutions of mouse rIL-la and -IL-Iß. Samples of 100 μι were assayed in duplicate or in 
triplicate. Samples from LPS-stimulated cells were assayed undiluted as well as in a 1:4 
dilution in RPMI. An aliquot (100 ul) of specific polyclonal antibody (rabbit anti-mouse 
IL-la or rabbit anti-mouse IL-Iß, respectively), diluted appropriately in assay buffer, was 
added to the reference standards and to the samples. After 24 h of incubation at room 
temperature, 104 cpm of radiolabeled IL-la or IL-Iß in 100 μι of assay buffer was added. 
After a further 2 days of incubation at room temperature, the first antibody was precipitated 
by adding 0.75 ml of a solution containing 1.6% goat anti rabbit IgG and 9% polyethylene 
glycol (16-20 kDa; Sigma). After incubation at room temperature for 1 h, samples were 
centrifuged at 1500 g for 15 min and the radioactivity pelleted in the assay tubes was counted 
in a gamma counter. Nonspecific binding (NSB) in the absence of first antibody was 
subtracted and the result expressed as a percentage of the zero standard (B0) minus NSB. 
Standard curves were plotted as percentage of B0 against cytokine concentation, and cytokine 
concentrations were read from the linear part of the curve. Sensitivity of the assay was 80 
pg/ml for IL-la and 320 pg/ml for IL-lß. When the original sample was diluted, the value 
is expressed as that of the original concentration. 
Mouse TNFa was determined by ELISA as described elsewhere [22]. In short, 96-well 
immunoassay plates (Nunc, Roskilde, Denmark) were coated overnight at 4°C with TN3, 
a hamster monoclonal antibody specific for murine TNF and lymphotoxin (kindly provided 
by К. С F. Sheehan and R. D. Schreiber Celltech, Slough, UK) [23]. Plates were blocked 
with 1% BSA. After four washings with wash-buffer, test samples were added to the plate 
for 1 h at room temperature. A standard titration curve was obtained by making serial 
dilutions of a known sample of recombinant murine TNF (Genzyme, Cambridge, MA) 
in medium identical to the test sample. Plates were then washed four times with wash-buffer 
and incubated with rabbit anti-mouse TNF immune serum (Genzyme) and peroxidase 
conjugated goat anti-rabbit IgG (Jackson, WestGrove, PA). After adding the substrate (o-
phenylenediamine; Sigma) for 10 minutes, the color-reaction was stopped with 1.0 M H2S04 
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and photospectrometry (492 nm) was done. The ELISA has a lower detection limit of 150 
pg/ml. 
Organ counts of bacteria. Forty-eight hours after the injection of K. pneumoniae, mice fed 
fish oil and control mice were anaesthetized with ether and bled from the retrobulbar vessels 
by eye extraction. Blood for cultures was taken and livers and spleens were removed 
aseptically, weighed, and homogenized in sterile saline in a tissue grinder. To bring the 
bacterial counts after culture into the optimal range for reading, samples of liver and spleen 
were diluted in sterile saline. The suspensions were plated on sheep blood agar, and after 
overnight incubation the colony forming units were counted. 
Statistical analysis. Survival curves were analysed using the Kaplan-Meier log rank test [24]. 
Other differences between groups were analysed using the Kruskal-Wallis test with chi-
square approximation. Differences between groups were tested for significance only when 
overall P-value was < .05 (regarded as significant). 
RESULTS 
K. pneumoniae infection. After 6 weeks of oil supplementation by gastric instillation, no 
differences in survival between fish oil, corn oil or palm oil-fed mice were seen. In this 
experiment, the K. pneumoniae inoculum was 105 cfu and the median survival was 32 h. 
In subsequent experiments, oil supplementation was increased to 15% (wt/wt). Using lower 
inocula of K. pneumoniae, fish oil-fed mice survived longer than control groups (figure 
1A). The effect was most prominent with the lowest bacterial inoculum used (figure IB, 
Ρ < .05). No differences in the numbers of К pneumoniae colony forming units in blood, 
liver, and spleen were found between the mice fed fish oil or normal lab chow. Indomethacin 
(1 mg/kg), given daily from infection until death, did not influence survival after K. 
pneumoniae infection (data not shown). 
Cerebral malaria. In the second week of the infection, 6 (31.5%) of 19 mice receiving the 
fish-oil supplementation by gastric instillation developed the cerebral malaria syndrome 
compared with 18 (95.7%; Ρ < .001) of 19 mice in the palm oil-fed group and 4 of 5 mice 
in the control group that did not receive dietary intervention. Cerebral malaria was suspected 
in animals that died in the second week after infection and was confirmed histologically. 
Parasitemia in the fish oil-fed mice was significantly lower than in the other diet groups (fish 
oil vs no oil, Ρ < .01 on days 7 and 9; fish oil vs palm oil, Ρ < .05 on day 9). On days 7 and 
9, parasitemia was significantly lower in the fish-oil group compared with the other groups. 
In mice fed a fat-free reference diet supplemented with 15% fat (wt/wt), cerebral malaria 
occurred in 7 (23.3%) of 30 animals in the fish-oil group, in 20 (60.6%) of 33 in the corn-oil 
group (fish oil vs com oil, Ρ < .02), in 25 (80.6%) of 32 in the palm-oil group (fish oil vs 
palm oil, Ρ < .001), while 18 (78.3%) of 23 mice in the group fed normal lab chow died 
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Figure 1. Survival of Swiss mice after intramuscular administration of (A) 0.5x10* and (B) 
0.5ХІ03 cfu of Klebsiella pneumoniae. Oil supplements constituted 15% of the diet (wt/wt). 
Results of repeated experiments; each group consists of at least 10 mice. In B, difference in 
survival between fish-oil fed mice and other diet groups is significant (P < .05). 
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Figure 2. A. Survival ofC57Bl/6 mice in the second week after infection with 103 erythrocytes 
parasitized with Plasmodium berghei. Diets were supplemented with 15% fish oil, corn oil, 
or palm oil (wt/wt), or normal lab chow (fish oil vs corn oil, Ρ < .02; fish oil vs palm oil, Ρ < 
.001; fish oil vs normal lab chow, Ρ < .001). В. Parasitemia expressed as percentage of 
erythrocytes parasitized; in this experiment, differences were statistically significant. 
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of cerebral malaria (fish oil vs normal lab chow, Ρ < .001). Although at days 9 and 11 
parasitemia was lower in the fish oil group than in the other groups, the differences were 
not significant (figure 2). 
Indomethadn. Of 23 mice treated with indomethacin, 15 (62.2%) developed cerebral malaria 
compared with 11 (57.9%) of 19 animals in the control group. Parasitemias between the 
two groups did not differ significantly (data not shown). 
IL-la, IL-lß and TNF. The effects of the different diets on the concentrations of cytokines 
associated with resident peritoneal cells cultured for 24 hours and the concentrations in 
the supernatants are depicted in figure 3. Concentrations of LPS-stimulated, cell-associated 
IL-la were significantly higher in animals fed fish oil than in those fed corn oil (P < .02) 
or palm oil (P < .01). Concentrations of secreted IL-la were low and did not differ between 
groups. On average, IL-lß concentrations were higher than those of IL-la; cell-associated 
IL-lß was the highest in palm oil-fed mice and secreted IL-lß the highest in the fish-oil 
group. These differences were not statistically significant. In the three experimental groups, 
concentrations of cell-associated TNF were low and mostly below the detection limit (data 
not shown). In contrast, concentrations of secreted TNF, both unstimulated and stimulated, 
were significantly higher in the fish-oil group compared with the palm-oil and corn-oil 
groups (P < .02 and Ρ < .01 respectively). 
DISCUSSION 
We have shown that raising the content of n-3 polyunsaturated fatty acids in the diet during 
a period of 6 weeks increased resistance to infection in two experimental models in mice, 
lethal K. pneumoniae infection and cerebral malaria. The results indicate that the immuno­
modulatory and possibly immunosuppressive effects of dietary fish-oil supplementation 
did not lead to decreased resistance to infection. These results are in agreement with the 
finding of increased survival of endotoxin shock following dietary fish-oil supplementation 
[3]. 
Rubin et aL did not find differences in the susceptibility of (NZBxNZW)Fl mice to Listeria 
monocytogenes, Pseudomonas aeruginosa, Candida albicans or murine cytomegalovirus after 
4 weeks of a fish oil-enriched diet [25]. In their study, fish-oil supplementation may have 
had no effect because of the shorter duration of supplementation. In at least one other study, 
the anti-inflammatory effect of fish oil did not become apparent until fish-oil feeding had 
been sustained for 6 weeks [4]. 
In the K. pneumoniae-mfection, protection in the fish oil-fed group was most prominent 
when the bacterial inoculum was low, resulting in a longer median survival in all experimen­
tal groups. Whatever mechanism is involved in the increased resistance to this bacterial 
infection after fish-oil feeding, it is clear that it does not become apparent when the course 
of infection is rapidly fatal. 
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Figure 3. Concentrations ofinterleukin-la(IL-la), interleukin-lß (IL-lß) and tumor necrosis 
factor (TNF) after culture of peritoneal cells during 24 h in presence or absence of lipopolysaccha-
ride (LPS, 100 nglml). Values for LPS-stimufoted, cell associated IL-lawere significantly higher 
for fish oil (FO) compared with palm oil (PO; Ρ < .01) or corn oil (CO; Ρ < .02). Values for 
secreted TNF were significantly higher in the FP group compared with the PO group (P < .02) 
or CO group (P < .01). n=5for each group. 
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Dietary fish-oil supplementation has been shown to reduce the production of eicosanoids 
like PGE2. Because increased survival to experimental endotoxin shock after treatment with 
a cydooxygenase inhibitor has been reported [26], we investigated whether a cydooxygenase 
inhibitor such as indomethacin would influence survival in our models. The absence of 
an effect of indomethacin on survival in these infections, argues against reduced prostaglan­
din synthesis as an explanation for the increased resistance to infection. 
In contrast to what was expected, the increase in survival in the K. pneumoniae infection 
and the P. berghei infection was not associated with a decreased production of IL-1 and 
TNF by peritoneal cells. In fact, cell associated IL-1 α and TNF production capacity of these 
cells was enhanced in the fish oil-fed mice. These findings are in disagreement with the 
reports of reduced IL-1 and TNF production by rat Kupffer cells and human peripheral 
blood mononuclear cells after dietary fish-oil supplementation [10,11,27]. One study 
reported increased IL-1 and TNF production by mouse peritoneal macrophages, but cells 
were studied after only 16 days of a fish oil-supplemented diet [12]. Differences in species, 
cell types and durations of diets should be considered to explain these divergent findings. 
In the models of infection studied here, protection by low dosages of exogenously 
administered IL-1 has been well documented [28-30]. The protection provided by fish-oil 
supplementation is similar to the protection by IL-1 administered exogenously 24 h before 
gram-negative infection and early in the course of experimental malaria. An exaggerated 
endogenous production of IL-1 and TNF early in infection induced by dietary fish-oil 
supplementation may have the same effect as the exogenous administration of these 
cytokines. 
Apart from interference with cytokine production, dietary fish-oil supplementation has 
been associated with attenuation of some of the responses to exogenously administered 
IL-1. In guinea pigs, the febrile response to rIL-1 injection was attenuated after 6 weeks 
of a fish oil-enriched diet [4]. In rats, feeding fish oil for 6 weeks attenuated the catabolic 
response to a combined infusion of rIL-1 and recombinant TNF, as reflected by reduced 
whole-body leucine oxidation and increased net hepatic protein anabolism [31]. Also, 
anorexia induced by IL-1 was reduced in rats following a fish oil-enriched diet [32]. Because 
many of these effects have also been observed after pretreatment with a cydooxygenase 
inhibitor before injection of IL-1 [33,34], modulation of these IL-1 effects by fish-oil 
supplementation could be due to the decreased prostaglandin production after the fish-oil 
supplemented diet. As mentioned before, in our study treatment with indomethacin did 
not influence outcome, thus making reduced prostaglandin synthesis not a plausible 
explanation for the observed increase in resistance to infection. Of note, the increase in 
survival after pretreatment with low-dose IL-1 was not influenced by a cydooxygenase 
inhibitor [17]. 
In conclusion, dietary fish-oil supplementation increases resistance to infection in the 
two experimental models studied. Reduced synthesis of prostaglandins does not seem to 
play a role here because treatment with the cydooxygenase inhibitor indomethacin did 
not influence outcome in these experimental infections. Contrary to expectations, the 
increased resistance to infection was associated with an enhanced ex vivo production of 
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IL-1 and TNF by peritoneal cells in the fish oil-fed animals. The relative importance of this 
enhanced cytokine production in the increased survival in these infections remains to be 
established. 
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ABSTRACT 
Dietary fish-oil (FO) supplementation has been shown to inhibit inflammation in various clinical 
disease states and to be beneficial in experimental models of inflammation and bacterial and 
plasmodial infection. In mice, FO induces macrophage activation as reflected by increased production 
of tumor necrosis factor alpha (TNF) by isolated peritoneal macrophages. Production of TNF has 
been reported to be important in the resistance of mice against various Leishmania spp. We 
investigated whether dietary supplementation with FO protects susceptible Balb/c mice against in 
vivo infection with Leishmania amazonensis. No influence of the FO diet on the course of infection 
was observed. Lipopolysaccharide (LPS)-induced TNF production of peritoneal cells was however 
significantly increased in FO fed mice (p < 0.01). When L. amazonensis was used as a stimulus, the 
ex vivo production of TNF by isolated peritoneal cells was minimal and did not differ between the 
various treatment groups. Addition of interferon gamma did not restore the effect of FO on TNF 
production capacity. We conclude that dietary supplementation with FO is of no benefit in 
Leishmaniasis in susceptible Balb/c mice, and that L. amazonensis is an insufficient trigger for TNF 
production in this model. 
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INTRODUCTION 
Dietary supplementation with n-3 fatty acids that are abundant in fish oil concentrates, 
has been shown to inhibit inflammation in various clinical disease states [1-3]. In 
experimental models of inflammation sometimes a profound antiinflammatory effect of 
n-3 fatty acids has been noted [4,5]. These antiinflammatory effects of n-3 fatty acids have 
been attributed to reduced formation of prostaglandins and leukotrienes. More recently, 
it was shown that dietary n-3 fatty acids influence the production of the proinflammatory 
cytokines interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF). When peritoneal 
macrophages of n-3 fatty acids-fed mice are stimulated ex vivo with endotoxin, their 
production of IL-1 and TNF is substantially increased compared with controls [6,7]. At 
the same time, resistance to various Gram-negative infections and to malaria was increased 
after n-3 fatty acids-supplementation in mice and other animals [6,8-10]. These observations 
might indicate that dietary n-3 fatty acids facilitate macrophage activation in mice. 
The protozoans of the genus Leishmania infect mammalian macrophages and produce 
a wide range of clinical diseases, from cutaneous to visceral. The outcome of an infection 
depends on whether macrophages become activated and destroy the intracellular parasites. 
In experimental models in mice, protection against I. major is associated with the 
production of interferon gamma and TNF, while interleukin-4 is detected at a high level 
in susceptible mice [11,12]. I. amazonensis, a New World species, and L. major, an Old 
World species, are similar in that they both cause cutaneous infections. However, L. 
amazonensis produces firm indurating lesions, whereas L. major produces soft disseminating 
lesions. The immunopathology in murine infection with L. major and I. amazonensis is 
basically similar [13-15]. We hypothesized that dietary supplementation with n-3 fatty acids 
might facilitate macrophage activation of susceptible mice and thereby increase their 
resistance to infection with L. amazonensis. 
MATERIALS AND METHODS 
Mice. Eight-weeks old, female Balb/c mice (Balb/cAnNCrlBR) with an approximate weight 
of 17 g, were purchased from Charles River Wiga (Sulzfeld, Germany). The animals were 
housed under specific pathogen-free conditions. After one week of acclimatisation, the 
animals were started on the experimental diets. The mice were weighed at regular intervals. 
Diets. The animals were divided into three groups, receiving dietary supplementation with 
fish oil (FO, n=20), palm oil (PO, n=19), or normal lab chow (n=23). The oil-supplemented 
diets were prepared from a fat-free standard reference diet as a dry powder (Hope Farms, 
Woerden, Netherlands), supplemented (wt/wt) with 14% FO concentrate (Epax, a kind 
gift of Pronova, Sandefjord, Norway) and 1% com oil (FO diet), or 15% palm oil (Kriskol, 
a kind gift of Loders-Croklaan, Wormerveer, Netherlands). Oil supplements represented 
about 28% of total caloric intake. The fatty acid composition of the oil supplements is given 
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Table 1. Fatty acid composition of the oil supplements 
Fatty acid Fatty acid methylestcrs per 100 g (g) 
Fish oil concentrate Palm oil 
Saturated fatty acids 12 5 36 9 
Monounsaturated fatty acids 20 1 49 1 
Polyunsaturated fatty acids 52 9 13 8 
(n-6) fatty acids 17 0 
(n-3) fatty acids 512 0 
in Table 1. Twice a week, the food containing the supplements was freshly prepared and 
stored at 4° С 
In vivo Leishmania infection. Leishmania amazonensis LV 79 was passaged in Balb/c mice 
by infection of 106 amastigotes in each of the hind footpads [ 16]. For the experimental infec­
tion, animals were injected in both hind footpads with 2xl05 amastigotes prepared from 
lesions and suspended in 50 μι. The animals were infected after six weeks of dietary oil-
supplementation, and the diets were continued thereafter until the end of the experiment. 
At regular intervals after infection, the footpad lesions were measured with a caliper. 
Ex vivo stimulation of peritoneal celh. On day 38 after infection, six mice of each dietary group 
were sacrificed and peritoneal cells were harvested by lavage of the peritoneal cavity, using 
ice-cold phosphate-buffered saline with 0.38% sodium citrate. Cells were then centrifuged 
and resuspended in RPMI 1640 Dutch modification (ICN Irvine, UK) containing 1% 
pyruvate, 1% glutamate and 1% gentamicin (Essex, Amstelveen, Netherlands). After coun­
ting, concentration was adjusted to 1 χ IO6 cells/ml and volumes of 100 μΐ of cell suspensions 
were brought onto flat-bottom microtiter plates (Greiner, Nürtingen, Germany). The cells 
were cultured in the presence of medium only or medium plus lipopolysaccharide 100 
ng/mL (Exoli serotype 055:B5; Sigma, St. Louis, LPS). After 24 h of culture at 37°C in a 
water-saturated atmosphere with 5% C02 , supernatants were taken off and medium was 
added to the cells. The samples were kept at -20°C until assay. 
For subsequent experiments, L. amazonensis LV 79 amastigotes were harvested from 
the footpads of infected mice and cultured at 25°C in bicarbonate-free RPMI 1640 with 
HEPES 25 mmol/L, gentamicin 50 Mg/mL and fetal calf serum 20%. For ex vivo stimulation 
of peritoneal cells, promastigotes from stationary cultures were used less than one month 
after the original harvest. For each dietary group ten uninfected mice were sacrificed after 
6 weeks of diet and peritoneal cells were harvested as described above. Cells were again plated 
at a concentration of 1 χ IO6 cells/ml and volumes of 100 uL of cell suspensions were brought 
onto flat-bottom microtiter plates. The cells were now cultured in the presence of either 
medium only, promastigotes at a ratio of 20:1, promastigotes plus recombinant rat-interfe-
ron gamma (IFN gamma) 10 U/mL (a gift of Peter van der Meijden, TNO, Rijswijk, 
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Netherlands), promastigotes plus IFN-gamma plus lipopolysaccharide 100 ng/mL, or LPS 
alone. Polymyxin В (10 μg/ml) was routinely included in all cultures where LPS was not 
added. After 24 h of culture at 37° С in a water-saturated atmosphere with 5% C02, the 
samples were kept at -20°C until assay. 
Determination of TNF. Mouse TNFa was determined by enzyme-linked immunosorbent 
assay (ELISA) as described elsewhere [17]. In short, 96-well immunoassay plates (Nunc, 
Roskilde, Denmark) were coated overnight at 4°C with TN3, a hamster monoclonal 
antibody specific for murine TNF and lymphotoxin (kindly provided by Celltech, Slough, 
UK). Plates were blocked with 1% BSA. After four washings with wash-buffer, test samples 
were added to the plate for three h at room temperature. A standard titration curve was 
obtained by making serial dilutions of a known sample of recombinant murine TNF (Genzy-
me, Cambridge, MA) in medium identical to the test sample. Plates were then washed four 
times with wash-buffer and incubated with rabbit anti-mouse TNF immune serum and 
peroxidase conjugated goat anti-rabbit IgG (Jackson, WestGrove, PA). After adding the 
substrate (o-Phenylene-diamine, Sigma) for 10 minutes, the color-reaction was stopped 
with 1.0 M H2S04 and photospectrometry (492 nm) was performed. The ELISA had a lower 
detection limit of 150 pg/mL. 
Statistical analysis. Differences in TNF production and in footpad thickness were analyzed 
using a non-parametric analysis of variance (Kruskal-Wallis). 
RESULTS 
Weight gain. After six weeks of diet, weight gain in the oil-supplemented groups was 
significantly higher than in the group receiving normal diet (18% vs. 10%), reflecting the 
difference in caloric intake (Table 2). Weight gain was equal in the palm-oil and the FO 
fed mice. 
Table 2. Body weights of the various groups before and after six weeks of dietary supplementation 
Diet 
Normal lab chow 
Fish oil 
Palm oil 
WeekO 
1 6 6 1 0 7 
170± 1 0 
17 1 ± 1 0 
Weight (g) 
Week 6 
183 + 09 
20 0 ± 0 9 
20 2 ± 1 0 
η 
23 
20 
19 
At week 0, body weights were not significantly different between the various dietary groups At week 6, the oil-fed mice had 
significantly higher body weights than the animals fed normal lab chow (p < 0 001) Results expressed as mean ± SO 
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Normal diet 
days after infection 
Figure 1. Course of footpad thickness in Balb/c mice infected with 2xl(? Leishmania amazonen-
sis-amastigotes on day 0. Development of the lesions was equal in the various dietary groups. 
Fish oil: n-20, Palm oil: n=19, Normal lab chow: n=23. 
FISH OIL IN CUTANEOUS LEISHMANIASIS IN MICE 75 
In vivo Leishmania infection. Footpad thickness increased equally in all experimental groups. 
At day 38 after infection, footpads were slightly thicker in both oil-supplemented groups 
than in the control group receiving normal diet (Figure 1). 
Ex vivo TNF production at 6 weeks after in vivo infection. Unstimulated peritoneal cells 
isolated 38 days after Leis/imania-infection, did not show spontaneous production of TNF. 
However, TNF production capacity of these cells was well preserved as indicated by high 
concentrations of TNF secreted by these cells after stimulation with LPS 100 ng/mL (Figure 
2). It appeared that LPS-stimulated TNF production was significantly increased in the FO 
fed mice (p < 0.01). 
Leishmania-induced ex vivo TNF production of uninfected mice. As expected, TNF secretion 
by unstimulated peritoneal cells was very low or below detection limit. Stimulation by L. 
amazonensis-promastigotes resulted in low concentrations of TNF in the culture super-
natants, and there were no differences between the various dietary groups (Figure 3). 
Addition of IFN gamma raised Leis/imama-induced TNF secretion in all dietary groups, 
although not significantly. Addition of both IFN gamma and LPS resulted in significantly 
higher concentrations of TNF in all dietary groups, but the differences between the various 
dietary groups were not significant due to the large variations in TNF production. However, 
when in this experiment LPS was the only stimulus, FO fed mice showed a significantly 
increased TNF-production capacity, similar to what was found in mice at 6 weeks after in 
vivo infection with Leishmania (ρ < 0.01). 
DISCUSSION 
Our results indicate that dietary FO supplementation does not influence outcome of in 
vivo infection with L. amazonensis in susceptible Balb/c mice. Given the important role 
of TNF in murine Leishmaniasis, we investigated TNF production capacity in FO fed mice 
and compared it with controls. The LPS-induced TNF production of peritoneal cells 
collected at day 38 after the in vivo infection with L. amazonensis, appeared significantly 
increased in the FO fed Balb/c mice. Similarly increased LPS-induced TNF production after 
dietary n-3 fatty acids supplementation was reported by us and by other groups in various 
other mouse strains [6,7,18]. Recently, Chiofalo et al. reported that peritoneal macrophages 
of Lew/imaMM-resistant mice produced significantly more TNF than peritoneal macrophages 
of Leùhmam'a-susceptible mice when Leishmania infantum was the stimulus [19]. In the 
present experiments, macrophages from susceptible Balb/c mice secreted low concentrations 
of TNFa when challenged with L. amazonensis-promastigotes, and dietary FO supplementa-
tion did not increase the production of the cytokine. Moreover, addition of IFN gamma 
resulted in a minor increase in secreted TNF concentrations without differences between 
the various dietary groups. 
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unstimulated cells 
LPS 100 ng/mL 
Fish oil Palm oil Normal diet 
Figure 2. Production of tumor necrosis factor alpha (TNF) by peritoneal cells ofBalb/c mice. 
Cells were harvested on day 38 after in vivo infection of the mice with Leishmania amazonensis, 
and cultured in vitro for 24 h with or without lipopolysaccharide (LPS) 100 ng/ml. CelL· of 
fish-oil fed mice secreted significantly more TNF than cells of control mice fed palm oil or normal 
lab chow (p < 0.01). Each group consisted of six animah. Results are given as means ± standard 
deviations. 
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Figure 3. Production of tumor necrosis f actor alpha (TNF) by peritoneal ceUs of uninfected ВаВз/с 
mice. Each dietary group consisted often mice. Cells were harvested after six weeks of diet, and 
cultured in vitro for 24 h in the presence of a. medium only (unstimulated), b. Leishmania 
amazonensis-promastigotes ata ratio of20:1 (Leishmania), с. promastigotesplus recombinant 
mouse interferon gamma (IFN gamma) 10 U/mL, d. promastigotes plus IFN gamma plus 
lipopolysaccharide (LPS) 100 ng/mL, or e. LPS 100 ng/mL only. When LPS was the only 
stimulus, fish-oil fed mice showed a significantly increased TNF-production capacity (p < 0.01). 
Results are given as means ± standard deviation. 
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In mice, genetically determined susceptibility to Leishmania is manifested by the 
preferential activation of Th2-cells that fail to induce the L-arginine dependent generation 
of inorganic nitrogen oxides in leis/imani'a-infected macrophages [20,21]. Few studies have 
been performed regarding the effects of dietary FO supplementation on T-cell functions 
[22,23]. These studies in humans showed a decrease in IL-2 production after FO supplemen­
tation. The results of our in vivo study indicate that dietary FO supplementation cannot 
overcome the defect in intracellular killing of Leishmania by infected macrophages. This 
finding might reflect the inability of this dietary intervention to change the cytokine 
production pattern of T-cells from the Th2 to the Thl phenotype. 
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ABSTRACT 
Experimental primary infection with Plasmodium berghei in rats is known to be influenced by several 
cytokines. Dietary supplementation of n-3 fatty acids has been shown to influence cytokine 
production capacity and to protect mice from cerebral malaria. We investigated the effect of dietary 
fish-oil (FO) supplementation on cytokine and nitric oxide production and on liver schizont 
development in male brown Norway rats. Control groups were fed either corn-oil supplemented 
diet (CO) or standard lab chow (LC). After six weeks on either diet, rats given supplementary FO 
had a significantly lower production of interleukin-1 (IL-1) and IL-6 after stimulation with lipopolys-
accharide, and also had significantly lower numbers of liver schizonts compared with CO- or LC-fed 
animals. We conclude that in rats, a FO-supplemented diet reduces the production capacity of IL-1 
and IL-6 and inhibits schizont development after intravenous inoculation of P. berghei sporozoites. 
Fish oil did not influence nitric oxide production by peritoneal macrophages. 
F I S H O I L E F F E C T S O N P L A S M O D I U M B E R G H E I L I V E R S C H I Z O N T S 8 3 
INTRODUCTION 
The development of liver schizonts oí Plasmodium berghei in rodent hepatocytes is known 
to be influenced by cytokines. In vitro, interferon gamma, tumor necrosis factor alpha (TNF-
a), interleukin-1 (IL-1) and interleukin-6 (IL-6) have been shown to inhibit both sporozoite 
penetration and schizont development [1-4]. This inhibition seems to be due to induction 
of a defensive response in hepatocytes, since preincubation of sporozoites with IL-6 has 
no influence on schizont development [4]. 
Dietary fish-oil (FO) supplementation is known to influence cytokine production in 
several species [5-7]. At the same time, it has been shown to exert a beneficial effect on the 
course of infectious diseases, such as gram-negative sepsis and cerebral malaria in mice 
[7]. We investigated whether FO-supplementation had an influence on schizont develop-
ment in rats, and whether this influence was accompanied by changes in cytokine production 
capacity. Nussler et al demonstrated the inducibility of nitric oxide by cytokines and also 
that nitric oxide strongly inhibits schizont development in vitro [8,9]. Therefore we assessed 
the synthesis of nitric oxide by peritoneal macrophages from FO-supplemented and control 
rats. 
MATERIALS AND METHODS 
Rats. Male brown Norway rats were obtained from Harlan Olac Ltd., Blackthorn, Bicester, 
UK. Rats were housed under specific pathogen-free conditions. At the start of the diets, 
the rats were five weeks old. 
Diets. Three groups of five rats were fed a fat-free standard reference diet as a dry powder 
(Purified Diet; Hope Farms, Woerden, The Netherlands), supplemented with 1) 14 % 
(wt/wt) FO (EPAX 3000 TG, kindly provide by Pronova Biocare A.S., Sandefjord, Norway) 
and 1% corn oil (to prevent essential fatty acid deficiency i.e., linoleic acid in the FO group) 
(Mazóla, CPC, Benelux, The Netherlands) (FO group) 2) 15% corn oil (corn oil group 
[CO]), and 3) a standard lab chow without supplementation (control group [LC]) (only 
in experiment 2). In these experiments, oil supplements represented about 28% of total 
calorie intake. To overcome the p-aminobenzoic acid (PABA) deficiency of the standard 
reference diet, PABA was added to the drinking water. 
Production of P. berghei sporozoites. Sporozoites oiP.berghei (ANKA strain) were harvested 
from Anopheles gambiae mosquitoes 21 days after infection and purified on a biphasic 
gradient containing urographin and fetal calf serum (FCS). Live sporozoites in 1 ml of 
medium 199 were injected into the tail vein of the rats. 
Evaluation of the number of schizonts. Forty-four h after injection of sporozoites, rats were 
anesthesized with ether and killed by cervical dislocation and livers were removed. Sections 
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of the left liver lobe were fixed in formaldehyde. Paraffin-embedded sections (7 цт) were 
prepared and stained with hematoxylin and eosin. The number of liver schizonts (exo-
erythrocytic forms [EEF]) per cm2 of liver section from each rat was assessed by light 
microscopy. 
In vitro stimulation of peritoneal macrophages. After six weeks on either diet (FO, CO, or 
LC) all rats in each group were anesthesized with ether and killen by cervical dislocation. 
The peritoneal cavity of each rat was rinsed with 30 ml of sterile PBS containing 5% FCS. 
The aspirate was centrifuged and resuspended in Iscove's modified Dulbecco's medium 
(IMDM), supplemented with 10% FCS, 50 μΜ ß-mercaptoethanol (all obtained from Gibco, 
Grand Island, NY), and 40 μg/ml gentamicin (Essex, Amstelveen, The Netherlands). The 
proportion of macrophages in each suspension was assessed by peroxidase staining. From 
each cell suspension, 2 χ 0.5 ml (all suspensions were cultured in duplicate) was seeded 
in 24 well culture plates (Costar, Cambridge, MA) at a density of 106 cells/ml. After overnight 
culture, supernatants were removed and fresh medium with or without lipopolysaccharide 
(LPS, serotype 0111 :B4; Sigma, Brussels, Belgium) ( 10 ng/ml), was added to each well. The 
cells were incubated for an additional 24 h and supernatants were stored at -20 °C until 
measurement of cytokine and nitric oxide levels. After aspiration of supernatants, fresh 
medium was added to the cells, which were then lysed by freezing and thawing. In these 
lysed cell suspensions, we measured cell-associated IL-1 concentrations. 
Measurement of IL-1. A cloned murine Τ cell line (D10.G4.1) was derived from primed 
lymph node Τ cells from AKR/J mice [10]. A subline of these cells, (D10(N4)M) can be 
propagated in vitro in the presence of EL4-conditioned medium. Cells were cultured in 
IMDM supplemented with 5% FCS, 5 χ ΙΟ"5 M ß-mercaptoethanol, penicillin, streptomycin, 
and 10% EL4-conditioned medium. For the assay, cells were harvested by centrifugation, 
washed once, and used at a concentration of 10" cells/200 ul flat-bottom wells of microtiter 
plates in the presence of a suboptimal concentration (300 U/ml) of recombinant human 
IL-2 (rhIL-2) (kindly provided by Hoffman-La Roche, Nudey, NJ,). Cells were labeled with 
37 kBq 3H-thymidine (specific activity = 0.7-1.1 χ 108MBq/mmol; Amersham International, 
Buckinghamshire, Amersham, UK) during the last 4 h of a 72 h culture period [11]. This 
assay measures IL-1 a and IL-1 β. Recombinant human IL-1 ß (kindly provided by Hoffman-
La Roche) was used as a standard. The sensitivity of this assay was 1 pg/ml. All cultures 
were performed in triplicate and the standard deviation was always < 10%. 
The EL4 cells (a murine thymoma-derived cell line) were grown in IMDM supplemented 
with 5% FCS, 5 χ ΙΟ"5 M ß-mercaptoethanol, penicillin, and streptomycin. To prepare EL4-
conditioned medium, EL4 cells were harvested by centrifugation and incubated at 106 
cells/ml in large culture flasks in the same medium, together with 10 μ^πιΐ concanavalin 
A and 10 ng/ml phorbol myristate acetate. After 18 h, the supernatant was harvested and 
stored at -20 °C until use. 
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B9 bioassayfor IL-6. Interleukin-6 levels were measured in supernatants by the B9 bioassay 
[12]. Briefly, the IL-6-dependent murine hybridoma cell line (B9) was grown in IMDM 
supplemented with 10% FCS, 50μΜ ß-mercaptoethanol, 40 μ{>/πι1 of gentamicin, and 8 
U/ml of rhIL-6 at a cell density of 0.1 -1 χ lOVml. Before the assay, the B9 cells were harve­
sted by centrifugation and washed twice with IL-6-free medium, then seeded at a 
concentration of 5000 cells/200 ul in flat bottom wells of microtiter plates (Costar Europe, 
Badhoevedorp, The Netherlands) in the presence of supernatant samples in appropriate 
dilutions. Proliferation was measured by a pulse with 3H-thymidine during the last 16 h 
of a 96-h culture period, with 37 kBq added per well. Samples were tested in triplicate and 
always related to a standard curve included in each experiment. One U/ml of IL-6 gave rise 
to half-maximal proliferation by definition. The sensitivity of the assay was 0.3 pg/ml. 
Measurement of nitric oxide. Nitric oxide synthesis by cultured macrophages, as reflected 
by nitric oxide levels in culture supernatants, was assessed by the Griess reaction [13,14]. 
Briefly, 100 ul aliquote of supernatants were plated in 96 well microtiter plates. An equal 
volume of Griess reagent (0.1% naphtylene diamine hydrochloride, 2.5% phosphoric acid, 
and 1% sulfanylamide dissolved in demineralised water) was added to each well. After 10 
minutes of incubation at room temperature, the optical density was measured in an ELISA 
reader at a wavelength of 540 nm. Samples were tested in triplicate and related to a standard 
curve included in each experiment. 
Statistical analysis. All data were analysed using Wilcoxon's f-test. 
RESULTS 
Inhibition ofschizont development by FO supplementation. In the first experiment, only the 
FO and CO groups were included. After six weeks of the diet, the rats were injected with 
5 χ 105 sporozoites intravenously. FO-fed rats developed significantly lower numbers of 
EEF/cm2 of liver section than rats on СО-supplemented diet (Table 1). These results do 
not exclude the possibility that the СО-supplemented diet enhanced the development of 
EEF. Therefore, the experiment was repeated with the addition of a control group, which 
was fed standard lab chow (LC group). In this experiment, the rats were injected with 4 
χ 105 sporozoites. The numbers of EEF/cm2 in the control group and in the CO-supplemen-
ted group did not differ significantly, but the rats on the FO-supplemented diet had 
significantly lower EEF densities. 
Influence of a FO diet on cytokine production capacity of peritoneal macrophages. The proporti­
on of macrophages in the peritoneal aspirates, as assessed by peroxidase staining, was always 
between 75 and 85 %. Cell-associated and secreted IL-1 were measured separately, because 
IL-1 α is hardly secreted in the supernatant [15]. Concentrations of bioactive IL-1 in 
supernatants of LPS-stimulated macrophages were significantly lower in FO-fed rats than 
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Table 1. Influence of diet on schtzont development* 
Exp 
I 
II 
η 
5 
5 
sporozoites 
5 x10 s 
4 x10s 
CO 
35 5 ± 4 2 
22 5 ± 3 0 
number of schizonts 
FO 
6 3 ± 6 
4 4 ± 2 2 
per cm1 
LC 
ND 
21 5 ± 8 
"After six weeks on a corn oil (CO)-, fish oil (FO)-supplemented diet, or lab chow (I C), rats were injected intravenously 
with Plasmodium berghei sporozoites After 44 h, schizont density was assessed in resected livers In both experiments, ГО-
supplemented diet significantly reduced schizont density (P < 0 05 by the Wilcoxon f-test), while the СО-supplemented diet 
had no influence on schizont development ND = not done 
in СО-fed or LC-fed rats (P < 0.05). Concentrations of cell-associated IL-1 were also lower 
in FO-fed rats, but the difference was not statistically significant (P = 0.06) (Figure 1). 
Similar results were obtained for IL-6 levels, which were significantly lower in FO-fed rats 
(Figure 2). 
Influence of a FO diet on LPS-stimulated nitric oxide synthesis by macrophages. It has been 
demonstrated that nitric oxide strongly inhibits schizont development in hepatic cultures 
[8,9]. Its synthesis can be induced in several cell types such as endothelial cells, hepatocytes, 
and macrophages [9,16,17]. Dietary fish-oil supplementation has been shown to augment 
nitric oxide synthesis in endothelial cells [ 18]. To investigate whether increased inducibility 
of nitric oxide production in macrophages from FO-supplemented rats could explain the 
reduced schizont development in this group, nitric oxide levels were measured in culture 
supernatants of peritoneal macrophages with and without LPS stimulation. Coculture with 
LPS induced a statistically significant increase of about 20%. However, there was no 
difference in nitric oxide levels between the three dietary groups (Table 2). 
Table 2. Nitric oxide levels in supernatants of peritoneal macrophages* 
LC 
CO 
FO 
-LPS 
59 0 ± 4 54 
41 1 ±11 89 
49 5 ± 9 47 
+LPS 
71 5 ± 12 29 
47 8 ± 12 96 
59 711167 
% increase 
214±122 
172 ± 11 6 
2 1 8 1 2 0 5 
Ρ 
03 
03 
03 
* Peritoneal macrophages were harvested from five rats from each group and were cultured separately with or without 
hpopolysacchandc (LPS, 10 ng/ml) Mean concentrations ± SD are expressed in mmol/ml In all groups, the nitnc oxide 
concentration was significantly higher in LPS- stimulated samples LC = lab chow, CO = com oil, FO = fish oil 
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Fish oil Corn oil Lab chow 
Figure 1. Reduction of interleukin-1 (IL-1) production capacity by peritoneal macrophages 
from rats feda fish oil-supplemented diet. Peritoneal macrophages from rats fed fish oil, corn 
oil, or lab chow were cultured for 24 h with or without lipopolysaccaride (LPS). The IL-1 levels 
were measured in (A) suspensions of lysed cells (cell-associated) and (B) supernatants of 
peritoneal macrophages (secreted) with a bioassay using DIO cells. In stimulated cultures, 
secreted IL-1 levels in the supernatants were significantly higher in the rats fed corn oil and 
lab chow compared with those fed fish oil (P < 0.05). A similar difference was found for cell-
associated IL-1 (P = 0.06). Bars show the mean and SEM of five rats per group. All peritoneal 
cell suspensions were cultured in duplicate and measurement of cytokine concentrations was 
performed in triplicate. 
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Figure 2. Reduction of interleukin-6 (IL-6) production capacity by peritoneal macrophages 
in rats fed a fish oil-supplemented diet. Peritoneal macrophages from rats fed fish oil, corn oil, 
or lab chow were cultured for 24 h with or without lipopolysaccaride (LPS). The IL-6 levels 
were measured in supernatants with a bioassay using B9 celk. In stimulated cultures, IL-6 levels 
in the supernatants from rats fed fish oil were significantly lower compared with those fed corn 
oil or lab chow (P < 0.05). Bars show the mean and SEM of five rats per group. All peritoneal 
cell suspensions were cultured in duplicate and measurement of cytokine concentrations was 
performed in triplicate. 
DISCUSSION 
Our results show that a FO-supplemented diet can strongly reduce schizont development 
upon intravenous administration of P. berghei sporozoites in rats. These findings suggest 
a protective effect of FO on primary malaria infection. We also demonstrated the reduced 
cytokine production capacity of peritoneal macrophages from FO supplemented rats. These 
results corroborate the findings of Billiar et al, who showed reduced IL-1 production by 
liver macrophages from FO-fed rats [6]. The difference between cell-associated and secreted 
IL-1 in our study suggests a stronger reductive effect of a FO-diet on the production of IL-Iß 
than on IL-la [15]. This is in agreement with the results of Endres et al. and Meydani et 
al. [5,19]. In their experiments in humans, a FO diet significantly reduced the ex vivo 
production of TNF, IL-Iß, and IL-6 by stimulated peripheral blood mononuclear cells. 
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In mice, however, Blok et al. found that protection against cerebral malaria was associated 
with increased cytokine production capacity of peritoneal macrophages [7]. This underlines 
once more that extrapolation of experimental results in an animal model to humans or 
other species can prove erroneous. 
In several in vitro experiments and also in our previous in vivo study, it was demonstrated 
that exogenous IL-1 and IL-6 both inhibit schizont development [3,20]. Also, the effect 
of exogenous IL-1 could be reversed by treatment with anti-IL-6 antibody. Thus, inhibition 
of schizont development seems to be accomplished by IL-6. In this study however, a FO-
supplemented diet inhibited schizont development, but at the same time reduced cytokine 
production capacity. This discrepancy urged us to look for an alternative mechanism by 
which dietary FO-supplementation might inhibit schizont development. Recently, Nussler 
et al. demonstrated the inhibitory effect of nitric oxide on schizont development in vitro 
[8,9]. We found that nitric oxide concentrations in macrophage culture supernatants from 
FO-fed rats were similar to those from CO- or LC-fed rats. This suggests that the inhibition 
accomplished by the FO-diet is not mediated through cytokines or nitric oxide, but through 
another yet unknown mechanism, and that this mechanism makes up for the reduced 
cytokine production. 
The effects of dietary polyunsaturated fatty acids on cells concern mainly membrane 
structure and function, enzyme production, and receptor expression on the cell surface 
[21 ]. Expression of several membrane receptors is known to be down-regulated by a FO-
supplemented diet [21-23]. Van Pelt et al. identified two membrane proteins in human 
hepatocytes that are involved in the penetration of sporozoites [24]. Possibly, parallel to 
other cell surface receptors, sporozoite-specific receptors on the hepatocyte surface may 
also be down-regulated by a FO-supplemented diet, thus leading to a reduced penetration. 
Kumaratilake et al. demonstrated a killing effect of n-3 and n-6 polyunsaturated fatty acids 
in vitro on P. falciparum and in vivo on P. berghei trophozoites [18]. They showed that this 
effect was accomplished by oxidation. Levander and Ager also demonstrated the susceptibil-
ity of malarial parasites to oxidative stress induced by polyunsaturated fatty acids [25]. 
Docosahaxanoic acid and eicosaapentanoic acid are both important components of FO. 
A direct effect of oxidants on intrahepatocytic development of sporozoites has been 
demontrated by Pied et al. [4]. Therefore, this mechanism is also a plausible explantaion 
for the effect of a FO diet on schizont development in vivo. Further studies are needed to 
clarify this phenomenon and to explore its clinical usefulness. 
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ABSTRACT 
In experimental studies in mice, dietary supplementation with n-3 fatty acids (FA) alleviates 
inflammation and increases resistance to infection. Nevertheless, TNF production capacity was found 
to be increased in n-3 FA-fed mice. We previously found increased relative spleen weights in n-3 
FA-fed mice. Here, the nature of this increased spleen size was further investigated. Spleen cellularity 
was significantly increased in mice fed n-3 FA (fish oil 15% w/w), compared to controls fed corn 
oil (15%) or normal lab chow (p<0.05). Experiments with T-cell deficient nude mice and experiments 
employing macrophage depletion through liposomal dichloromethylene-biphosphonate (C12MDP), 
revealed that the increase in spleen cellularity is T-cell independent and largely due to macrophage 
accumulation in the spleen. Accumulation of marginal zone and red pulp macrophages was 
histologically and immunohistochemically confirmed. N-3 FA induced peripheral blood monocytosis 
and an aspecific increase in bone marrow cellularity. Post-endotoxin circulating TNF concentrations 
were significantly increased in n-3 FA-fed mice compared to controls. Splenectomy did not abolish 
this increase in circulating TNF. However, after macrophage depletion through liposomal C12MDP, 
circulating TNF was not detectable after endotoxin challenge. Circulating concentrations of colony 
stimulating factor-1 (CSF-1 ) did not differ between the various experimental groups. It is suggested 
that the cellular changes observed relate to increased constitutive production of TNF. 
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INTRODUCTION 
N-3 fatty acids (FA) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
are poly-unsaturated FA in which the last double bond is located between the third and 
fourth carbon atom from the methyl end of the fatty acid chain. Dietary supplementation 
with n-3 FA results in modification of the fatty acid composition of the cell membranes, 
thereby reducing the production and biological activity of prostaglandins and leukotrienes 
[1]. More recently, dietary supplementation with n-3 FA has been associated with 
modulations in the production of the pro-inflammatory cytokines interleukin-1 (IL-1) and 
tumor necrosis factor (TNF), the principal polypeptide mediators of inflammation [2,3]. 
In experimental studies, dietary supplementation with n-3 FA has been shown to alleviate 
inflammation in various clinical disease states and in animal models [4-11]. Preliminary 
evidence indicates that dietary n-3 fatty acid supplementation may increase resistance to 
infection in multi-trauma patients [12]. N-3 FA increase survival following endotoxic shock 
or infections with live microorganisms in various animal models [13-18], and dietary n-3 
FA increase IL-la and TNF production capacity of mouse peritoneal cells [15,19,20]. In 
the course of our experiments in mice, we noticed a 1.5-fold increase in relative spleen 
weight in n-3 FA-fed mice compared to controls. Similar observations have been reported 
by other groups studying mice or rats [21-23]. 
To elucidate the mechanism of the enhanced resistance to infections and possibly relate 
this to the increased spleen weight in mice, we studied the effects of dietary n-3 FA on the 
cellular composition of spleens, peripheral blood and bone marrow. Also, the effects of 
dietary n-3 FA on circulating concentrations of endotoxin-induced TNF and steady-state 
colony stimulating factor-1 (CSF-1) were investigated. 
MATERIALS AND METHODS 
Mice. In most experiments, 6 weeks old female Swiss mice, approximate weight 25 g were 
used. The animals were housed in plastic cages (type II and type III, Macrolon, Beyer en 
Eggelaar, the Netherlands), under specific pathogen free conditions at 23 ± 2°C and 7 
ventilations/h. In some experiments, normal female Balb/c and T-cell deficient female Balb/c 
nude mice (nu/nu) were used. Nude mice were housed in cages covered with sterilized 
filter bonnets. 
Diet. Mice were fed a fat-free standard reference diet as a dry powder, supplemented with 
14% fish oil concentrate and 1 % corn oil (fish-oil group; FO), 15% com oil (CO), or normal 
lab chow. The FO concentrate used was EPAX 3000 TG, a kind gift of Pronova, Bergen, 
Norway. The FO concentrate contained 37.1% n-3 FA, i.e. 17.7% EPA and 14.4% DHA 
(w/w). D-alpha tocopherol (0.67 mg/g) and a natural mix of tocopherols (0.525 mg/g) were 
added to avoid autooxidation. CO was a commercialy available preparation (Mazóla). 1 
% CO was added to the FO diet to avoid essential fatty acid deficiency. The FO concentrate 
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was kept under strict anaerobic conditions until preparation of the diet to avoid autooxida-
tion. Diets were prepared at least twice per week, and kept at 4CC until administration. 
Spleen analysis. The mice were anesthesized with ether and blood was taken from the 
retrobulbar vessels after eye extraction. The animals were killed by neck dislocation and 
spleens were removed and weighed. Total body weight was determined immediately before 
bleeding, and relative spleen weight was calculated afterwards. A suspension of spleen cells 
was made over a nylon filter, and cells were counted with a Coulter counter. The effect of 
dietary n-3 FA on spleen weight was determined in normal Swiss mice, normal Balb/c mice 
and T-cell deficient nude Balb/c mice (nu/nu). 
Spleen cells were phenotypically characterized with flowcytometry using a set of mono-
clonal antibodies specific for mouse cells: 59-AD 2.2 detecting Thy 1 (T-lymphocytes), RA3 
6B2 detecting B220 (B-lymphocytes), H129.19 detecting MT4 (CD-I-positive T-lympho-
cytes), 53-6.72 detecting Ly-2 (CD8-positive T-lymphocytes), KT3 (CD3-positive T-
lymphocytes), and F4/80 (macrophages). Details concerning these antibodies can be found 
in Leenen et al. [24]. 
After immunohistochemical staining of spleen sections with RA3 6B2 (anti-B220), a 
monoclonal antibody specific for mouse B-cells, the relative surface area of white pulp was 
quantitated using a Leitz Diaplan light microscope and a Videoplan image processing system. 
To analyze the role of mature phagocytic macrophages in the increase in spleen size, 
mice were fed FO for 0, 2, or 4 weeks. Subsequently the animals were injected intravenously 
in the tail vein with 1 mg of liposomal dichloromethylene-biphosphonate (C12MDP or 
clodronate), 24 h before LPS challenge, to deplete macrophages [25]. Control animals 
receiving the same diet were injected simultaneously with saline. Liposomal C12MDP was 
prepared as described [25]. Spleen histology was studied in treated and untreated animals 
to verify macrophage depletion. 
Peripheral blood cells. Peripheral blood cell count was performed by separately determining 
hematocrit and the total white blood cells count (using Coulter counter). Differential white 
blood cell count was performed by quantifying the light scatter profile of nucleated cells. 
Bone marrow analysis. Bone marrow was obtained from both femora of each mouse by 
flushing the femur shafts with 3 ml culture medium (RPMI, Dutch modification, Flow, 
Irvine, Scotland). Nucleated cells were counted with a Coulter counter. Soft-agar cultures 
of bone marrow cells were stimulated with macrophage colony stimulating factor (M-CSF) 
for 2 weeks and the number of macrophage precursors in the original preparation was 
quantitated by counting the number of macrophage colonies and clusters (<50 cells); ma-
crophage colony forming cells (M-CFC), and macrophage cluster forming cells (M-clustFC) 
are given per 104 nucleated bone marrow cells (NBMC) [26]. NBMC were phenotypically 
characterized with flowcytometry using monoclonal antibodies detecting antigens of mouse 
macrophage and granulocyte precursors. The monoclonal antibodies were produced at 
the Department of Immunology, Erasmus University, Rotterdam, Netherlands, as described 
N-3 FATTY ACIDS AND MACROPHAGES 97 
[27]. The following monoclonal antibodies were used: ER-MP12 and ER-MP20, identifying 
subpopulations of macrophage precursors, ER-MP58, identifying myeloid cells, and ER-
MP21, identifying transferrin-receptor expressing cells [28]. 
Post endotoxin circubting TNF. 1.5 h after i.p. administration of 10 μg lipopolysaccharide 
(E. colt, serotype 055:B5, Sigma, St. Louis) (LPS), mice were anesthesized with ether and 
blood was taken from the retrobulbar vessels after eye extraction. Blood samples (approxi­
mately 1 ml) were mixed with 100 ul EDTA-solution (21.4 mg/ml EDTA in H20) and kept 
on ice until centrifugation at 1500 g during 5 min. Resultant plasma was isolated and stored 
at -20° С until assay. 
TNFec was measured by ELISA using TN3, a hamster monoclonal antibody specific for 
murine TNFa and lymphotoxin, as described [29,30]. 
In separate experiments, the effect of splenectomy on post-endotoxin circulating TNF 
was studied. Splenectomy was performed after ether anesthesia in four week old mice, two 
weeks before the animals were started on the experimental diets. 
CSF-1. CSF-1 was determined in unstimulated serum samples by specific RIA as described 
in detail elsewhere [31]. This assay is based on the competition by CSF-1 for the interaction 
between 125I-labeled, purified mouse L cell CSF-1 glycoprotein with a rabbit polyclonal 
antibody to purified L cell CSF-1 [32] and is more sensitive than the conventional CSF-1 
bioassay based on bone marrow colony formation. Assays were carried out in duplicate 
on 20 ul samples. The concentration of CSF-1 in units/ml (1 unit=12 pg) was determined 
with reference to a standard curve prepared using a stable, partially purified L cell CSF-1 
preparation. 
Statistical analysis. Differences between groups were analyzed using the Kruskal-Wallis non-
parametric ANOVA test, corrected for ties. Results were considered statistically significant 
at P-value < .05. 
RESULTS 
Effects ofFO supplementation on spleen cellularity. The effects of dietary n-3 FA on spleen, 
peripheral blood, and bone marrow cells are summarized in the Table. The following 
experiments were done to elucidate the mechanisms of the increased spleen weight in FO 
fed mice. After four weeks of dietary supplementation with FO or CO, experimental Swiss 
mice were compared with control animals on normal lab chow. FO fed mice had significantly 
increased relative spleen weights (P = 0.01) and spleen cellularity (P = 0.02). In separate 
experiments, time-effect relationships in these responses were investigated. Mice were 
studied simultaneously after 0, 2,4, and 6 weeks of dietary FO supplementation. Increases 
in spleen weight were most prominent after 2 weeks and appeared somewhat blunted after 
6 weeks (Fig. 1 A). Similar results were obtained in normal Balb/c mice. To investigate 
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Figure 1. Time-effect refotionships of dietary n-3 FA on relative spleen weight (A) and on post-
endotoxin circulating TNF (В). Relative spleen weight was significantly increased from 2 weeks 
on fish-oil diet on, as was post-endotoxin circulating TNF (n=12). 
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whether the increase in spleen size was accounted for or mediated by T-cells, T-cell deficient 
female Balb/c mice were fed FO for 0,2, or 4 weeks. Relative spleen weight was significantly 
increased from 2 weeks on, indicating that the increase in spleen weight was independent 
of the presence of T-cells (results not shown). 
Phenotypical characterization of spleen cells using a set of monoclonal antibodies, 
revealed no percentual differences in T-lymphocytes or macrophages between the various 
dietary groups. However, FO fed mice had a small but significant increase in B220 positive 
B-lymphocytes (table). 
Pretreatment with liposomal C12MDP 24 h before endotoxin challenge did not significant­
ly affect spleen weight. However, in mice that had been on FO diet for 2 or 4 weeks, liposo­
mal C12MDP resulted in a decrease in spleen weight (Fig. 2 A). In these FO fed mice, 
treatment with liposomal C12MDP resulted in spleen weights that were not significantly 
different from mice that had been on normal diet only. Depletion of marginal zone and 
red pulp macrophages was histologically confirmed but accurate quantitation of F4/80 
positive macrophages was not possible in cell suspensions, where their numbers were equal 
in control and FO fed mice. However, for other reasons (see below), the results indicate 
that the increase in spleen weight in FO fed mice is mainly attributable to an increase in 
the splenic macrophage population that is depleted by pretreatment with liposomal CljMDP. 
To a lesser extent, B-lymphocytes seem to contribute to the increased spleen cellularity 
in FO fed mice. Quantification of the relative surface area of red and white pulp in spleen 
sections, indicated a decrease in Τ and B-cell containing white pulp (Fig 3). A significant 
number of B220-positive B-cells, however, is also present in the red pulp. We therefore 
conclude that FO fed mice had a significantly increased content of red-pulp area, containing 
mainly macrophages. F4/80 staining of spleen sections, identifying the red pulp areas, 
confirmed the relative increase of the red pulp area in the FO fed mice. 
The effect ofFO supplementation on peripheral blood cells. To investigate a possible relation 
between circulating blood cells and changes in spleen cellularity, peripheral blood cells were 
quantitated. Hematocrit did not differ between the various treatment groups. White blood 
cells count was higher in FO fed mice, but this difference did not reach statistical signifi­
cance. Analysis of the light-scatter profile of peripheral blood cells showed a significant 
increase in percentage of monocytes in FO fed mice (P = 0.02, n=6). 
The effect ofFO supplementation on bone marrow cells. Possible relations between changes 
in spleen and peripheral blood cellularity and the cellular composition of bone marrow 
were investigated. Bone marrow cellularity was significantly increased in FO fed mice 
compared with mice fed CO or normal lab chow. This increase in bone marrow cellularity 
was equally distributed over the various hemopoietic lineages, since differential flow 
cytometric analysis of bone marrow cells, using ER-MP12 and ER-MP20 monoclonal 
antibodies, showed no significant differences between the various experimental groups 
(Table). Moreover, soft agar cultures of bone marrow cells did not reveal a relative increase 
in macrophage precursors, measured as M-CFC or M-clustFC. 
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Table 1. Effect of dietary N-3 FA on spleen, peripheral blood, and bone marrow cells 
Spleen 
Relative spleen weight (mg/g) 
Spleen cellulanty (x 108) 
В 220 positive spleen cells (%) 
Peripheral blood 
Hematocrit 
White blood cell count (x 106/mL) 
Lymphocytes (%) 
Granulocytes (%) 
Monocytes (%) 
Bone marrow 
Cellulanty (x 106) 
M-CFC 
(# macrophage precursors/10* NBMC) 
M-clustFC 
(# macrophage precursors/ΙΟ4 NBMC) 
ER-MP 21 high (erythroid cells) (%) 
ER-MP 58 high (myeloid cells) (%) 
ER-MP 12 high/20 neg 
(committed progenitors) (%) 
ER-MP 12 pos/20 pos 
(immature myeloid precursors) (%) 
ER-MP 12 neg/20 high 
(monocytes) (%) 
Fish oil 
5 9 ± 0 5 
2 7 ± 0 2 
41 ±4 
43 ±2 6 
1 2 2 ± 4 0 
55 ± 8 
34 ± 8 
11 ± 2 
24 ± 5 
58 ±15 
94 ±22 
22 ± 5 
50 ±7 
1 2 ± 0 3 
54 ± 1 2 
5 7 ± 0 9 
Diet group 
Corn oil 
4 8 ± 0 3 
2 0 ± 0 2 
36 + 2 
42 + 32 
9 1 ± 1 9 
69 + 4 
25 ± 4 
6 ± 1 
21 + 7 
51 ±17 
80 ±18 
25 ± 3 
50 ±2 
1 7 ± 0 2 
5 6 ± 0 5 
62 + 08 
Normal 
4 6 ± 0 2 
I 4 ± 0 5 
31 ±6 
4 3 ± 1 6 
7 9 ± 1 3 
64 ±5 
31 ± 6 
5 ± 1 
13±5 
77 ±20 
98 ±27 
22 ± 5 
54 ±6 
1 6 ± 0 5 
5 0 ± 1 2 
5 7 ± 1 2 
Ρ 
0 01 
0 02 
0 04 
NS 
NS 
NS 
NS 
0 02 
0 02 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
The effect ofFO supplementation on post-endotoxin TNF. To investigate the suggested increase 
in mononuclear phagocyte functionality, we measured circulating TNF concentrations after 
endotoxin challenge. Post-endotoxin concentrations of circulating TNF were significantly 
higher in FO-fed mice than in control mice. Post-endotoxin TNF was 10.4 ± 6.6 ng/ml in 
FO-fed mice, 2.2 ± 1.4 in СО-fed mice, and 2.7 ± 1.3 in mice fed normal diet (mean ± 
standard deviation, Ρ < 0.05). In separate experiments, time-effect relationships in TNF 
production and FO diet were investigated. Similar to the increase in spleen weight, increases 
in post-endotoxin circulating TNF were most prominent after 2 weeks of FO diet, and appea­
red somewhat blunted after 6 weeks (Fig. 1 B). Post-endotoxin TNF in T-cell deficient nude 
Balb/c mice was significantly increased from 2 weeks on, indicating that the increase in post-
endotoxin circulating TNF was independent of the presence of T-cells (results not shown). 
Splenectomy, performed 2 weeks before starting on the FO supplemented diet, did not 
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influence the increase in post-endotoxin circulating TNF concentrations after 2 and 4 weeks 
of diet: at both timepoints, post-endotoxin circulating TNF concentrations were significantly 
increased compared to baseline (results not shown). At baseline and at 2 and 4 weeks of 
dietary FO supplementation, post-endotoxin circulating TNF was not detectable in liposomal 
Cl2MDP-treated mice (Fig. 2 B). These observations suggest that splenic macrophages, 
despite their accumulation after dietary FO supplementation, are not the most important 
contributors to the production of circulating TNF. On the other hand, the macrophage 
population that is depleted by liposomal C12MDP and that does not reside in the spleen, 
appears to be the most important producer of post-endotoxin circulating TNF. 
The effect ofFO supplementation on circulating concentrations of CSF-1. The mononuclear 
phagocyte growth factor, CSF-1, is required for the development of the majority of mouse 
macrophages [33]. To accurately measure circulating concentrations of CSF-1, serum 
samples were subjected to a mouse CSF-1 specific RIA. In biological samples, this RIA detects 
only biologically active CSF-1 [32,34], including both glycoprotein and proteoglycan forms 
[35]. Circulating concentrations of immunoreactive CSF-1 did not differ between the various 
diet group: 702 ± 89 U/ml in FO-fed mice, 753 ± 96 in СО-fed mice, and 802 ± 158 in mice 
fed normal diet (mean ± standard deviation, ρ = 0.40). 
DISCUSSION 
The present study shows that dietary n-3 FA supplementation has a significant effect on 
the generation and distribution of mononuclear phagocytes in mice: n-3 FA induce a 
generalized increase in bone marrow cellularity, peripheral blood monocytosis, and 
accumulation of macrophages in the spleen leading to an increase in spleen size. What could 
be the mechanism of these n-3 FA-induced changes? 
The aspecific increase in bone marrow cellularity without preferential stimulation of 
monocytopoiesis is in accordance with our observation on CSF-1: this specific monocyte 
growth factor was not increased in the n-3 FA fed mice. The generalized increase in bone 
marrow cellularity suggests that earlier, broad spectrum hematopoietic growth factors such 
as interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) 
are involved. The production of these factors is largely regulated by pro-inflammatory 
cytokines including IL-1 [36,37]. We have previously shown that IL-la production capacity 
is increased in mice after dietary n-3 FA [15]. Increased constitutive production of this 
cytokine may be involved in the increased bone marrow cellularity observed in the present 
study. Moreover, Peius and others have shown that PGF^ has an important modulatory 
effect on hematopoiesis in mice: exogenous administration of PGEj reduced nucleated bone 
marrow and splenic cellularity, while blockade of PGF^ biosynthesis increased bone marrow 
and splenic cellularity, especially in the presence of IL-la [38-42]. These observations may 
partly explain the results obtained in the present study, since dietary supplementation with 
n-3 FA in mice basically leads to increased IL-la and a decreased PGF^ production capacity. 
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Figure 2. Balb/c mice were fed fish oil for 0,2, or 4 weeks. At the end of the diet period, subsets 
of mice were injected iv with liposomal Cl^/LDP 24 h before LPS challenge. In contrast to mice 
injected with saline, animah injected with liposomal Cl¡MDP did not show a significant increase 
in relative spleen weight following 2 or 4 weeks offish-oil supplementation (A). Post-endotoxin 
circulating TNF was not detectable in the liposomal Cl^ADP-treated mice (B). * indicates a 
statistically significant difference compared to mice that had no fish oil diet. 
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Figure 3. Spleen sections were stained for B220, an antigen specifically expressed by mouse В 
celh. The rebtive surface area of white pulp was quantitated using a Leitz Diaplan light mi­
croscope and a Videoplan image processing system. The boundaries of white pulp areas could 
be established easily since В 220 staining is confluent in the peripheral В cell zones of the white 
pulp but only scattered in the red pulp. Rektive surface areas are expressed as mean ± SD. 
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Peripheral blood monocytosis induced by dietary n-3 FA has not been described before, 
but may be induced through a feed-back mechanism following the accumulation of 
macrophages in the red pulp of the spleen. It is apparently not due to increased concentra-
tions of CSF-1. This is in accordance with the observation that the number of red pulp 
macrophages is only slightly reduced in CSF-1 deficient op/op mice [43]. Other factors, 
including IL-3, GM-CSF, and the pro-inflammatory cytokines may be considered. The 
results of our experiments with macrophage depletion using liposomal C12MDP suggest 
that the observed increase in spleen size following dietary FO supplementation is largely 
due to accumulation of macrophages in the spleen. The immunohistochemical staining 
of spleen sections with B220 showed a decrease in the relative surface area of white pulp 
in the FO-fed mice, thereby supporting the concept of accumulation of red-pulp macropha-
ges in FO-fed mice. As regulator cells, macrophages are responsible for the growth of 
lymphoid organs such as the spleen. Since TNF is an important growth factor for lymphoid 
organs, increased endogenous TNF production in FO-fed mice may contribute to this effect 
[44]. The phenotypical characterization of spleen cell suspensions using a set of monoclonal 
antibodies is not suitable for the assessment of the number of macrophages in the spleen, 
since especially tissue-fixed macrophages are lost in the process of making a cell suspension 
over a nylon filter. We therefore regard the concept that dietary FO supplementation leads 
to macrophage accumulation in the spleen as valid. 
The increase in spleen size after dietary n-3 FA appeared to be accompanied by increased 
circulating concentrations of post-endotoxin TNF. We and others have previousy shown 
that peritoneal macrophages of mice fed n-3 FA have increased TNF production capacity 
at the level of the single cell [ 15,20,45]. Since splenectomy did not affect the increased TNF 
concentrations following dietary n-3 FA, macrophage accumulation in the spleen is not 
responsible for the increased TNF concentrations. Interestingly, macrophage depletion by 
liposomal C12MDP completely abolished post-endotoxin circulating TNF. It might be 
expected that Kupffer cells of the liver, due to their sinusoidal location, might be a major 
target for the uptake of liposomal C12MDP. In fact, recent evidence indicates that 
macrophage depletion in mice results in a 50-70% reduction in TNF mRNA in the liver 
following endotoxin challenge [46]. Therefore, the Kuppfer cells may be the most important 
contributors to the production of post-endotoxin TNF. Similar to peritoneal macrophages, 
Kuppfer cells may have increased TNF production capacity at the single cell level following 
dietary n-3 FA. We did not assess the number of Kupffer cells. The small increase in relative 
liver weight in FO-fed mice does not rule out a substantial increase in the number of Kupffer 
cells. 
In conclusion, dietary n-3 FA supplementation in mice induces an aspecific increase 
in bone marrow cellularity, peripheral blood monocytosis, accumulation of macrophages 
in the spleen, and increased post-endotoxin circulating concentrations of TNF. The mecha-
nism of these changes remains to be elucidated. 
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ABSTRACT 
Epidemiological and experimental studies suggest that vitamin A deficiency decreases resistance 
to infection. We examined the influence of vitamin A deficiency on survival and quantitative organ 
cultures in NMRI mice after Klebsielb pneumoniae-inkction. In addition, infection-induced and 
endotoxin-induced production and production capacity of the pro-inflammatory cytokines 
interleukin 1 (IL-1) and tumor necrosis factor (TNF) were studied. Vitamin A deficiency had no 
effect on mortality. However, 24 h after infection, bacterial counts in blood, liver and spleen, and 
plasma concentrations of TNF were significantly increased in vitamin A deficient mice (P < 0.05). 
Vitamin A deficiency tended to increase plasma TNF concentrations 90 min after injection with 
10 μg LPS. Endotoxin-induced ex vivo production of TNF and IL-lß, but not IL-lcc was enhanced 
in peritoneal cells of vitamin A deficient mice. 
We conclude that vitamin A deficiency interferes with bactericidal mechanisms, despite increased 
production of pro-inflammatory cytokines. 
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INTRODUCTION 
Epidemiological studies suggest a relationship between vitamin A supplementation and 
decreased morbidity and mortality from infectious diseases in children in developing 
countries [1]. In animal studies, vitamin A has been shown to have a substantial impact 
on various aspects of host defense, such as humoral and cellular immunity [2-6]. In addition, 
vitamin A increases the expression of the genes encoding for interleukin Iß (IL-lß) [7], 
and facilitates the release of tumor necrosis factor α (TNF) [8]. Although the pro­
inflammatory cytokines TNF and IL-1 play an important role in the host defense against 
infection [9], the effects of vitamin A on IL-1 and TNF production have not been studied 
intensively. To investigate whether changes in the production of pro-inflammatory cytokines 
may relate to impaired host defense in vitamin A deficiency, we studied the outcome of 
a Gram-negative infection in normal and vitamin A deficient mice. Moreover, we studied 
whether vitamin A deficiency induces changes in the production or production capacity 
of these pro-inflammatory cytokines in experimental endotoxemia. 
MATERIALS AND METHODS 
Mice. Parent NMRI-mice were obtained from IFFA-CREDO Broekman (Someren, 
Netherlands). Vitamin A deficiency was produced using a two generation model. The 
mothers were randomly divided into three groups, which were fed semipurified diets that 
contained either normal vitamin A (Апопш1, 500 IU/kg) [ 10], low vitamin A (A1™, 100 IU/kg) 
or no vitamin А (Аиго). Retinyl-palmitate was used as the source of vitamin A. Diets were 
manufactured by TNO-ILOB (Wageningen, Netherlands) and were stored in the dark. Each 
diet group was randomly divided into two cohorts. The first cohort started the experimental 
diets upon arrival in the laboratory (three weeks before mating). The second cohort started 
the Anoralal diet upon arrival in the laboratory until mating and started the experimental diets 
afterwards. The litters were weaned 18 days after birth and the weanlings were fed the same 
diet as their mothers until the end of the experiments. Experiments were performed with 
the offspring only. Diets and water were supplied ad libitum. Offspring was weighed weekly. 
Mice were held under specific pathogen free conditions. 
Determination of vitamin A status. At 4,6,8 and 10 weeks of age serum retinol concentrations 
were determined in six mice per diet group. High performance liquid chromatography was 
used to quantify serum retinol [11]. Detection limit of the analysis was 0.035 μπιο17ί. 
Gram-negative bacterial infection. Eight weeks old female second generation mice on vit­
amin Α-diets were injected in the left thigh muscle with a LD50-inoculum of Klebsielh 
pneumoniae (ATCC 43816). Survival was scored up to 8 days after infection. 24 h after 
infection subsets of mice from each diet group were anesthesized with ether and bled from 
the retroorbital vessels. Approximately 1 ml of blood was collected in Eppendorf-cups 
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containing 100 μΐ EDTA/Trasylol mixture (containing 7150 kallikreine inactivating units 
and 21.4 mg/ml EDTA in H20) for determination of TNF. A small aliquot of blood was 
used for quantitative bacterial culture. For TNF determination, the blood samples were 
centrifuged (1500g, 10 min) and the plasma was isolated and stored at -20°C until analysis. 
Livers and spleens were removed aseptically for quantitative cultures of bacteria. The organs 
were weighed and homogenized in sterile saline in a tissue grinder. To bring the bacterial 
counts after culture in the optimal range for reading, samples of liver and spleen were diluted 
in sterile saline. The suspensions were plated on sheep blood agar, and after overnight 
incubation the colony forming units (CFU's) were counted. Each experiment was performed 
at least twice. 
Cytokine production. Either six or ten weeks old mice from each diet group were anesthesized 
with ether and injected with 10 μg lipopolysaccharide (LPS, E. coli serotype 055:B5, Sigma, 
St. Louis) into the orbital vene. 90 min after LPS-injection, subsets of mice were bled from 
the retroorbital vessels after ether anesthesia and were killed afterwards. Peritoneal cells 
were harvested by rinsing, using cold PBS with 0.38% sodium citrate. Cells were then 
centrifuged and resuspended in RPMI 1640 (Dutch modification; ICN, Irvine, UK) 
containing 0.11 g/1 pyruvate, 2 mM L-glutamine and 0.05 mg/mL gentamicin (Essex, 
Amstelveen, Netherlands). The concentration was adjusted to 2xl06 cells/ml and volumes 
of 100 ul of cell-suspensions were layered onto 96-wells-round-bottom microtiter plates 
(Greiner, Nürtingen, Germany). Either 100 μι medium or 100 μΐ medium containing E. 
co/i-LPS (final concentration 100 ng/mL) was added, experiments were performed in 
triplicate. After 24 h of incubation (37°C, 5% C02, relative humidity 77-82%), culture 
supernatants were harvested and immediately frozen at -20°C. Until assay, 200 μΐ of 
medium was added to the adherent cells and these cells were also frozen at -20 °C. Three 
freeze-thaw cycles were done before assay of the cell-associated IL-la. 
Cytokine assays. TNFa, IL-la, ILl-ß were assayed by specific radio immuno assay. Murine 
recombinant TNF (rTNF; gift of G. Adolf, Ernst Boehringer Institut, Vienna, Austria), 
murine rILl-a (gift of P. Lomedico, Hoffman-Laroche, Nutley, NJ, USA) and murine rILl-ß 
(gift of P. Graber, Glaxo, Geneva, Switzerland) were used and the assays were performed 
as described [12]. 
Statistical analysis. Survival curves were analysed using the Kaplan-Meier Log rank test. 
All other data were analysed using the Kruskal-Wallis test. In all tests Ρ < 0.05 was regarded 
as significant. 
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RESULTS 
Vitamin Α-status. Vitamin A deficiency in mice was produced using a two generation model. 
Mice on Аиго diets showed a steep decline in serum retinol levels between 4 and 6 weeks 
of age (from 0.6 to 0.05 umol/L, Ρ < 0.01 ). After week 6, levels were just above the detection 
limit (0.035 μιηοΙ/L), and decreased much slower. At weeks 6, 8, and 10, serum vitamin 
A concentrations were significantly different between AnonMl and Aœro mice (P < 0.05). The 
differences between Alow and A2*"1 mice did not reach statistical significance. Experiments 
were not performed until after week 6. 
In none of the experiments we found differences between the cohorts, indicating that 
vitamin A concentrations were equal in the two groups, regardless whether the mothers 
of the experimental mice started the experimental diets at mating or three weeks before 
mating. Therefore, data of the combined cohorts are presented. Vitamin A deficiency had 
no effect on growth (results not shown). Mean body weights of animals on the various diets 
did not differ at any time and showed a steady rise with age, until week 10. 
Klebsiella pneumoniae-infection. After infection of eight weeks old female mice with K. 
pneumoniae no differences in survival were observed between the diet groups. Nevertheless, 
quantitative bacterial cultures from various organs were significantly different between the 
various dietary vitamin A groups (Figure 1): blood, liver and spleen cultures from Aœr° mice 
yielded up to two log CFU's more than in Anormal mice (blood Ρ < 0.05; liver and spleen Ρ 
< 0.01). In cultures from Atow-mice, the number of CFU's was also higher than in cultures 
from Ancnnal-mice (P < 0.01). Liver and spleen weights 24 h after infection were not 
influenced by vitamin A deficiency. 
24 H after infection with LDM K. pneumoniae, plasma TNF concentrations were higher 
in Aœro-mice than in Anoraial-mice (AKr°: 0.33 ± 0.28, Anormal: 0.07 ± 0.05 ng/mL, Ρ < 0.01). 
Of the values in the AZ£ro-group, 54% was above the detection limit against 20% in the Alow 
and 6% in the Anormal-group. 
In vivo LPS-stimuhtion. Plasma TNF-concentrations at 90 min after injection of 10 μg LPS 
tended to be higher in the male Aar0 group than in the Anormal group (Аию: 12.7 ±2.7, Anonreü: 
5.3 ±1.0 ng/mL, Ρ = 0.057). In females, these differences were smaller. There were no diffe­
rences between Alow and Anormal mice. 
LPS stimuhtion of peritoneal cells. Despite prior in vivo administration of LPS, the isolated 
peritoneal cells produced significant quantities of cytokines after ex vivo LPS-stimulation. 
LPS-induced IL-la production in cultured peritoneal cells widely varied and did not differ 
between the three dietary groups or between sexes (Figure 2). In supernatants from males, 
IL-Iß secretion was significantly higher in the AMr°-group than in the A"ormal-group, either 
with or without LPS stimulation ex vivo (P < 0.05). The same trend was observed in females, 
although not significant. TNF secretion in supernatants of A^-cells was higher than in A """"^  
cells, either with or without in-vitro LPS-stimulation (P < 0.01 and Ρ < 0.05 respectively). 
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Figure 1.10Log (mean ± sd) of the number ofCFU's in blood, liver, and spleen of female NMRI 
mice, infected with 1.5x10? K. pneumoniae. 24 h after infection, blood and organ samples were 
plated on sheep blood agar. CFU's were counted after overnight incubation (37 °C). Bacterial 
counts in the organs ofAmo-group were significantly higher compared with Am"md-group (blood: 
p<0.05; liver and spleen: p<0.01). 
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Figure 2. CeH associated IL-1 a (A), and secreted IL-1β (В) and TNF (С) (mean ± sd) after 
24 h culture of peritoneal cells in the presence or absence of LPS, 100 ng/ml. IL-la did not differ 
significantly between groups. IL-lß secretion in the male Aaw-group was significantly higher 
compared with AmTmal-group (P < 0.05). The same effect, but not significant, was observed in 
females. TNF secretion in males and females was significantly higher in Am°-group compared 
with Anormü-group (P < 0.05). 
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DISCUSSION 
Our study shows that vitamin A deficiency can be produced in mice using a two generation 
model. The importance of the two generation model is underscored by the fact that, even 
after 28 weeks on the experimental diets, first generation mothers did not become vitamin A 
deficient (results not shown). This may be due to the large liver reserves of vitamin A that 
are built up during the ingestion of standard lab chow, which contains much more vitamin 
A than advised for mice [ 10]. In our study, the differences in vitamin Α-status between the 
various diet groups were large enough to cause significant experimental results. Some studies 
have found that a drop in weight accompanies severe vitamin A deficiency in mice [6,13]. 
We did not find such an effect in our experiments. 
Vitamin A deficiency had no effect on survival after infection with K. pneumoniae. 
However, outgrowth of K. pneumoniae was increased in the organs of vitamin A deficient 
mice. This finding is in accordance with the reported decline in blood clearance of E. coli 
in vitamin A deficient rats and the decreased phagocytic activity of polymorphonuclear 
leucocytes in vitro [5]. Thus, vitamin A deficiency may decrease phagocytosis and 
intracellular killing by polymorphonuclear leukocytes, leading to the increased organ counts 
of K. pneumoniae. 
Retinoic acid upregulates the production of IL-Iß and facilitates the release of TNF in 
human monocytes [ 7,8 ]. However, contrary to our expectations we found increased plasma 
TNF concentrations in vitamin A deficient mice after K. pneumoniae-infection. This 
enhanced TNF production in vitamin A deficiency cannot be explained by increased 
outgrowth of bacteria, since a similar trend was found after administration of LPS. 
Moreover, isolated peritoneal cells also exhibited increased cytokine production capacity 
in vitamin A deficient mice. This indicates that in mice, vitamin A deficiency in itself 
increases cytokine production capacity. 
The mechanism of the increased cytokine production in vitamin A deficiency remains 
to be elucidated. Carman et al. found that Τ lymphocytes from vitamin A deficient mice 
secrete substantially more IFN-gamma than normal mice [2,3]. It is conceivable that an 
increased IFN-gamma production enhances the IL-1 and TNF production. 
In our previous studies in mice, dietary or pharmacological manipulation of cytokine 
production yielded results that are opposite to the results of the present study. Dietary fish-
oil supplementation increased cytokine production and enhanced resistance to gram-
negative infection [14], while pharmacological inhibition of TNF production decreased 
resistance to infection [15]. Thus, vitamin A deficiency in mice seems to inhibit bactericidal 
mechanisms despite increased production of pro-inflammatory cytokines which are expected 
to stimulate phagocytic activities of leukocytes. 
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ABSTRACT 
Tumor necrosis factor α (TNFa) and interleukin-lß (IL-Iß) are principal mediators of septic shock; 
inhibition of TNFa production may ameliorate outcome in severe infections. Pentoxifylline, 
chlorpromazine, and thalidomide inhibit TNFa production. Their effects were tested in lethal 
endotoxemia in sensitized mice. Only chlorpromazine significantly improved survival. Chlorproma-
zine and pentoxifylline significantly reduced post-endotoxin circulating TNFa, by 89% and 76% 
respectively. Chlorpromazine also significandy reduced IL-Iß and soluble TNF receptor-P75. None 
of the drugs improved survival in Klebsiella pneumoniae-infected mice, despite significantly lower 
circulating TNFa concentrations in chlorpromazine- or pentoxifylline-treated animals. The three 
compounds decreased circulating TNFa in Candida albicans-infected mice, but survival was not 
influenced. In neutropenic mice, chlorpromazine had no influence on Candida organ counts, but 
in normal mice Candida counts in kidneys were higher in chlorpromazine-treated mice. Thus, inhibi-
tion of TNFa production was of no benefit in K. pneumoniae-initcúon and worsened outcome in 
C. albicans infection. 
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INTRODUCTION 
The pro-inflammatory cytokines interleukin-lß (IL-Iß) and tumor necrosis factor α (TNFa) 
play an important role in the pathophysiology of sepsis [1]. TNFa and IL-Iß concentrations 
are increased early in sepsis, and clinical studies demonstrate that high concentrations of 
TNFa in the circulation correlate with the severity of the disease and with a poor prognosis 
[2,3]. Treatment with anti-TNFa antibodies attenuates the lethal effects of endotoxin in 
mice and protects against shock after infusion of gram-negative bacteria in primates [4,5]. 
Similarly, treatment with either of the naturally occurring antagonists of IL-1 and TNF, 
IL-1 receptor antagonist (IL-IRa) and soluble TNF receptors (sTNFR), has been shown 
effective in lethal endotoxemia and in various models of experimental infection [6-11]. 
TNFa also appears to have an important role in experimental Candida albicans-miection. 
The mannoprotein constituents of the Candida cell wall induce the in vitro production 
of TNFa by macrophages [12], and in-vivo infusion of C. albicans in mice induces a rise 
in TNFa plasma concentrations which peak at 24 hours [13]. Therefore, TNFa synthesis 
may be an important target for pharmacological intervention in severe infections. 
Pentoxifylline, a methylxanthine derivate and phosphodiesterase inhibitor, inhibits the 
generation of mRNA for TNFa in vitro [14] and decreases the in vivo production of TNFa 
in humans and in experimental animals [15-17]. Pentoxifylline has been reported to increase 
survival of mice in endotoxic shock [16]. Chlorpromazine is a phenothiazine derivative 
with a broad spectrum of actions, that protects against the toxicity of endotoxin in various 
experimental models. At least part of this protection is achieved through inhibition of TNF 
synthesis [18]. Thalidomide has been used in the past as a sedative and antiemetic drug. 
Because of its teratogenic effects it has limited use as an antiinflammatory and immunosup-
pressive agent in the treatment of erythema nodosum leprosum, rheumatoid arthritis, and 
severe graft versus host disease [19-21]. Thalidomide has been shown to inhibit TNFa 
production by monocytes when these cells are triggered with endotoxin [22]. 
In the present study, we evaluated to what extent treatment with pentoxifylline, chlorpro-
mazine or thalidomide could increase survival after endotoxin challenge in sensitized mice. 
We measured circulating concentrations of TNFa, IL-Iß, and of the two soluble TNF 
receptors, sTNFR-P55 and sTNFR-P75, after endotoxin challenge. We also evaluated the 
effects of pentoxifylline, chlorpromazine and thalidomide in lethal infections with Klebsiella 
pneumoniae and with C. albicans. Because of the major importance of the polymorphonu-
clear leukocytes (PMN) in the defense against C. albicans [23], and their involvement in 
the actions of the cytokines during the infection, we studied the effects of the drugs in 
normal and in neutropenic mice infected with C. albicans. 
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MATERIALS AND METHODS 
Animals. Female Swiss mice, 6-8 weeks old, weight 20-25 g, were obtained from a local 
colony. The animals were fed standard lab chow (Hope Farms, Woerden, Netherlands), 
and were housed under specific pathogen-free conditions. 
Drugs. Pentoxifylline was obtained from Hoechst Pharma (Frankfurt am Main, Germany). 
Chlorpromazine was obtained from Rhone-Poulenc Rorer (Amstelveen, Netherlands), and 
thalidomide was provided by K. Zwingenberger (Grunenthal, Stolberg, Germany). 
Pentoxifylline (40 or 80 mg/kg) and chlorpromazine (4 mg/kg) were given in pyrogen-free 
saline by intraperitoneal (ip) injection, since this is a convenient and effective route of 
administration of these compounds [ 16,18]. Because no water-soluble form of thalidomide 
is availible, this drag was administrated by gastric instillation in 1% carboxymethylcellulose 
at a dose of 400 mg/kg. Control mice received vehicle by the same route. Pentoxifylline 
and chlorpromazine were given 30 min and thalidomide 1 h before endotoxin injection. 
In the experiments with live microorganisms, all treatments were started one day before 
infection and continued daily thereafter. Pentoxifylline was given at a dose of 80 mg/kg/day 
twice daily, chlorpromazine 4 mg/kg/day once daily, and thalidomide 400 mg/kg/day once 
daily. 
Lethal endotoxemia in sensitized mice. Lipopolysaccharide (LPS, Escherichia coli serotype 
055:B5) was obtained from Sigma (St. Louis). Mice were sensitized with actinomycin D 
(Sigma) or D-galactosamine (Merck, Darmstadt, Germany). Animals were injected ip with 
actinomycin D (0.6 or 0.8 mg/kg) 10 min before the ip injection of LPS (30 μg/kg) as 
described [ 18]. In the experiments in which the mice were sensitized with D-galactosamine, 
the animals were given D-galactosamine (560 mg/kg) and LPS (40 pg/kg) simultaneously 
ip [24]. After injection of LPS, 6 mice from each treatment group were anesthesized with 
ether and bled from the retroorbital plexus at 90 min for measurement of circulating TNFcc 
concentrations, and another 6 mice per treatment group at 3 h for measurement of 
circulating concentrations of IL-Iß and sTNFR-P55 and -P75. In the remaining mice, 
survival was assessed daily for 7 days. 
K. pneumoniae infection. K. pneumoniae (ATCC 43816), a strain that produces a lethal 
infection in normal mice, was inoculated in the left thigh muscle of the animals as described 
elsewhere [25]. Inocula ranged from 2xl02 to 2xl05 cfu. Twenty-four hours after infection, 
subgroups of mice were sacrificed and blood was collected for TNFa plasma concentrations. 
To quantitate the recovery of the microorganisms from the livers and spleens, the organs 
were removed aseptically, weighed, and homogenized in sterile saline in a tissue grinder. 
To bring the bacterial counts after culture into the optimal range for reading, samples of 
liver and spleen were diluted in sterile saline. The suspensions were plated on sheep blood 
agar, and the colony-forming units were counted after overnight incubation. Survival of 
the animals was observed for 5 days after infection. In a separate experiment the animals 
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were infected with an inoculum of 104 cfu and subgroups of 6 mice were sacrificed to 
measure the TNFa plasma concentrations at various time points after infection. In these 
animals we measured the recovery of the microorganism from blood, liver and spleen. 
C. albicans infection. С albicans ( 104 cfu) was given intravenously (iv) in the lateral tail vein. 
At 24 h after injection, subgroups of mice were sacrificed, blood was taken for determination 
of plasma TNFa concentrations, and the recovery of the microorganisms from livers, 
kidneys, and spleens was quantitated in a manner similar to the quantitation of K. 
pneumoniae. Organ suspensions were plated on Sabouraud dextrose agar, and colonies were 
counted after overnight incubation. Survival of the animals was monitored for 8 days. In 
addition, mice that were rendered granulocytopenic by subcutaneous injections of cydop-
hosphamid, 150 mg/kg 4 days before and 100 mg/kg 1 day before infection, were injected 
with 104 cfu C. albicans. 
TNF a measurement. Blood was collected in 1 mL tubes containing 7.5 pg EDTA (Becton 
and Dickinson, Rutheford, NJ) and 250 μι aprotinin (Bayer, Leverkusen, Germany), and 
centrifuged for 5 min. at 13000 g. After separation, the plasma was stored at -20° С until 
assayed for TNFa by ELISA. Briefly, 96-well immunoassay plates were coated overnight 
at 4° С with V1Q, a rat monoclonal antibody specific for mouse TNFa (provided by Peter 
Krammer, Institute for Immunology and Genetics, German Cancer Research Center, 
Heidelberg, Germany) [26]. Nonoccupied binding sites were blocked with 1% bovine serum 
albumin (BSA). The samples were added onto the plate for 1 h at room temperature. A 
standard titration curve was obtained by serial dilutions of a known sample of recombinant 
mouse TNFa in medium identical to the samples. Plates were then washed four times with 
wash-buffer and incubated with a rabbit anti-mouse polyclonal antibody and peroxidase-
conjugated swine anti-rabbit IgG. After substrate was added for 18 min., the reaction was 
stopped with 4 M H2S04, and photospectrometry (450 nm) was done. The lower detection 
limit was 300 pg/mL. In some of the experiments, ELISA was done with TN3 as the mono­
clonal antibody directed against mouse TNFa as described [27]. TN3 was provided by 
Celltech (Slough, U.K.) [28]. 
IL-lß measurement. Plasma was collected in the same manner as for TNFa measurement. 
IL-lß was measured on plasma samples obtained at 3 h after LPS injection by specific RIA 
as described [29]. 
sTNFR measurement. Plasma was collected in the same manner as for TNFa measurement. 
sTNFR-P55 and sTNFR-p75 were measured in plasma samples obtained 3 h after LPS 
injection by specific ELISA as described [30]. 
Statistical analysis. Survival curves were analyzed using the Kaplan-Meier logarithm of rank 
test [31]. Differences in concentrations of circulating cytokines and differences in organ 
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counts of the microorganisms were analyzed using the Kruskal-Wallis test with chi-square 
approximation. Results were considered statistically significant at Ρ < .05. 
RESULTS 
Lethal endotoxetnia in sensitized mice. Mortality occured in the first 48 h after endotoxin 
injection without further mortality during the next 5 days of follow-up. In the two models 
of endotoxin-induced mortality studied, i.e. actinomycin D- and in D-galactosamine-
sensitized mice, treatment with chlorpromazine significantly improved survival (P < .05). 
control 
chlorpromazine 
pentoxifylline 
thalidomide 
20 30 
hours 
40 50 
Figure 1. Percentage survival of D-Galactosamine-sensitized Swiss mice with after injection 
with lipopolysaccharide (n=10, results ofl representative experiment). Ρ < .05 for chlorproma­
zine treatment. In mice sensitized with actinomycin D, same trends were seen. 
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Treatment with pentoxifylline and thalidomide did not result in a better survival than 
control treatment (figure 1 ). In a separate experiment in which treatment with pentoxifylline 
was started 48 h before endotoxin challenge, survival of treated mice was not better than 
that of controls. Chlorpromazine and pentoxifylline had a strong inhibitory effect on 
immunoreactive TNFoc concentrations in plasma 90 min after endotoxin, whereas 
thalidomide did not influence circulating TNFcc (figure 2A). In actinomycin D-sensitized 
mice, TNFcc concentrations did not differ significantly between the groups treated with 
pentoxifylline and chlorpromazine, but in mice sensitized with D-galactosamine, TNFa 
concentrations in chlorpromazine-treated mice were significantly lower than in pentoxifyl-
line-treated mice (P < .01; results not shown). 
The effects of the drugs on circulating IL-1 ß concentrations 3 h after endotoxin injection 
are shown in figure 2B. Plasma IL-lß concentrations in chlorpromazine-treated mice were 
significantly lower than in control animals, but pentoxifylline and thalidomide did not influ-
ence circulating IL-lß concentrations. 
None of the compounds influenced the concentrations of sTNFR-P55 3 h after endotoxin 
(not shown). However, chlorpromazine significantly decreased the concentration of sTNFR-
P75 compared with controls (figure 2C). 
K. pneumoniae infection. At 30 min after intramuscular (im) injection of 104 cfu oiK.pneu-
moniae, blood cultures were still sterile, and TNFa was not detectable in the circulation. 
However, at 90 min, TNFa could be detected and remained relatively constant during the 
observation period (concentration range 1.1 - 3.3 ng/mL); from this timepoint on, the 
microorganisms were present in the blood, liver and spleen, indicating that there was an 
ongoing sepsis in these animals. 
Plasma TNFa concentrations at 24 h after infection were significantly decreased in the 
groups treated with pentoxifylline and chlorpromazine compared with controls. Pento-
xifylline reduced TNFa by 22% (from 0.9 ± 0.1 to 0.7 ± 0.2 ng/mL, n=10, £ < .05), 
chlorpromazine reduced TNFa by 30% (0.5 ± 0.2 to 0.3 ± 0.07 ng/mL, n=10, Ρ < .05). 
Although thalidomide reduced circulating TNFa concentrations by 69%, this difference 
was not statistically significant, because of the large variation in the control group (controls: 
1.3 ± 1.5, thalidomide-treatment: 0.4 ± 0.1 ng/mL, n=10). 
Survival was not significantly improved by either drug. Bacterial counts tended to be 
lower in the livers and spleens of the treated animals, regardless of the drug used, but these 
differences did not consistently reach statistical significance. Because chlorpromazine had 
the strongest effect on bacterial counts, we investigated the antimicrobial effect of 
chlorpromazine in vitro. Chlorpromazine did not inhibit the growth o(K. pneumoniae in 
vitro (data not shown). 
С albicans infection in поп-neutropenic mice. Plasma TNFa concentrations were lower in 
the chlorpromazine- and the thalidomide-treated animals than in their respective controls, 
while pentoxifylline was not able to inhibit the TNFa production significantly during this 
infection (figure ЗА). Survival was not influenced by any of the drugs used. Candida 
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Figure 2. Circulating concentrations of cytokines after lipopolysaccharide (LPS) injection. A, 
TNF a after 90 min (*P < .01 andP< .005 forpentoxifylline [POF] and chlorpromazine [CPZ], 
respectively). B, Interleukin-1 β (IL-lß) after 3h(*P< .001 for CPZ). C, Soluble TNF receptor-
P75 (sTNFR-P75) after 3 h (*P < .01 for CPZ). Results are mean ± SD (n = 6). TLD, 
thalidomide. 
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Figure 3. TNFaplasma concentrations 24 h after injection of Candida albicans into nonneutro-
penic mice (A; *P < .05) or neutropenic mice (B; *P < .05). POF, pentoxifylline; CPZ, 
chlorpromazine; TLD, thalidomide. Results are mean ± SD (n > 10 mice). 
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outgrowth tended to be higher in the pentoxifylline- and thalidomide-treated animals than 
in controls, but these differences were not statistically significant. However, chlorpromazine-
treated animals showed significantly higher Candida counts in kidneys than did controls 
(figure 4). 
С albicans infection in neutropenic mice. Pentoxifylline significandy lowered plasma TNFa 
concentrations (figure 3B). Chlorpromazine and thalidomide tended to inhibit the TNFa 
synthesis (P = .065 and Ρ = .07 respectively). It is of note that circulating TNFa concentrati­
ons were substantially higher in the neutropenic mice than in non-neutropenic animals. 
Survival and recovery of C. albicans from the organs were not influenced by any of the drugs 
tested (figure 4). 
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Figure 4. Candida ulbLans outgrowth from kidne)>s of noi ¡neutropenic and neutropenic animals 
after treatment with chlorpromazine (CPZ) compared with controls. Results are mean ± SD; 
n> 10 mice. *P < .05. 
DISCUSSION 
In this study we investigated the influence of three pharmacological inhibitors of TNFa 
synthesis on outcome of lethal endotoxemia and infection. Endotoxin induced mortality 
was studied in mice sensitized with D-galactosamine or actinomycin D. Normal mice exhibit 
a low and varying sensitivity to endotoxin, thus hampering reproducibility of experiments. 
Endotoxin induced mortality in sensitized mice has been shown to be mediated by cytokine 
PHARMACOLOGICAL INHIBITION OF CYTOKINE PRODUCTION 129 
production [ 10,18,24]. To rule out specific effects of either D-galactosamine or actinomycin 
D, both compounds were used in the experiments with sensitized mice. We found that chlor-
promazine was the most powerful inhibitor of post-endotoxin TNFa production, and the 
only one that increased survival in lethal endotoxemia. Despite substantial reduction in TNFa 
production by pentoxifylline, this drug did not improve survival after endotoxin challenge 
in our experiments. Our findings with chlorpromazine are in accordance with those of Gadina 
et al. [18], but despite equal and even higher dosage schedules of pentoxifylline used in our 
experiments, we could not confirm the data of Schade et al. [ 16 ] who showed a beneficial 
effect of pentoxifylline on survival. These differences cannot readily be explained. Thalido-
mide appeared not to be an inhibitor of TNFa production after in vivo administration of 
endotoxin. This finding underscores the differences in influence on cytokine production 
that maybe observed in in vivo versus in vitro experiments [22]. However, thalidomide did 
decrease plasma TNFa concentrations after Candida infection in non-neutropenic mice. 
Differences in pharmacokinetics between the orally administered thalidomide and the ip 
chlorpromazine and pentoxifylline may account for these divergent effects. 
Since pentoxifylline also substantially reduced post-endotoxin circulating TNFa 
concentrations, it is clear that reduction of TNFa production cannot solely account for 
the beneficial effect of chlorpromazine in lethal endotoxemia. In addition to substantially 
reducing TNFa production, chlorpromazine profoundly decreased post-endotoxin IL-Iß, 
and as far as we know this has not been reported before. As antagonism of IL-1 increases 
survival after lethal endotoxemia in mice [7], interference with the production of this 
cytokine may contribute to the effects observed. Chlorpromazine has a wide range of 
pharmacological activities, from antipsychotic and antihistaminic actions [32] to inhibition 
of phospholipase A2 [33]. To what extent these activities contribute to the effects in lethal 
endotoxemia is not clear. Pentoxifylline did not influence circulating IL-Iß concentrations, 
a finding in accordance with reports that phosphodiesterase inhibitors such as pentoxifylline 
selectively decrease TNFa production without affecting IL-1 production capacity [34]. 
It is of interest that chlorpromazine strongly reduced the concentration of circulating 
sTNFR-P75 at 3 h post endotoxin, without affecting the concentration of circulating sTNFR-
P55. It was recently reported that injection of endotoxin in mice results in an increase in 
both STNFR-P55 and sTNFR-P75 as early as 30 min after the injection. sTNFR-P55 slowly 
diminished after a peak 30 min after LPS, whereas sTNFR-P75 increased to a plateau concen-
tration 4 - 8 h after LPS administration [30]. Since both sTNFR-P55 and sTNFR-P75 are 
well detectable in the plasma 3 h after LPS injection, it is unlikely that we missed a difference 
in sTNFR-p55 concentrations induced by one of the compounds. Recently, evidence was 
gained that in mice, sTNFR-P75 and not sTNFR-p55 is responsible for the inactivation 
of TNF and clearance of the cytokine from the circulation [35]. It is unlikely that the strong 
decrease of sTNFR-P75 by chlorpromazine is brought about by its inhibiting effect on the 
production of TNFa or IL-lß, since neither anti-TNF antibody nor IL-1 receptor antagonist 
decreased the concentration of circulating sTNFR's after endotoxin injection [30]. Thus, 
the mechanism by which chlorpromazine reduces sTNFR-P75 concentration is probably 
more direct but remains to be elucidated. 
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From a clinical standpoint, it is somewhat worrisome that despite a marked inhibition 
of circulating TNFa concentrations, neither of the drugs we have tested improved outcome 
in the K. pneumoniae infection. An infection with live microorganisms gives rise to a much 
more complicated response of the host than an injection of LPS. After LPS injection, 
circulating TNFa concentrations peak at 90 min, and decrease rapidly thereafter [2]. As 
shown here, there is an ongoing release of TNF after im injection of К pneumoniae. These 
data are in accordance with the observations of others regarding the efficacy of anti-TNF 
antibodies in experimental E. coli infection: they may be protective after iv but not after 
ip injection of E.coli [36]. Thus, the lack of an effect of pharmacological TNF inhibition 
is reminiscent of the inability of anti-TNF antibodies to improve outcome in animal models 
of infection that resemble the gram-negative infection we have studied [4,26,37]. 
In the C. albicans infection in mice, we found no influence of the three drugs studied 
on the survival of the animals. A recent study also failed to show an effect of pentoxifylline 
on outcome of infection with C. albicans in rats [17]. In our pentoxifylline-treated 
nonneutropenic mice, the concentrations of TNFa tended to be reduced, but they were 
significantly inhibited only in the chlorpromazine- and thalidomide-treated groups. Only 
pentoxifylline significantly affected TNFa concentrations in neutropenic mice. Since the 
same doses of pentoxifylline and chlorpromazine did decrease the TNFa synthesis in the 
K. pneumoniae infection, these differences may be due to differences in the regulation of 
TNFa production in the two infection models. In this respect it should be mentioned that 
endotoxin does not induce TNFa synthesis in the endotoxin-resistant СЗН/HeJ mice, while 
C. albicans does [13]. 
In nonneutropenic mice, chlorpromazine treatment was associated with an increased 
outgrowth of Candida from the kidneys. However, in the neutropenic mice, none of the 
drugs tested influenced the recovery of the microorganisms from the organs. This observa­
tion is in accordance with the report by Steinshamn and Waage [38], who found that 
treatment with a monoclonal antibody against TNFa increased the outgrowth of С albicans 
from the kidneys of normal but not of neutropenic mice. Taken together, these observations 
in infection models are in agreement with the observations that TNFa increases the 
intracellular killing of С albicans by neutrophils in vitro [39,40]. Apart from its influence 
on TNF production, direct interference with killing function of neutrophils may also play 
a role in the increased outgrowth of Candida in the chlorpromazine-treated mice [41-43]. 
We conclude that chlorpromazine protects sensitized mice against death due to lethal 
endotoxemia and that this protection is accompagnied by a strong inhibition of in-vivo 
TNFa and IL-Iß synthesis. The anticytokine effect of chlorpromazine may be counteracted 
by decreased concentrations of circulating sTNFR-P75. Pentoxifylline, chlorpromazine, 
and thalidomide do not improve survival in the models of bacterial and fungal infections 
studied. In the experimental infections, which are probably more relevant for infections 
in humans than LPS challenges, the capacity of the drugs tested to inhibit TNFa production 
appeared limited. In the case of chlorpromazine, the potential benefit of reducing circulating 
concentrations of TNFa in lethal infections seems to be counteracted by a reduced 
phagocytosing capacity of neutrophils. In these experimental infections, the effects of 
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pharmacological inhibition of TNFcc production are reminiscent of the effects observed 
with antibodies to TNFa. 
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Despite the development and widespead use of broadspectrum antimicrobial drugs, 
morbidity and mortality from nosocomial infections still are an immense problem, especially 
in the growing number of immunocompromised patients. Today's research in infectious 
disease medicine not only aims at the development of more powerful antimicrobial drugs 
but also focusses on means to enhance natural resistance to infection. The immune response 
to an offending microorganism is primarily mediated by leukocytes, of which phagocytic 
cells and lymphocytes are most important. Phagocytic cells such as monocytes, macrophages, 
and granulocytes represent the innate or non-specific arm of host defense. Lymphocytes 
that specifically recognize individual pathogens are responsible for the specific arm of host 
defence. Most immune responses are made up of both innate and specific components, 
and thus require an intense communication between the many cell types involved. Cytokines 
are small signalling molecules that serve as intercellular messengers. The pro-inflammatory 
cytokines interleukin (IL)-lcc and -ß, tumor necrosis factor a (TNF), and IL-6 are mainly 
produced by cells of the mononuclear phagocytic system upon activation by an infectious 
agent. IL-1 and TNF are crucial in host defense, but in severe infections unchecked release 
of pro-inflammatory cytokines may worsen outcome. The physiologic roles of the pro-
inflammatory cytokines as well as that of their anti-inflammatory counterparts (interleukin-1 
receptor antagonist and soluble TNF receptors) are discussed in Chapter 2. 
Researchers have tried to manipulate host defense by exogenous administration of pro-
inflammatory cytokines before the infectious challenge or by blocking the action of cytokines 
through the administration of specific antibodies or anti-inflammatory cytokines. The stu-
dies presented in this thesis describe efforts to modulate cytokine production through 
nutritional or pharmacological interventions. An overview of the effects of dietary fish oil 
supplementation on inflammation and cytokine production is given in Chapter 2, because 
five of the seven interventional studies presented here use fish oil as a way to modulate 
cytokine production. Based on the literature we conclude that dietary fish oil supplementa-
tion convincingly inhibits inflammatory responses in experimental animals (especially in 
mice), but that fish oil has only limited anti-inflammatory potential in chronic inflammatory 
diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. Responses 
to dietary fish oil supplementation in terms of cytokine production capacity differ 
considerably between species. Whether the anti-inflammatory effect of dietary fish-oil 
supplementation is mediated by its effect on cytokine production remains speculative. 
In Chapter 3 we questioned whether the findings of Endres et al. [ 1 ] could be reproduced 
in a long-term placebo-controlled study. In our study in healty volunteers, the type of fatty 
acid supplemented had no effect on ex-vivo whole blood stimulated production of IL-1, 
TNF, IL-6 and IL-1 receptor antagonist. The duration of fatty acid supplementation was 
substantially longer in our study than in any other study reported. Future research may 
clarify whether the duration of dietary intervention may be an explanation for the lack of 
an effect in our study. 
In Chapter 4, 5, and 6, dietary fish-oil supplementation was used as a means to modulate 
cytokine production and the effects of this dietary intervention on host defense were studied 
in experimental models of infection in which the role of cytokines was well-established. 
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Based on the findings of Billiar et al. [2] and Endres et al. [1], we hypothesized that dietary 
fish-oil supplementation might reduce cytokine production capacity in mice and thereby 
ameliorate outcome in gram-negative infection and cerebral malaria. In the study in Chapter 
4, we indeed found enhanced resistance to these infections, but to our surprise ex-vivo IL-1 
and TNF production of isolated peritoneal cells was increased. This finding has now been 
confirmed by other groups. It is still unclear whether the increased resistance to these 
infections is the result of increased cytokine production capacity. However, the combination 
of enhanced resistance to infections and increased cytokine production capacity remains 
intriguing and this finding puts questionmarks at attempts to inhibit cytokine production 
in severe infections. 
Because cytokine production capacity was increased in mice, we argued that dietary fish-
oil supplementation facilitates the activation of macrophages in these animals. The outcome 
of an infection with protozoans of the genus Leishmania is dependent on the activation 
of infected macrophages to kill this intracellular pathogen. However, our study (described 
in Chapter 5) yielded negative results: dietary fish-oil supplementation had no effect on 
the growth of cutaneous Leishmania lesions, despite increased ex-vivo cytokine production 
after stimulation of macrophages with lipopolysaccharide. When Leishmania was used as 
a stimulus for the ex-vivo cytokine production, macrophages of fish-oil fed mice did not 
produce more TNF than controls, indicating that the effect offish oil on cytokine production 
capacity is dependent on the type of stimulus used. We conclude that dietary fish-oil 
supplementation cannot overcome the deficient macrophage activation pathways that are 
present in Lei5/jma«ia-susceptible mouse strains. 
Others have shown that dietary fish-oil supplementation inhibits cytokine production 
capacity in rats [2]. In Chapter 6 we studied the effect of fish oil on the development of 
Plasmodium berghei liver schizonts in rats. Prior studies had shown that exogenous 
administration of IL-6 ameliorates outcome in this infection [3], and therefore we questio-
ned whether modulation of cytokine production by dietary fish-oil supplementation might 
alter the outcome of this infection. Fish oil inhibited the development of liver schizonts 
and reduced IL-1 and IL-6 production. Again, the question arises whether the observed 
effects of fish oil are related to its effects on cytokine production. 
In our studies on the effect of dietary fish-oil supplementation in mice, we consistently 
noted an increase in spleen size in the fish-oil fed animals. In Chapter 7 we attempted to 
elucidate the mechanism of this increased spleen size, because this phenomenon might relate 
to the enhancement of host defense against infections. Fish oil proved to increase the number 
of macrophages in the spleen, to induce peripheral blood monocytosis, and to increase bone 
marrow cellularity. Also, fish-oil fed mice had increased concentrations of circulating TNF 
after in-vivo administration of endotoxin. Thus, increased numbers of mononuclear 
phagocytes and facilitation of activation of these cells may explain the enhancement of 
resistance to some infections in fish-oil fed mice. 
Epidemiological studies suggest a relationship between vitamin A supplementation and 
decreased morbidity and mortality from infectious diseases in children in developing coun-
tries. Vitamin A has been shown to have a substantial impact on humoral and cellular 
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immunity, and to increase the expression of the genes encoding for IL-1 and to facilitate 
the release of TNF. In Chapter 8 we investigated the effect of vitamin A deficiency on 
resistance to gram-negative infection in mice and we attempted to relate these findings to 
ex-vivo and in-vivo cytokine production. Although survival was not influenced, vitamin 
A deficiency worsened outcome of gram-negative infection because bacterial counts in blood, 
liver and spleen. At the same time, infection-induced and endotoxin-induced cytokine 
production was increased in vitamin A deficient mice. Thus, vitamin A deficiency interfered 
with bactericidal mechanisms, despite increased production of pro-inflammatory cytokines. 
Many researchers have investigated the effects of specific anti-cytokine strategies in 
endotoxin-induced shock in experimental animals. Antibodies against pro-inflammatory 
cytokines, IL-1 receptor antagonist, and soluble TNF receptors have been proven effective 
in this setting. However, these substances have the disadvantage of high costs. Several 
pharmacological substances have been shown to inhibit cytokine production in various 
species and cell types. In Chapter 9, we investigated the effect of three pharmacological 
substances (chlorpromazine, pentoxifylline, and thalidomide) on endotoxic shock and on 
outcome of gram-negative and Candida infection in mice. Chlorpromazine proved to be 
the most powerful inhibitor of IL-1 and TNF production, and protected strongly against 
endotoxic shock. However, outcome of gram-negative infection was not better and outcome 
of Candida infection actually was worse in chlorpromazine-treated mice. The effects of 
pentoxifylline and thalidomide were weaker but pointed in the same direction. Although 
additional mechanisms such as decreased phagocytosis may play a role here, these findings 
indicate that inhibition of cytokine production is not generally benificial in experimental 
infections and may sometimes be dangerous. 
The studies in this thesis report on various ways to modulate cytokine production and 
on the consequenses this modulation has on resistance to infection. However, the results 
of these two outcome measurements, cytokine production and outcome of experimental 
infection, are not consistent over the various interventions and the various models studied 
(Table). Therefore, the general question "should we modulate cytokine production in severe 
infections?" cannot be answered on the basis of these studies. The studies show that in one 
species different interventions can lead to similarly increased cytokine production but still 
have opposite effects on outcome of gram-negative infection (fish oil supplementation and 
vitamin A deficiency). 
Similarly, the same intervention in different species (fish oil in mice and rats) leads to 
opposite responses in terms of cytokine production but ameliorates the outcome of the 
experimental infections in both species. Of the various interventions studied, dietary fish-oil 
supplementation seems the most promising for clinical application in certain patient groups 
such as post-operative intensive care unit patients. Further clinical studies are needed in 
this field. Future studies may also aim at elucidating the contribution of cytokines to the 
observed effects of fish oil on resistance to infection. 
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Intervention 
Fish oil 
Fish oil 
Fish oil 
Vitamin A 
deficiency 
Pharmacological 
inhibition of cytoki­
nes 
Species 
Humans 
Mice 
Rats 
Mice 
Mice 
Cytokine 
response 
1L-1 = 
TNF = 
IL-6 = 
IL-lra = 
IL 1 t 
TNFt 
IL-1 1 
IL 6 I 
IL 1 t 
TNF I 
IL 1 1 
TNF J 
Experimental infection 
nd 
К pneumoniae 
Ρ berghei (cerebral 
malaria model) 
L amazonensts (cutaneous 
Leismama model) 
Ρ berghei (liver schizonts) 
К pneumoniae 
Endotoxemia 
К pneumoniae 
С albicans 
Outcome of infection 
nd 
Survival t 
Bacterial counts = 
Survival I 
Parasitemia -
Leishmania-infected 
footpads = 
Liver schizonts 1 
Survival = 
Bacterial counts 1 
Survival endotoxemia t 
Survival К pneumoniae = 
Bacterial counts -
Survival С albicans = 
Fungal counts t 
Abbreviations IL 1 interieukin-1, TNF tumor necrosis factor IL 6 ïnterleukin 6, IL Ira ïnterleukin 1 receptor antagonist 
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De afgelopen vijftig jaar is de incidentie van de traditionele infectieziekten in de westerse 
wereld sterk afgenomen. Deze ontwikkeling kan worden teruggevoerd op een combinatie 
van verbeterde volksgezondheidszorg, vaccinatieprogramma's en de ontwikkeling van 
antimicrobiële middelen. Desondanks vormen infecties in toenemende mate een probleem 
bij patiënten met een verminderde gastheerweerstand, bijvoorbeeld door hoge leeftijd, 
immunosuppresieve therapie, kanker en de chemotherapeutische behandeling daarvan. 
Daarnaast hebben ontwikkelingen in de chirurgie en de intensive care, zoals het inbrengen 
van vreemd lichaam materiaal en de orgaantransplantatie, voor een geheel nieuwe 
infectiologische problematiek gezorgd. Vandaag de dag is het wetenschappelijk onderzoek 
met betrekking tot de infectieziekten dan ook niet meer uitsluitend gericht op de ontwikke-
ling van nog krachtiger antimicrobiële middelen, maar ook op mogelijkheden om de 
weerstand tegen infecties te verbeteren. In dit proefschrift worden een aantal onderzoeken 
beschreven waarin de centrale vraag was of het mogelijk is de weerstand tegen infecties te 
beïnvloeden door de productie van cytokinen te beïnvloeden. 
De weerstand van een organisme tegen een infecterend microorganisme wordt in de 
eerste plaats tot stand gebracht door de leukocyten, en dan met name door fagocyterende 
cellen en lymfocyten. Monocyten, macrofagen en granulocyten zijn in staat om micro-
organismen te fagocyteren en zij vertegenwoordigen de niet-specifieke arm van de 
gastheerweerstand. Lymfocyten kunnen de afzonderlijke pathogène microorganismen 
herkennen en vormen dus de specifieke arm van de gastheerweerstand. In de meeste gevallen 
zijn zowel fagocyterende cellen als lymfocyten betrokken bij het bestrijden van pathogène 
microorganismen en wordt de weerstand tegen infecties tot stand gebracht door een combi-
natie van specifieke en niet-specifieke elementen. Om de vele cellen die bij een afweerreactie 
betrokken zijn goed te laten samenwerken is een hoog ontwikkeld intercellulair communi-
catiesysteem nodig. Zowel lymfocyten als fagocyterende leukocyten produceren vele 
verschillende signaaleiwitten die, eenmaal uitgescheiden in de omgeving van de cel, andere 
cellen beïnvloeden. Dergelijke signaaleiwitten worden cytokinen genoemd en het samenspel 
tussen de vele verschillende cytokinen en de leukocyten leidt tot het "cytokinen netwerk". 
De pro-inflammatoire cytokinen (interleukine (IL)-la en ß, tumor necrosis factor α (TNF) 
en interleukine-6) worden voornamelijk geproduceerd door de cellen van het mononucléaire 
fagocyterende systeem na activarie door een infectieus agens. IL-1 en TNF spelen een cruciale 
rol bij de afweer tegen infecties, maar ongebreidelde productie van deze stoffen bij ernstige 
infecties kan uiteindelijk het herstel verhinderen. De fysiologische rol van de pro-
inflammatoire cytokinen en van hun anti-inflammatoire tegenpolen (interleukine-1 receptor 
antagonist en de circulerende TNF receptoren [Eng. soluble TNF receptors]) wordt be-
sproken in Hoofdstuk 2. 
Verschillende onderzoekers hebben getracht om de weerstand tegen infecties te beïnvloe-
den door voorafgaand aan de infectie, de gastheer een pro-inflammatoire cytokine toe te 
dienen. Ook is getracht om het effect van pro-inflammatoire cytokinen te blokkeren door 
het toedienen van specifieke antilichamen gericht tegen de pro-inflammatoire cytokinen 
of door het toedienen van anti-inflammatoire cytokinen. Bij de onderzoeken in dit proef-
SAMENVATTING EN CONCLUSIES 143 
schrift hebben wij geprobeerd om de endogene cytokinenproductie van de gastheer te 
manipuleren door middel van diètaire of farmacologische interventies. 
Omdat in vijf van de zeven interventie-onderzoeken in dit proefschrift een visolie-verrijkt 
dieet gebruikt wordt om de cytokinenproductie te beïnvloeden, wordt in Hoofdstuk 2 een 
overzicht gegeven van de literatuur betreffende het effect van visolie op ontsteking en op 
cytokinenproductie. Visolie bevat zogenaamde n-3 vetzuren, die na ingestie preferentieel 
worden ingebouwd in de celmembraan. Als gevolg van deze veranderde membraansamen-
stelling treed er een wijziging op in de productie en samenstelling van stoffen die bij de 
ontstekingsreactie betrokken zijn, zoals Prostaglandinen en leukotriënen. Recenter is 
gebleken dat ook de productie van pro-infiammatoire cytokinen beïnvloed kan worden 
door ingestie van visolie. Op grond van de literatuur komen wij tot de conclusie dat een 
visolie-verrijkt dieet de ontstekingsreactie remt in verschillende proefdiermodellen, met 
name bij muizen. Uit klinisch onderzoek bij patiënten met chronische ontstekingsziekten 
zoals reumatoïde arthritis, colitis en psoriasis blijkt echter dat visolie slechts een beperkte 
ontstekingsremmende werking heeft. De invloed van visolie op de productie van cytokinen 
blijkt aanzienlijk te verschillen tussen de ene diersoort en de andere. Of het ontste-
kingsremmende effect van visolie tot stand gebracht wordt door de invloed die het heeft 
op de cytokinenproductie is nog onduidelijk. 
In Hoofdstuk 3 hebben wij ons de vraag gesteld of we de resultaten van Endres et al. [ 1 ] 
konden bevestigen in een lange-termijn placebo-gecontroleerd onderzoek. In tegenstelling 
tot wat anderen vonden bleek in ons onderzoek het soort vetzuur in het dieet (visolie of 
niet) niet van invloed op de ex-vivo productie van IL-1, TNF, IL-6 en IL-1 receptor 
antagonist, gemeten na stimulatie van vol bloed monsters. Nu werd in ons onderzoek 
aanzienlijk langer een vetzuur-verrijkt dieet gegeven dan in enig ander gerapporteerd 
onderzoek. Mogelijk dat in de toekomst duidelijk wordt of de lange duur van het dieet 
verantwoordelijk is voor gebrek aan verschillen tussen de diverse dieetgroepen in ons 
onderzoek. 
In Hoofdstuk 4, 5 en 6 hebben we het effect van een visolie-verrijkt dieet op de gastheer-
weerstand onderzocht Hiertoe hebben we gebruik gemaakt van een aantal dierexperimentele 
infectiemodellen waarin de rol van cytokinen al eerder uitvoerig bestudeerd was. De 
bevindingen van Billiar et al. [2] en van Endres et al. [1] sterkten ons in de hypothese dat 
een visolie-verrijkt dieet de cytokinenproductie bij muizen zou afremmen en dat dienten-
gevolge deze dieren minder gevoelig zouden zijn voor een Gram-negatieve infectie en voor 
cerebrale malaria. Het in Hoofdstuk 4 beschreven onderzoek toont aan dat de weerstand 
van muizen tegen deze infecties inderdaad is toegenomen na een visolie-dieet, maar tot 
onze verrassing bleek de ex-vivo productie van IL-1 en TNF door geïsoleerde peritoneale 
cellen toegenomen in plaats van afgenomen. Deze bevinding is inmiddels door andere 
onderzoeksgroepen bevestigd. Nog steeds is niet duidelijk of de toename van de cyto-
kinenproductie de oorzaak is van de verbeterde overleving van infecties bij muizen. 
Niettemin is de combinatie van de twee fenomenen, een toegenomen cytokinenproductie 
en een verbeterde overleving van infecties, intrigerend en deze bevinding relativeert de 
waarde van het remmen van cytokinenproductie bij ernstige infecties. 
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Nu de cytokinenproductie capaciteit bij muizen verhoogd bleek, veronderstelden wij 
dat visolie de activatie van macrofagen zou vergemakkelijken. Leishmania is een parasitair 
microorganisme dat zich specifiek nestelt in de macrofagen van de gastheer. Of een muis 
een infectie met Leishmania te boven komt hangt af van de mate waarin geïnfecteerde 
macrofagen van het dier in staat zijn om deze intracellulaire parasiet te doden. Wij 
veronderstelden dat visolie tot een zodanige activatie van macrofagen zou leiden, dat 
Leishmania effectief zou worden uitgeschakeld. Ons onderzoek kon deze hypothese echter 
niet bevestigen: een visolie-vemjkt dieet had geen invloed op de groei van de Leishmania-
lesies, ondanks de toegenomen cytokinenproductie door geïsoleerde peritoneal macrofagen 
wanneer lipopolysaccharide van een Gram-negatieve bacterie als stimulans werd gebruikt. 
Wanneer we Leishmania als stimulus voor de ex-vivo cytokinenproductie van macrophagen 
gebruikten, bleek visolie niet meer te leiden tot een toegenomen cytokinenproductie. Dit 
duidt erop dat het effect van visolie op cytokinenproductie capaciteit afhankelijk is van de 
stimulus die gebruikt wordt om cytokinenproductie op te wekken. Blijkbaar kan een 
visolieverrijkt dieet de tekortschietende activatie van macrofagen bij voor Leishmania gevoe-
lige muizenstammen niet herstellen. 
Andere onderzoekers hebben aangetoond dat een visolie-verrijkt dieet de cytok-
inenproductie capaciteit verlaagt bij ratten [2]. In Hoofdstuk 6 hebben we het effect van 
visolie op de ontwikkeling van leverstadia van de malaria parasiet Plasmodium bergheï 
onderzocht bij ratten. Voorafgaand onderzoek had al aangetoond dat het toedienen van 
IL-6 aan ratten een gunstig effect had bij deze infectie [3], en daarom vroegen wij ons af 
of het beïnvloeden van cytokinenproductie middels visolie zou leiden tot verandering in 
de ontwikkeling van leverstadia van P. bergheï. Visolie bleek inderdaad de ontwikkeling 
van leverstadia afte remmen, en tegelijkertijd was de productie van IL-1 en IL-6 afgenomen. 
Opnieuw komt dan de vraag naar voren of het effect van visolie op de infectie samenhangt 
met het effect op de cytokinenproductie. 
Tijdens ons onderzoek naar de effecten van visolie bij muizen viel ons steeds op dat de 
met visolie gevoederde dieren een vergrote milt hadden. In Hoofdstuk 7 hebben we een 
poging gedaan om het mechanisme van deze miltvergroting te achterhalen, omdat het 
mogelijk zou kunnen samenhangen met de toegenomen weerstand tegen infecties. Onder 
invloed van visolie bleek het aantal macrofagen in de milt toe te nemen, er ontstond een 
monocytose in het perifere bloed, en de cellulariteit van het beenmerg nam toe. Bovendien 
bleek de concentratie van circulerend TNF na in-vivo toediening van endotoxine hoger 
bij de met visolie gevoederde muizen. Deze gegevens overziende zou een toename van het 
aantal mononucléaire fagocyten alsmede een makkelijker activatie van deze cellen na een 
visolie dieet de toegenomen weerstand tegen sommige infecties bij muizen kunnen verklaren. 
Epidemiologisch onderzoek bij kinderen in ontwikkelingslanden duidt erop dat 
toevoeging van extra vitamine A aan het dieet de morbiditeit en mortaliteit ten gevolge 
van infectieziekten vermindert. Vitamine A heeft een belangrijke invloed op de humorale 
en cellulaire afweer. Bovendien neemt de expressie van de genen die coderen voor IL-1 toe 
onder invloed van vitamine A en wordt het vrijmaken van TNF bevorderd. In Hoofdstuk 
8 hebben wij bij muizen het effect van vitamine A deficiëntie op de weerstand tegen een 
SAMENVATTING EN CONCLUSIES 145 
Gram-negatieve infectie onderzocht en we hebben getracht om onze bevindingen te relateren 
aan het effect van vitamine A deficiëntie op de ex-vivo en in-vivo cytokinenproductie. 
Hoewel de overleving van de muizen na de infectie niet werd beïnvloed leidde vitamine 
A deficiëntie wel tot een toegenomen hoeveelheid bacteriën in het bloed, de lever en de 
milt. Vitamine A deficiëntie interfereert dus met bactericide mechanismen ondanks een 
toegenomen productie van pro-inflammatoire cytokinen. 
Het effect van specifieke anti-cytokine Strategien op de overleving van proefdieren na 
een zogenaamde endotoxinenshock is door diverse onderzoeksgroepen onderzocht. Zo 
bleek het toedienen van antilichamen tegen pro-inflammatoire cytokinen, het toedienen 
van IL-1 receptor antagonist of van "soluble TNF receptors" effectief de sterfte van 
proefdieren te verminderen. Al deze stoffen hebben echter het nadeel dat ze zeer duur en 
schaars zijn. Van diverse farmacologische stoffen is echter ook aangetoond dat ze de 
productie van cytokinen kunnen remmen. In Hoofdstuk 9 hebben we het effect onderzocht 
van drie farmaca (chloorpromazine, pentoxifylline en thalidomide) op de overleving na 
endotoxinenshock, een Gram-negatieve infectie en een Candida infectie bij muizen. 
Chloorpromazine bleek de krachtigste remmer van de endogene productie van IL-1 en TNF 
te zijn, en dit middel bood de meeste bescherming tegen endotoxinenshock Chloorproma-
zine had echter geen invloed op het beloop van de Gram-negatieve infectie en het middel 
had een ongunstige invloed op het beloop van de Candida infectie. De effecten van 
pentoxifylline en thalidomide waren minder uitgesproken maar wezen toch in dezelfde 
richting. Hoewel deze farmaca natuurlijk hun eigen intrinsieke invloed op het beloop van 
deze infecties kunnen hebben, zoals een remming van de fagocytose, duiden onze resultaten 
er toch op dat remming van cytokinenproductie niet in het algemeen als gunstig gezien 
moet worden bij experimentele infecties en soms zelfs gevaarlijk kan zijn. 
In dit proefschrift worden diverse methoden beschreven om de productie van cytokinen 
te beïnvloeden en wordt gerapporteerd wat deze beïnvloeding van cytokinenproduktie voor 
consequenties heeft voor de weerstand tegen infecties. De invloed van onze interventies op 
deze twee variabelen (cytokinenproductie en weerstand tegen infecties) is echter niet 
eenduidig (zie Tabel). De meer algemene vraag of we bij ernstige infecties moeten proberen 
om de cytokinenproductie te manipuleren kan op grond van deze onderzoeken niet 
beantwoord worden. In een en hetzelfde proefdiermodel leiden verschillende interventies 
tot een vergelijkbare toename van cytokinenproductie en toch hebben deze interventies een 
tegengestelde invloed op de weerstand tegen een Gram-negatieve infectie (visolie-dieet en 
vitamine A deficiëntie). Ook blijkt dezelfde interventie bij verschillende proefdieren (visolie 
bij muizen en ratten) een tegengestelde invloed te hebben op de cytokinenproductie terwijl 
het beloop van de experimentele infecties in beide diersoorten gunstig wordt beïnvloed. Voor 
zover de onderzoeken uit dit proefschrift klinische betekenis hebben lijkt visoliesuppletie 
nog het meest toepasbaar in geselecteerde patiëntenpopulaties zoals postoperatieve patiënten 
op de intensive care. Goed gecontroleerde klinische onderzoeken zijn op dit gebied 
noodzakelijk. Wellicht dat toekomstig onderzoek meer duidelijkheid kan brengen in de 
bijdrage van de cytokinen aan de effecten van visolie op de weerstand tegen infecties. 
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Tabel. Overzicht van de onderzoeken in dit proefschrift 
Interventie 
Visolie 
Visolie 
Visolie 
Vitamine A 
deficiëntie 
Farmacologische rem 
ming van cytokmen 
productie 
Soort 
Mens 
Muis 
Rat 
Muis 
MUIS 
Cytokmen respons 
IL-1 = 
TNF = 
IL 6 = 
IL lra = 
1L-1 Г 
TNFI 
IL 1 1 
IL 6 1 
IL 1 I 
TNFI 
IL 1 1 
TNFI 
Experimentele infectie 
niet onderzocht 
К pneumoniae 
Ρ berghei 
(cerebrale malaria model) 
L amazonensis 
(cutaan Leismania model) 
Ρ berghei 
(lever schizonten) 
К pneumoniae 
Endotoxinemie 
К pneumoniae 
С albicans 
Beloop van de infectie 
niet onderzocht 
Overleving I 
Bactenegroei = 
Overleving I 
Parasitemie = 
Leismania lesies = 
Lever schizonten 1 
Overleving = 
Bactenegroei 1 
Overleving I 
Overleving = 
Bactenegroei = 
Overleving = 
Candidagroei t 
Afkortingen IL 1 ïnterleukine 1, TNF tumor necrosis factor; IL 6 mterleukine 6, IL Ira ïnterleukine 1 receptor antagonist 
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1. Een visolieverrijkt dieet verhoogt de productie van рго-inflammatoire cytokinen 
en verbetert de weerstand tegen een Gram-negatieve infectie bij de muis. 
2. Een visolieverrijkt dieet leidt bij de muis tot miltvergroting door accumulatie 
van macrofagen in de rode pulpa en de marginale zone. 
3. Wanneer mensen dagelijks placebocapsules of capsules met verschillende hoeveel­
heden visolie consumeren, is hun ex-vivo cytokinenproductie capaciteit na 1 jaar 
onafhankelijk van het soort capsules dat zij hebben geslikt. 
4. In relevante proefdiermodellen is remming van de productie van pro-
inflammatoire cytokinen nadelig voor het beloop van experimentele infecties. 
5. Regulier overleg tussen clinici, medisch microbiologen en ziekenhuisapothekers 
is een voorwaarde om te komen tot een rationeel antibioticabeleid. 
6. Bij tevoren gezonde jonge volwassenen die in aansluiting aan een keelontsteking 
hoge koorts ontwikkelen dient het syndroom van Lemierre in de differentiaal 
diagnose betrokken te worden (Blok et aL Ned Tijdschr Geneeskd 1993; 137:1013-
1016). 
7. Multidisciplinaire geneeskunde leidt gemakkelijk tot fragmentarische 
geneeskunde. 
8. De onverschilligheid van de overheid die het artsen toestaat om homeopathische 
middelen voor te schrijven staat in schril contrast tot de zorgvuldigheid van de 
procedure om tot registratie van een nieuw geneesmiddel te komen. 
9. Eventuele negatieve effecten van de eigen bijdrage kunnen wellicht worden 
tegengegaan door het uitreiken van Airmiles bij een eerste polikliniekbezoek. 
10. Vanuit het principe dat de vervuiler betaalt dient accijns geheven te worden op 
hondenvoer. 
11. De vouw in een spijkerbroek is een aarzeling tussen twee culturen. 
12. Nu zowel voorkeurspelling als voorkeursspelling zijn toegestaan, is er voor 
voorkeursspelling geen voorkeurspelling meer. 



